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Abstract
Melanocytes are specialized melanin-producing cells found in the skin, inner ear and heart.
Melanocyte abnormalities cause many human disorders, including pigmentation defects,
deafness, and melanoma. A better understanding of melanocyte biology is essential to address
those disorders. Integrin-linked kinase (ILK) is a ubiquitous scaffold protein, essential for
epidermal development. Importantly, the mechanisms by which ILK modulates the
development and functions of melanocytic lineage cells remains unknown. To help address
this void, I have developed cell-based models, as well as a reporter mouse model that allows
tamoxifen-inducible Ilk gene inactivation specifically in melanocytic cells.
I observed that inactivation of Ilk in first-wave melanoblasts significantly reduces their ability
to form long pseudopods, migrate and proliferate. As a result, they do not populate the
developing epidermis and hair follicles, normally. In post-natal melanocytes, ILK is required
for proliferation and formation of cell extensions. Rac1 activation in response to growth
factors, as well as Rac1-associated morphological changes in response to collagen-1 are
defective in the absence of ILK. Exogenous expression of constitutive active Rac1 restores, to
some degree, the formation of cell extensions. Thus, Rac1 functions downstream from ILK to
regulate melanocyte morphology.
Melanocytes synthesize melanin in vesicles termed melanosomes. The latter travel along
microtubule tracks to the tip of dendrites, where they are then transferred to neighbouring
keratinocytes. I have examined the role of ILK in melanosome trafficking and melanin transfer
to keratinocytes. In the absence of ILK, melanosome trafficking is abnormal, but is partially
restored following stabilization of microtubules. Thus, it is likely that the alterations in
melanosome movement are due to microtubule destabilization in the absence of ILK.
Furthermore, I have shown that dendrite formation and melanin transfer in response to
keratinocyte-secreted factors is severely reduced in the absence of ILK. Inhibition of GSK-3
partially restored dendricity, suggesting that ILK may be required to modulate GSK-3 activity
and promote dendrite formation. In summary, my data suggest key roles for ILK in
establishment of the melanocyte lineage, and for postnatal melanocyte functions.

ii

Lay Summary
Melanocytes are specialized cells found in the skin, inner ear, and heart. Their basic function
is to produce a protective pigment termed melanin. Alterations in melanocytes cause many
human disorders such as pigmentation defects, loss of vision and hearing, and melanoma. In
order to identify preventative therapies to address these disorders, we need to better understand
the molecular basis of these disorders. Integrin-linked kinase (ILK) is a scaffold protein
essential for maintaining skin homeostasis, but its role in melanocytes remains unexplored. My
studies explored how ILK regulates melanocyte development and functions.
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Chapter 1

1

Introduction and Current State of Knowledge

1.1 Structure and function of the skin
The skin is the largest organ of the human body (Sil et al., 2018). In mammals, the skin is
composed of the epidermis, dermis and hypodermis. The epidermis, which is the outermost
layer of the skin, is a stratified epithelium that contains keratinocytes, melanocytes and
immune cells (Koster and Roop, 2007; Yousef and Sharma, 2019). The epidermis is
separated from the dermis by a basement membrane mainly composed of extracellular
matrix (ECM) proteins (Fig. 1-1) (McMillan et al., 2003). The dermis is a thick layer that
functions as the main structural component of the skin. Fibroblasts are the primary cell type
in the dermis, and produce proteins such as collagens and elastin (Richmond and Harris,
2014). Skin appendages, such as hair follicles and sweat glands, as well as sensory neurons
and blood vessels, are found in the dermis (Fig. 1-1) (Yousef and Sharma, 2019).
Underneath the dermis is the hypodermis, which is the innermost layer of the skin and is
mainly composed of adipose tissue (Yousef and Sharma, 2019).
As the primary barrier between an organism and the environment, the skin is the body’s
first line of defense against both physical and chemical insults (Proksch et al., 2008). Other
functions of the skin include regulation of body temperature, water and electrolyte
retention, sensory perception and pigmentation (Yousef and Sharma, 2019). In the skin,
melanocytes are specialized melanin-producing cells (Fig. 1-1), which play key roles in
pigmentation and protection against UV radiation (Brenner and Hearing, 2008; Mort et al.,
2015).
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Epidermis

Basement
Membrane

Hair
Follicle

Dermis

Melanocytes

Figure 1-1. Structure of the skin.
The epidermis is separated from the dermis by the basement membrane. Skin appendages,
such as hair follicles, are found in the dermis.
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1.2 Embryonic origins of melanocytes
1.2.1

The neural crest

Melanocytes and their precursor cells, melanoblasts, arise from the neural crest (Li, 2014).
The neural crest is a transient structure unique to vertebrate embryos (Sauka-Spengler and
Bronner-Fraser, 2008). During gastrulation, the presumptive neural crest is induced at the
neural plate border in response to fibroblast growth factor (FGF), bone morphogenic
protein (BMP) and Wnt (Fig. 1-2A) (Bronner, 2012; Sauka-Spengler and Bronner-Fraser,
2008). These factors activate the expression of the transcription factor-encoding genes
Snail2, Sox10, FoxD3, and Pax3, which distinguish neural crest-derived cells from those
of other ectodermal domains (Ernfors, 2010). As the neural plate folds to form the neural
tube, pre-migratory neural crest cells reside within the elevating neural folds (Fig. 1-2B).
These neural crest cells respond to signals from the ECM, as well as from members of
transforming growth factor-b (TGFb) and FGF families, undergoing epithelial to
mesenchymal transition (EMT) (Simões-Costa and Bronner, 2015). In this manner, neural
crest cells delaminate from the neuroepithelium, and become a migratory cell population
(Fig. 1-2C, D) (Simões-Costa and Bronner, 2015). Neural crest cells are initially
multipotent, exhibit stem-cell-like properties and are highly motile (Bronner-Fraser and
Fraser, 1988). They migrate throughout the developing embryo, giving rise to smooth
muscle cells, craniofacial cartilage and bones, sensory neurons of the peripheral nervous
system, Schwann cells, and melanocytes in the skin (Mayor and Theveneau, 2013). The
behavior and migration of neural crest cells is strongly influenced by interactions with other
cell types and by signals from their surrounding environment (Bronner and LeDouarin,
2012).
There are four distinct populations of neural crest cells characterized by their location along
the anterior-posterior axis: cranial, vagal, truncal and sacral. Melanocytes are generated
from neural crest cells in the cranial and truncal regions (Mort et al., 2015). Multiple gene
regulatory networks are involved in melanocyte development. They include the SRY-box
factor-10 (SOX10), the paired box transcription factor-3 (PAX3), the basic helix-loophelix leucine zipper microphthalmia-associated transcription factor (MITF), as well as the
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receptor tyrosine kinase KIT (c-Kit) and its ligand Steel Factor (SCF) (Jackson, 1997).
Their role in melanocyte development will be discussed in the following sections.

1.2.2

Specification of melanoblasts from neural crest cells.

Melanocytes are formed as a result of the sequential specification of melanoblasts from
neural crest cells, their proliferation, migration and differentiation into pigment-producing
cells (Cichorek et al., 2013). In mice, delamination of neural crest cells from the neural
tube is complete by embryonic day (E) 10.5. These neural crest cells then embark on one
of two migration pathways that determine their fate: 1) a dorsolateral path, to adopt a
melanoblast fate, or 2) a ventral lateral path, giving rise to neurons, Schwann and glial
cells, or endoneural fibroblasts (Ernfors, 2010). A transcription factor that regulates the
lineage choice between these two pathways is FOXD3 (Thomas and Erickson, 2009).
FOXD3 is expressed in the neural tube and in migrating neural and glial precursors, but is
downregulated as neural crest cells become specified to the melanocyte lineage (Zaid
Alkilani et al., 2015)(Kos et al., 2001). In avian embryos, FOXD3 silencing results in an
increase in the number of melanoblasts at the expense of neuronal and glial lineages (Kos
et al., 2001). In addition, loss of FOXD3 function in mouse neural crest results in ectopic
expression of melanocyte markers in the developing nerves, suggesting a switch from glialfated cells to the melanoblast lineage (Nitzan et al., 2013). The proposed mechanism by
which FOXD3 regulates this lineage choice involves inhibition of Mitf transcription
(Thomas and Erickson, 2009). MITF is considered the master regulator of the melanocyte
lineage, as it is essential for the activation of several genes involved in melanoblast survival
and differentiation (Levy et al., 2006). One of the most abundant isoforms of MITF in
neural crest-derived melanocytes is MITF-M (hereafter termed MITF), whereas in the
retinal pigmented epithelium MITF-H and MITF-D are highly expressed (Bharti et al.,
2008; Shibahara et al., 2001). MITF is required to upregulate expression of Kit, which
encodes a receptor tyrosine kinase essential for melanoblast survival (Opdecamp et al.,
1997). MITF also promotes expression of the melanogenic enzymes tyrosinase (Tyr),
tyrosinase-related protein 1 (Trp1) and dopachrome tautomerase (DCT) (Ludwig et al.,
2004). In the absence of MITF, neural crest-derived melanocytes are almost completely
lost in mice, quail and zebrafish (Hodgkinson et al., 1993; Lister et al., 1999; Mochii et al.,
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1998; Opdecamp et al., 1997). Reciprocally, ectopic expression of MITF can induce
melanocytic characteristics in other cell types. For example, NIH/3T3 fibroblasts
transfected with MITF develop a dendritic morphology and express Tyr and Trp1
(Tachibana et al., 1996). MITF is the earliest marker of commitment to the melanocyte
lineage identified to-date (Goding, 2000). In mice, melanoblasts begin to express MITF
just prior to initiation of migration at E10.5 (Mort et al., 2015). In addition to FOXD3, the
transcription factors PAX3 and SOX10 directly regulate the expression of MITF during
melanoblast specification (Medic and Ziman, 2009). SOX10 activates the Mitf promoter,
and this activation is enhanced by PAX3 (Potterf et al., 2000; Watanabe et al., 1998). Mice
homozygous for inactivating mutations in either Pax3 or Sox10 exhibit severely reduced
melanoblast numbers, underlining their central roles in the generation of melanocytic
lineage cells (Goding, 2000; Hornyak et al., 2001; Medic and Ziman, 2009; Potterf et al.,
2000; Watanabe et al., 1998).

1.2.3

Melanoblast migration

In vertebrates, melanoblasts are generated from neural crest cells that migrate along two
distinct paths (Fig. 1-3)(Mort et al., 2015). Following delamination from the neural tube, a
subset of neural crest cells become specified as melanoblasts as described above and
embark along a dorsolateral migration route, around E10.5-E11. A second wave of
melanoblast formation occurs after neural crest cells that migrated along a ventral path
detach from nerve endings and become melanoblasts (Adameyko et al., 2009; Mort et al.,
2015). By E15.5, melanoblasts from both waves populate the basal layer of the epidermis
and by E16.5 they additionally localize to the developing hair follicles (Mort et al., 2015).
Around birth, a subset of melanoblasts differentiate into melanocytes to provide pigment
to the hair shaft during the first hair follicle cycle. Other melanoblasts form a stem cell
population that gives rise to mature melanocytes throughout postnatal life (Mort et al.,
2015).
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Figure 1-2. Vertebrate neural crest cell development.
(A) The presumptive neural crest is induced at the neural plate border. (B) As the neural
tube is formed, pre-migratory neural crest cells reside within the elevating neural folds. (C)
Neural crest cells undergo epithelial-to-mesenchymal transition (EMT), and delaminate
from the neuroepithelium. (D) Neural crest cells migrate to populate to a variety of tissues.
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Figure 1-3. Development of the melanocyte lineage.
Following delamination from the neural tube, neural crest cells migrate along the
dorsoventral pathway (black arrow), to give rise to nerves associated with the dorsal root
ganglia (DRG), and the dorsolateral pathway (red arrow), to give rise to MITF-expressing
melanoblasts. During the first wave of melanoblast formation and following specification,
melanoblasts pause in the migration staging area (MSA) adjacent to the neural tube, where
they receive proliferation and survival signals. Melanoblasts migrate between the somites
and the ectoderm towards the skin. During the second wave of melanoblast formation,
Schwann cell precursors detach from nerve endings, migrate along the ventral lateral
pathway (green arrow) and differentiate into melanoblasts. Following their colonization
of the skin melanoblasts differentiate into melanocytes. NT, neural tube; S, somite; N,
notochord: MITF, microphthalmia-associated transcription factor; DCT, dopachrome
tautomerase; TYR, tyrosinase; Trp1, tyrosinase-related protein 1.
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1.2.3.1

First wave of melanoblast formation

Melanoblasts migrating along the dorsolateral pathway require the receptor tyrosine kinase
c-Kit and its growth factor ligand SCF for survival, motility and proliferation (WehrleHaller and Weston, 1995; Yoshida et al., 1996). Inactivating mutations in the genes
encoding either c-Kit or SCF result in cutaneous pigmentation defects (Moore and Larue,
2004). SCF is expressed as two different splice-variants. One remains associated with the
cell membrane, whereas the larger variant (termed soluble SCF) contains an extracellular
proteolytic cleavage site allowing it to be released from the cell surface (Flanagan et al.,
1991). The two variants have distinct functions in melanocyte development (Wehrle-Haller
and Weston, 1995). Just prior to migration, melanoblasts pause in a region known as the
migration staging area (MSA, Fig. 1-3). Activation of c-Kit by soluble SCF is required for
melanoblast survival in the MSA and to initiate migration along the dorsolateral pathway
(Wehrle-Haller and Weston, 1995). On the other hand, membrane bound SCF is essential
for survival of melanoblasts once they localize to the dermis (Wehrle-Haller and Weston,
1995).
During their migration, melanoblasts encounter different microenvironments such as the
dermal mesenchyme along the dorsolateral path, the epidermis, and eventually the hair
matrix (Nishimura et al., 1999). Throughout these complex environments, the adhesion
properties of melanoblasts are regulated by different cadherin-mediated cell-cell junctions
(Nishimura et al., 1999). At E11.5, melanoblasts are E-and P-cadherin negative, but over
the next few days, they alter their cadherin profile to match that of keratinocytes or
fibroblasts, which help localize them to specific sites. For example, E- and P-cadherin
negative melanoblasts remain in the dermis. Melanoblasts with high E-cadherin and low
P-cadherin expression are retained in the interfollicular epidermis, whereas those with high
E-cadherin and medium-high P-cadherin levels associate with keratinocytes in the hair
follicles (Nishimura et al., 1999). Chemokines also play a very important role in guiding
melanoblasts to their correct location during migration. Stromal cell-derived factor 1 (SDF1) secreted by hair follicle cells is an important chemokine that binds chemokine receptor
4 (CXCR4) receptors in melanoblasts, directing them towards the hair follicles (Belmadani
et al., 2009). In the skin of CXCR4-deficient mice or in skin explants treated with a CXCR4
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antagonist, there is an increase in the number of melanoblasts concentrated in the epidermis
(Belmadani et al., 2009). Melanoblasts also instruct each other through cell-cell contact, so
that two melanoblasts cannot occupy the same physical space, thus allowing their even
distribution throughout the skin (Laurent-Gengoux et al., 2018).

1.2.3.2

Second wave of melanoblast formation

Cutaneous melanocytes are also generated by other progenitors, in addition to neural crest
cells migrating along the dorsolateral path. Indeed, a second wave of melanoblast
formation occurs at E14.5 in mice (Adameyko et al., 2009; Mort et al., 2015). Schwann
cell precursors generated from neural crest cells that migrated along the ventral lateral
pathway detach from nerve endings and differentiate into melanoblasts (Fig. 1-3) (Huszar
et al., 1991; Wilkie et al., 2002). As much as 65% of cutaneous melanocytes are estimated
to derive from Schwann cell precursors (Adameyko et al., 2009).

1.2.3.3

Molecular mechanisms regulating melanoblast migration

Melanoblasts migrate using fundamental molecular processes involved in cell movement
(Mort et al., 2015; Petit and Larue, 2016). To migrate, melanoblasts extend protrusions that
form both short stubs and long pseudopods (Laurent-Gengoux et al., 2018). The small
GTPase Rac1 is necessary for the formation of long pseudopods. Rac1 promotes F-actin
assembly through activation of the Scar/WAVE and ARP2/3 complexes. Deletion of Rac1
from the melanocyte lineage results in mouse coat color defects, due to decreased
formation of protrusions and impaired migration (Li et al., 2011). Additionally, Rac1-null
melanoblasts show defects in cell-cycle progression, demonstrating a role for Rac1 in
melanoblast proliferation (Li et al., 2011). Proteins that regulate Rac1, including the Rac1
guanine nucleotide exchange factor P-Rex1, are also essential for melanoblast migration
and homing to the skin (Lindsay et al., 2011). The importance of other Rho family
GTPases, such as Cdc42 in establishment of the melanocyte lineage has also been shown.
Melanocyte-specific deletion of Cdc42 resulted in mouse coat color defects. Cdc42deficient melanoblasts exhibited an elongated morphology, which is different from that of
Rac1-null melanoblasts, which are round and lacked protrusions. However, Cdc42-null
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cells were also unable to organize Arp2/3 and Scar/WAVE complexes and showed defects
in migration (Woodham et al., 2017).

1.3 Postnatal melanocytes
The last step in melanocyte development is the differentiation of melanoblasts into mature
melanocytes. A key feature that marks the differentiation of melanoblasts is the production
of melanin, which begins around birth (Hirobe, 1984). Melanocytes express specific
proteins involved in melanin synthesis and storage, including MITF, Tyr, Trp1, DCT, as
well as the melanosome-associated proteins Pmel17 and Melan-A (MART-1) (Plonka et
al., 2009). A defining characteristic of melanocytes is the formation of multiple cell
extensions, called dendrites, which allow their interactions with neighbouring
keratinocytes and fibroblasts in the skin (Cichorek et al., 2013). In mice, the number of
epidermal melanocytes peaks on postnatal day 4, with approximately 95 cells/0.1 mm2 in
dorsal skin and 25 cells/0.1 mm2 in ventral skin (Hirobe, 1984). After that time, the number
of epidermal melanocytes rapidly declines, and no interfollicular melanocytes are detected
in the dorsal and ventral skin in adult mice, with the exception of the ear, nose and tail
(Hirobe, 1984). In humans, both interfollicular and follicular melanocytes are present in
adult skin (Mort et al., 2015).

1.3.1

Melanocytes in the interfollicular epidermis

Melanocytes account for 8-10% of the cells in the basal epidermal layer (Tang et al., 2014).
Through their dendritic extensions, melanocytes can simultaneously interact with up to 3040 keratinocytes, forming what is known as an “epidermal-melanin unit” (Fitzpatrick and
Breathnach, 1963). This close association allows melanocytes to transfer melanin to
keratinocytes (Cichorek et al., 2013; Mort et al., 2015). Keratinocytes regulate melanocyte
functions through different pathways that include cell-cell and cell-matrix adhesion (Haass
et al., 2005). Melanocyte expression of E-cadherin is essential for adhesion to keratinocytes
(Tang et al., 1994). Keratinocytes and dermal fibroblasts also secrete many factors that
regulate melanocytes in a paracrine manner. For example, a-melanocyte stimulating
hormone (a-MSH) and adrenocorticotropic hormone (ACTH) secreted by keratinocytes
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stimulate melanin production and dendrite formation in melanocytes by activation of the
melanocortin-1 receptor (MC1R) expressed on melanocytes (Slominski et al., 2000).
Endothelin-1 (ET1) increases tyrosinase activity through activation of protein kinase C
(PKC) and protein kinase A (PKA) (Imokawa et al., 1997). ET1, granulocyte-macrophage
colony-stimulating factor (GM-SCF) and basic fibroblast growth factor (bFGF) increase
melanocyte proliferation through activation of the mitogen activated protein kinase
(MAPK)/ERK pathway (Halaban et al., 1988; Hara et al., 1995; Imokawa et al., 1996).
Dermal fibroblasts secrete soluble SCF, which can bind to Kit, stimulating proliferation
via MAPK/ERK signalling (Wang et al., 2017). These interactions among melanocytes,
keratinocytes and fibroblasts are essential for skin pigmentation and photoprotection.

1.3.2

Mature melanocytes and melanocyte stem cells in the hair
follicle

Once melanoblasts reach the hair follicle, some of them differentiate into mature
melanocytes, to provide melanin to the hair shaft during the first hair follicle cycle. Other
melanoblasts adopt a stem cell fate (Nishimura, 2011a). Mature melanocytes are located in
the hair bulb matrix that surrounds the dermal papilla (Fig. 1-4). The ratio of melanocytes
to keratinocytes in the epidermis is about 1:10, but in hair follicles the ratio is about 1:5
(Slominski et al., 2005a). Hair follicle melanocytes are also larger and more dendritic
(Slominski et al., 2005a). Melanin production in the epidermis is continuous, but in the hair
follicle melanin synthesis is tightly coupled to the hair cycle. During anagen, the growth
phase of the hair follicle, melanocytes transfer melanin to adjacent keratinocytes that form
the hair shaft (Slominski et al., 2005a). During catagen, which is characterized by hair
follicle regression, melanocytes die through apoptosis. Melanocyte stem cells are activated
in the subsequent anagen phase, and give rise to new mature melanocytes (Slominski and
Paus, 1993).
Melanocyte stem cells are located in the bulge region of the hair follicle (Fig. 1-4). No
specific molecular markers for melanocyte stem cells have been identified to-date. Instead,
they are characterized by their morphology, location in the bulge region, low proliferative
levels, reduced expression of c-Kit and MITF, and absence of pigment (Nishimura et al.,
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2002; Ueno et al., 2014). Melanocyte stem cells remain quiescent until activated in anagen
(Nishimura, 2011a). Activation of melanocyte stem cells is associated with upregulation
of melanogenic genes. They also form multiple dendrites and undergo cell division
(Nishimura et al., 2002). By mid-anagen, melanocyte stem cells downregulate melanogenic
enzymes and return to a quiescent state (Nishimura et al., 2005). The melanocyte stem cell
progeny formed during anagen then differentiates into melanin-producing melanocytes in
the hair matrix (Nishimura, 2011b).
Maintenance of melanocyte stem cells is critical for normal hair pigmentation, and loss of
melanocyte stem cell function results in hair graying (Harris et al., 2013). Although Sox10
is expressed in both melanocyte stem cells and mature melanocytes of the hair bulb, the
two cell types uniquely regulate its levels (Harris et al., 2013). To maintain their selfrenewal capacity, melanocyte stem cells express low levels of Sox10, through a negative
feedback loop that involves MITF (Harris et al., 2013). Transcriptional downregulation of
Sox10 is a proposed mechanism by which embryonic melanoblasts migrating into hair
follicles acquire a melanocyte stem cell fate (Harris et al., 2013). On the other hand,
melanoblasts that localized to the bulb region maintain high levels of Sox10 and undergo
differentiation (Harris et al., 2013).
Melanocyte stem cells are also regulated by interactions with hair follicle stem cells located
in the bulge region. Hair follicle stem cells provide a niche for melanocyte stem cells that
is dependent on TGFb signalling. TGFb secreted by hair follicle keratinocyte stem cells
activates TGFb signalling in melanocyte stem cells, and promotes their immaturity through
downregulation of MITF (Nishimura et al., 2010; Tanimura et al., 2011). If TGFb
signalling from hair follicle stem cells is disrupted, melanocyte stem cells are depleted and
progressive hair greying occurs (Tanimura et al., 2011).
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Figure 1-4. Distribution of postnatal melanocytes in the skin.
In the skin, mature melanocytes are located in the basal layer of the epidermis and in the
bulb region of the hair follicle. Melanocyte stem cells are located in the bulge region.
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1.4 Melanin biosynthesis and melanosomes
A major function of postnatal melanocytes is melanin production. The synthesis of melanin
generates toxic intermediates such as quinones and hydrogen peroxide. For this reason,
pigment cells have developed the ability to produce melanin within the lumen of
specialized organelles termed melanosomes, thus reducing cell exposure to those toxic
intermediates (Cichorek et al., 2013).

1.4.1

Biological properties of melanin

Melanin is a complex polymer derived from tyrosine (Park et al., 2009). Melanin
production is one of the most widespread adaptations of living organisms. From simple
invertebrates to humans, melanin is used for camouflage, heat regulation, pigmentation,
and protection against damage from exposure to UV radiation (Costin and Hearing, 2007).
For the latter, melanin absorbs UV light and converts it into heat, which is a much less
toxic form of energy (Park et al., 2009). In humans, melanin is the main determinant of
eye, hair, and skin color. Interestingly, the number of melanocytes is similar across
different ethnicities. Phenotypic diversity in pigmentation is instead due to differences in
the type of melanin produced, the number and composition of melanosomes, and the
amount of melanin transferred to keratinocytes (Lin and Fisher, 2007). There are two types
of melanin: eumelanin that is a brown-black insoluble polymer and pheomelanin, which is
a yellow-red soluble polymer (Ito and Wakamatsu, 2003). Melanin content in human skin
is inversely related to the incidence of skin carcinomas and melanomas (Rouzaud et al.,
2005). Dark skin contains more eumelanin than fair skin, and individuals with dark skin
are less likely to develop skin cancer (Brenner and Hearing, 2008). In contrast,
pheomelanin is produced more in individuals with light skin who show a significantly
increased prevalence of basal and squamous cell carcinoma, as well as melanoma (Rouzaud
et al., 2005). Eumelanin is more efficient at protecting against UV light-induced damage
because of its increased resistance to degradation and superior ability to reduce ROS
(Kadekaro et al., 2003).
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1.4.2

Melanosome biogenesis

Melanosomes are lysosome-related organelles, but they have a unique structure and
specific proteins. Melanosomes undergo four distinct stages of maturation that are
characterized based on morphology. Stage 1 pre-melanosomes are immature as they do not
contain melanin. They are identified by the presence of unorganized proteinaceous fibres
within intraluminal vesicles. In stage II melanosomes, the melanosome-specific
glycoprotein Pmel17 initiates striation of the unorganized fibres. Stage III melanosomes
contain melanin deposited on the internal fibres, which contributes to the darkening of
melanosomes. By stage IV, melanin completely masks the internal structures of
melanosomes (Berson et al., 2001; Marks and Seabra, 2001). Progression of melanosomes
through the biogenesis pathway is accompanied by differential enrichment of melanosomal
proteins (Raposo et al., 2001a). For example, Pmel17 is highly enriched in stage I and II
melanosomes, but by stage IV the levels of Pmel17 significantly decrease. On the other
hand, Trp1 is almost undetectable in stage I and II organelles and is mainly associated with
stages III and IV (Raposo et al., 2001b). Different stages of melanosomes can also be
identified by their association with Rab GTPases. Rab7 mainly associates with stage I and
II melanosomes, whereas Rab27a is mainly associated with stage III and IV melanosomes
(Jordens et al., 2006).

1.4.3

Melanogenic enzymes

Following the formation of stage II melanosomes, the melanogenic enzymes Tyr, Trp1 and
DCT (also known as Trp2) are delivered to these organelles. Tyr is a glycoprotein localized
to the melanosomal membrane (Park et al., 2009). Tyr is composed of an inner catalytic
domain that contains histidine residues to bind copper ions that are necessary for its
function, a transmembrane domain, and a cytoplasmic domain (Park et al., 2009). Trp1 and
Trp2 share 40% amino acid homology with Tyr and are also found spanning the
melanosome membrane (Videira et al., 2013). Trp1 forms a complex with Tyr and has been
suggested to play a role in activating and/or stabilizing Tyr (Kobayashi et al., 1998; Orlow
et al., 1994). The cytoplasmic domains of Tyr and Trp1 contain membrane-proximaldileucine-based targeting signals, which target them to stage II melanosomes (Calvo et al.,
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1999; Vijayasaradhi et al., 1995). These enzymes also interact with Adaptor Protein (AP)
complexes that function to transport them to melanosomes (Sitaram and Marks, 2012).

1.4.4

Melanin biosynthesis pathway

Tyr, Trp1 and Trp2 control the biosynthetic pathway that produces melanin, which is
illustrated in Fig. 1-5. The first and rate-limiting step of melanogenesis is the hydroxylation
of tyrosine to L-3,4-dihydroxyphenylalanine (DOPA), which is rapidly oxidized to
DOPAquinone, and both reactions are catalyzed by Tyr. DOPAquinone can give rise to
pheomelanins, or spontaneously rearrange to form DOPAchrome, which rapidly loses a
carboxy group and generates 5,6-dihydroxyindole (DHI). The latter undergoes oxidization
and polymerization, yielding dark brown-black DHI-melanin. In the presence of Trp2,
DOPAchrome is converted into DHI-2-carboxyclic acid (DHICA). Tyr and Trp1 then
convert DHICA to lighter brown DHICA-melanin (Cichorek et al., 2013).

1.4.5

Regulation of melanin biosynthesis

Melanin production is modulated by paracrine signals from factors secreted by
neighbouring keratinocytes and dermal fibroblasts (Park et al., 2009). The principal
pathways that regulate melanin production are described below and are illustrated in Figure
1-6.

1.4.5.1.1

Melanocortin 1 receptor

The melanocortin 1 receptor (MC1R) is a G-protein coupled receptor (GCPR) localized in
the melanocyte plasma membrane. Signalling from MC1R is key for melanin biosynthesis
(D’Mello et al., 2016). MC1R is activated by a-MSH and ACTH, which are both secreted
by keratinocytes. Upon UV radiation-induced DNA damage, p53 activity increases in
keratinocytes, promoting transcription of the POMC gene. POMC encodes proopiomelanocortin, which is the precursor for a-MSH and ACTH (Cui et al., 2007).
Binding of a-MSH or ACTH to MC1R results in activation of adenylyl cyclase and a
subsequent increase in cAMP levels. The latter leads to the activation of PKA, which
phosphorylates and activates the transcription factor CREB. CREB translocates to the
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nucleus and binds the cAMP response element (CRE) in the MITF promoter, activating
MITF expression. MITF in turn upregulates Tyr, Trp1 and Trp2 expression, resulting in
the synthesis of eumelanin (Fig. 1-6) (Luger et al., 1997; Rouzaud et al., 2005).
Agouti signalling protein (ASP) is the only known naturally-occurring antagonist of MC1R
(Videira et al., 2013). It negatively regulates MC1R signalling by competing with a-MSH
for binding to this receptor. ASP is expressed in both humans and mice, although its role
in human pigmentation is not fully understood (Park et al., 2009). During mouse hair
follicle development there is a brief time during which MC1R signalling is inhibited.
During this time, pheomelanin is produced instead of eumelanin. This produces a yellow
band on an otherwise dark hair, which is known as the agouti phenotype in mice (Walker
and Gunn, 2010). Expression of the human agouti gene in transgenic mice produces a
yellow coat color. Additionally, expression of human ASP in mouse melanoma cells
competes with a-MSH and inhibits MC1R signalling. Thus, human ASP may have a
similar role as its mouse counterpart in the synthesis of pheomelanin (Wilson et al., 1995).
The human gene that encodes MC1R is highly polymorphic. To-date, over 200
nonsynonymous coding region variants and 50 single nucleotide polymorphisms (SNPs)
have been identified in Caucasian populations (Herraiz et al., 2017). These variants are a
major determinant of skin and hair color in different ethnic backgrounds. At least 9 of the
variants are loss-of-function mutations. Some variants result in an impaired ability of
MC1R to promote cAMP formation upon a-MSH binding, whereas others are completely
incapable of binding to a-MSH. There are three variants Arg151Cys, Arg160Trp and
Asp294His, also known as the “red-hair-color” alleles, that are mainly associated with red
hair, fair skin, a poor tanning ability and increased susceptibility to carcinoma formation
(Schaffer and Bolognia, 2001). In contrast, there is little variation in the MC1R coding
region in African populations, which suggests selection imposes strong constraint on
MC1R to maintain high levels of eumelanin production (Rana et al., 1999).
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Figure 1-5. Melanin biosynthesis.
Tyr catalyzes the conversion of tyrosine to DOPA, and then subsequently oxidizes DOPA
to DOPAquinone. DOPAquinone can is converted into both pheomelanins or eumelanins.
DOPA, L-3,4-dihydroxyphenylalanine; DHI, 5,6-dihydroxyindole; DHICA, DHI-2carboxyclic acid; Tyr, tyrosinase; Trp1, tyrosinase-related protein 1; DCT, dopachrome
tautomerase.
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1.4.5.1.2

Keratinocyte modulation of melanocyte responses

Melanocytes express both a1 and b2 adrenergic receptors (a1-AR and b2-AR, respectively).
Catecholamines, such as epinephrine and norepinephrine, are the endogenous ligands for
adrenergic receptors. Epidermal melanocytes produce norepinephrine, but are unable to
synthesize epinephrine (Gillbro et al., 2004). Melanocyte-derived norepinephrine binds to
a1-AR, leading to an increase in diacylglycerol, activation of PKC-b and stimulation of
tyrosinase activity through phosphorylation of residues in its cytoplasmic domain (Park et
al., 1999). In response to UVB irradiation, keratinocytes secrete epinephrine that binds to
melanocyte adrenergic receptors and increases melanin synthesis via the cAMP pathway
(Fig. 1-6) (Grando et al., 2006; Sivamani et al., 2009).
SCF/c-Kit signalling regulates both melanocyte development and melanin biosynthesis.
Following UVB irradiation, keratinocytes and melanocytes, upregulate expression of SCF
and Kit, respectively (Hachiya et al., 2001). Keratinocyte-secreted SCF binds to c-Kit on
melanocytes, and results in receptor autophosphorylation and activation of MAPKs. The
latter phosphorylate and activate MITF, inducing transcription of melanogenic enzymes
and synthesis of eumelanin (Fig. 1-6).
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Figure 1-6. Mechanisms regulating melanin synthesis.
Following ultraviolet radiation (UVR)-induced DNA damage, keratinocytes secrete
paracrine factors that stimulate melanin synthesis. Melanin is transferred to keratinocytes
through the protease-activated receptor 2 (PAR2) expressed on keratinocytes. Within
keratinocytes, melanosomes form a perinuclear cap and protect DNA from further UVinduced damage. POMC = proopiomelanocortin, a-MSH = alpha melanocyte stimulating
hormone, ACTH = adrenocorticotropic hormone, MC1R = melanocortin receptor 1, cAMP
= cyclic adenosine monophosphate, PKA = protein kinase A, CREB = cyclic AMP
response element binding protein, CRE = cre response element, MITF = microphthalmiaassociated transcription factor, Tyr = tyrosinase, Tyr 1 and 2 = tyrosinase-related proteins
1 and 2, PAR2 = protease activated receptor 2, SCF = stem cell factor, b2-AR = b2adrenorecptor.
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1.4.6

Melanosome transport

Melanosomes can travel bidirectionally with fast or slow kinetics along microtubule tracks
prior to becoming associated with the actin cytoskeleton at dendritic tips (Bruder et al.,
2012; Wu et al., 1998). Kinesin and dynein are the microtubule-based motors that transport
mature melanosomes towards the cell periphery (centrifugal motion) or back towards the
nucleus (centripetal motion), respectively (Fig. 1-7) (Hume and Seabra, 2011). The
coupling of melanosomes to the actin cytoskeleton at the cell membrane occurs through
the coordinated actions of proteins that constitute the “capture complex” (Wasmeier et al.,
2008). In the absence of any of these proteins, melanosomes accumulate in perinuclear
regions, where microtubule networks are most abundant. The actin-based motor protein
Myosin-Va, Rab27a and melanophilin are essential for capture of melanosomes from
microtubules to cortical F-actin (Huang et al., 1998; Matesic et al., 2001; Wilson et al.,
2000). Rab27a is necessary to recruit Myosin-Va to mature melanosomes and link them to
the actin fibres found at dendritic tips (Wu et al., 2001). Melanophilin binds simultaneously
to Rab27a and MyosinVa through its N-terminal and first C-terminal coiled-coil domains,
respectively (Nagashima et al., 2002), allowing for the formation of a tripartite complex
necessary for normal melanosome trafficking (Fig 1-7) (Wu et al., 2002). Of note, MyosinVa also plays a role in centrifugal melanosome transport, together with kinesin.
Specifically, Myosin-Va transports melanosomes along dynamic F-actin tracks whose plus
(or barbed) ends are oriented towards the plasma membrane (Evans et al., 2014).

1.4.7

Melanin transfer to keratinocytes

The tips of melanocyte dendrites are the primary sites of melanin transfer to neighbouring
keratinocytes, through poorly understood mechanisms. Putative transfer mechanisms that
have been proposed include (i) cytophagocytosis of melanocyte dendrites containing
melanosomes by keratinocytes, (ii) shedding of melanosome-loaded exosomes and their
phagocytosis by keratinocytes, (iii) direct fusion of melanocyte and keratinocyte plasma
membranes and (iv) exocytosis of melanin granules into the intercellular space followed
by phagocytosis by keratinocytes (Bossche et al., 2006).

21

N

N
Microtubule Track

Melanosome

Actin Filaments

Rab27a

MyosinVa

Melanophilin

Kinesin

Dynein

Melanocyte

Keratinocyte

Figure 1-7. Melanosome transport.
Mature melanosomes are transported bidirectionally along microtubule tracks by Kinesin
and Dynein. At the plasma membrane, Rab27a together with melanophilin and Myosin-Va
couple melanosomes to actin filaments. Melanin is transferred to neighbouring
keratinocytes and accumulates in the perinuclear region.
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Although it is possible that melanin transfer occurs through combinations of different
mechanisms, there is substantial evidence that supports the exocytosis of melanin granules
into the intercellular space followed by phagocytosis by keratinocytes (Delevoye, 2014).
Keratinocytes, but not fibroblasts, induce melanin exocytosis by melanocytes in co-culture
conditions (Tarafder et al., 2014). It has been demonstrated that keratinocytes phagocytose
melanin, and this process is enhanced by treatment with aMSH or UV-radiation (Virador
et al., 2002). In keratinocytes, melanin uptake by phagocytosis is mediated by the PAR2
and the KGF receptors (Fig. 1-6) (Correia et al., 2018; Seiberg et al., 2000). PAR2
upregulation is induced by UVB, and PAR2 inhibition interferes with UV-induced
increases in pigmentation (Seiberg, 2001). Furthermore, melanin granules phagocytosed
by keratinocytes contain a single membrane that lacks melanosome membrane markers,
such as Trp1 (Tarafder et al., 2014). Together, these data support the idea that exocytosis
of melanin granules by melanocytes and their subsequent phagocytosis by keratinocytes is
a major mechanism by which melanin transfer occurs in the skin. Once melanin is
transferred to keratinocytes, it accumulates in the supranuclear region as a protective
parasol against DNA damage induced by UV-radiation (Fig. 1-6) (Correia et al., 2018).

1.5 Diseases associated with abnormalities in melanocytic
lineage cells
Understanding the ontogeny and biology of melanocytes is essential to developing new
therapies for pigmentation disorders and melanoma (Mort et al., 2015). Over 350 genetic
loci involved in pigmentation have been identified in mice, and many of them are mutated
in humans who present with pigmentation disorders. Some of the most common and/or
important disorders are discussed below (Yamaguchi and Hearing, 2014).

1.5.1

Waardenburg syndrome

Waardenburg syndrome is characterized by loss of melanocytes in the skin, hair, eyes and
ears. Its prevalence is 1/42,000 and accounts for 1-3 % of all congenital deafness (Issa et
al., 2017). Waardenburg syndrome Types I and III are caused by inactivating mutations in
PAX3. Type II generally involves mutations in MITF or SOX10. Type IV is caused by
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inactivating mutations in SOX10, and is characterized by deafness, depigmentation and
intestinal aganglionosis (also called Hirschsprung disease) (Bondurand et al., 2007;
Pingault et al., 2010; Read and Newton, 1997).

1.5.2

Oculocutaneous albinism

Oculocutaneous albinism (OCA) is a rare inherited disorder characterized by a reduction
or complete lack of melanin in hair, skin and eyes (Kamaraj and Purohit, 2014). In OCA,
reduced melanin increases sensitivity to UV radiation and is associated with a higher
susceptibility to skin cancer (Oetting and King, 1999). Inactivating mutations in TYR cause
OCA1, in which melanin is completely absent. Some mutations produce Tyr enzyme with
residual activity, and individuals affected present a spectrum of skin, hair and eye pigment
abnormalities, classified as OCA1B (Oetting and King, 1999). OCA2 is the most prevalent
form of albinism, in which individuals are born with some pigment, but the skin usually
lacks the ability to tan. OCA2 arises from of a mutation in the OCA2 gene, which encodes
a protein that is localized to the melanosome membrane and is involved in tyrosine
transport. The incidence of OCA2 is 1:37,000 in Caucasians, 1:15,000 in African
Americans and 1:3,900 in Southern Africans of Bantu-speaking origin (Ramsay et al.,
1992; Witkop et al., 1972). OCA3 is caused by inactivating mutations in Trp1, and is
characterized by minimal pigmentation at birth, but somewhat increased pigmentation as
individuals age (Manga et al., 1997).

1.5.3

Hermansky-Pudak syndrome

Hermansky-Pudak Syndrome (HPS) results from defects in melanosomes, platelet dense
bodies and lysosomes, which cause OCA, prolonged bleeding (due to platelet storage pool
deficiency) and ceroid deposition. In HPS mice, hypopigmentation has been linked to
defects in melanosome maturation and/or melanin transfer (Nguyen et al., 2002). HPS has
been associated with known mutations in the genes that encode AP3 and BLOC-1, -2 and
-3, involved in the trafficking of proteins to melanosomes (Di Pietro and Dell’Angelica,
2005; Wei, 2006; Wei et al., 2013). HPS is extremely debilitating, it often leads to
premature mortality, and has no treatment at present (Zatik et al., 2002).
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1.5.4

Chediak-Higashi syndrome

Chediak-Higashi Syndrome (CHS) is a rare autosomal recessive disorder that causes
albinism (Helmi et al., 2017). Mutations in the CHS1 gene, which encodes a lysosomal
trafficking regulatory gene, cause CHS, resulting in decreased fission of lysosomes and
most likely other lysosome-related organelles, such as melanosomes, although its exact
function in this process is poorly understood (Sitaram and Marks, 2012). A hallmark of
CHS is the presence of large cytoplasmic granules within granulocytes and other cell types
that contain lysosomal enzymes and are peroxidase positive, suggesting they are enlarged
lysosomes, or in the case of melanocytes, enlarged melanosomes (Introne et al., 1999).
Currently, there is no cure for CHS and patients often die within the first decade of life due
to infection and bleeding.

1.5.5

Griscelli syndrome

Griscelli syndrome is another rare autosomal recessive genetic disorder characterized by
partial albinism, as well as neurological and immunological defects (Yamaguchi and
Hearing, 2014). Silvery grey hair, hypopigmented skin and accumulation of melanosomes
within melanocytes are the most prominent features. Mutations in MYO5A, Rab27a and
MLPH cause the syndrome subtypes GS1, GS2, and GS3, respectively (Minocha et al.,
2017). Myosin-Va is highly expressed in the brain, and individuals with GS1 present with
central nervous system defects without involvement of the immune system (Ridaura-Sanz
et al., 2018). GS2 involves severe immunological defects and patients often develop
recurrent infections due to the role of Rab27a in controlling cytotoxic granule exocytosis,
a key function of the immune system (Ménasché et al., 2000). GS3 results in partial
albinism as a mutation in melanophilin prevents binding of melanosomes to the actin
cytoskeleton and optimal exocytosis (Minocha et al., 2017; Ridaura-Sanz et al., 2018). The
prognosis of patients with GS1 depends on the extent of central nervous system
abnormalities, whereas the most common subtype GS2 is often fatal (Minocha et al., 2017).
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1.5.6

Vitiligo

Vitiligo is the most common pigmentation disorder, affecting 0.5-1% of the total
population in the world (Ezzedine et al., 2012). It is an acquired pigmentation disorder that
causes selective destruction of melanocytes (Yamaguchi and Hearing, 2014). Vitiligo is
identified by patchy skin pigmentation. Although the underlying mechanisms are poorly
understood, vitiligo is thought to be a multifactorial disease that results from genetic
predisposition, autoimmune destruction of melanocytes, free radical-mediated melanocyte
damage, impaired melanocyte adhesion and environmental factors (Bishnoi and Parsad,
2018). The immune component in the etiology of this disease is based on its association
with other autoimmune disorders such as thyroiditis (Gey et al., 2013). The skin of vitiligo
patients contains activated cytotoxic T lymphocytes found in close proximity to
disappearing melanocytes (Ogg et al., 1998). Interventions for vitiligo include topical
treatments, phototherapies and surgery, which aim at restoring pigmentation by inducing
T-cell apoptosis, as well as by stimulating proliferation and/or migration of melanocytes in
the adjacent healthy skin or melanocyte stem cells in hair follicles (Esmat et al., 2017).
There is no cure for vitiligo, and therapy effectiveness varies greatly among patients
(Ezzedine et al., 2015).

1.5.7

Melanoma

Disruption of the normal balance in the epidermal-melanin unit can result in dysregulated
proliferation of melanocytes and development of melanoma (Haass et al., 2005).
Melanomas are extremely metastatic skin tumours that account for the majority of skin
cancer-related deaths in Canada and the United States (Gershenwald and Guy, 2016).
Metastatic melanoma is highly aggressive, with a 5-year survival rate of only ~14%
(Bandarchi et al., 2013). Over 65% of malignant melanomas arise from cell damage due to
UV-radiation exposure (Bandarchi et al., 2010). Other risk factors include genetic factors,
pale skin, blond or red hair, susceptibility to develop freckles with a tendency for sunburn,
exposure to tanning lamps, Xeroderma pigmentosum, immunosuppression and exposure to
various chemical (Bandarchi et al., 2010). When melanocytes become transformed into
melanoma cells, they no longer respond to keratinocyte signals. This process involves
down regulation of proteins important for adhesion to keratinocytes, such as E-cadherin,
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as well as upregulation of receptors and signalling molecules important for melanomamelanoma and melanoma-fibroblast interactions, such as N-cadherin, ZO1 and melanoma
cell adhesion molecule (Mel-CAM). Altered integrin expression also occurs in melanoma
cells, resulting in loss of anchorage to the basement membrane in the skin (Haass et al.,
2005). Melanoma cells are also characterized by the activation of signalling pathways
involved in proliferation and migration of embryonic melanoblasts. For example, Rac1 is
essential for embryonic melanoblast migration (Li et al., 2011), and many human
melanomas exhibit driver mutations in the RAC1 gene, which promotes melanoma cell
proliferation and migration (Krauthammer et al., 2012). Similarly, the Rac1 activator PRex1 is necessary for melanoblast migration, and high P-Rex1 levels occur in human
melanomas (Lindsay et al., 2011). Understanding the signalling pathways that regulate
melanocyte development has provided key insights into the processes that contribute to
melanocyte malignant transformation.

1.6 Integrin signalling in melanocytic cells
Integrins that contain b1 and b3 subunits are essential for the interactions of neural crest
cells with their surrounding environment, and contribute to survival and migration along
the dorsolateral pathway in these cells (Testaz and Duband, 2001). b1 integrins are
particularly important for the establishment of the melanocyte lineage (Moore and Larue,
2004). Integrins lack enzymatic activity, and consequently, recruitment of adaptor and
signalling proteins to the integrin adhesome is essential to trigger cell responses to integrin
activation (Schiller et al., 2011). Integrin-linked kinase (ILK) is an important adaptor that
directly binds to the cytoplasmic domains of b1 and b3 integrins (reviewed in Widmaier et
al., 2012). ILK is a ubiquitous scaffold pseudokinase that plays essential roles in cell
proliferation, migration, survival and cytoskeletal dynamics in many cell types. Several
subcellular ILK pools have been identified, including the cytoplasm, focal adhesions, cellcell adhesion sites, centrosomes and the nucleus (Widmaier et al., 2012). ILK is
indispensable for development, as ILK-null mouse embryos fail to implant due to defects
in actin cytoskeleton organization and cell polarization (Sakai et al., 2003).
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1.6.1

ILK signalling pathways

ILK is composed of three main domains: an N-terminal region with five ankyrin repeats,
followed by a pleckstrin homology (PH)-like domain and a pseudokinase domain at the Cterminus (Fig. 1-8) (Widmaier et al., 2012). ILK interacts with myriad proteins, forming
several complexes. One such complex is termed the IPP complex, which contains ILK,
Pinch and Parvin (Fig. 1-8). The IPP complex connects integrins to the actin cytoskeleton
through direct interactions between F-actin and Parvin (Fig. 1-8). ILK binds Pinch through
its N-terminal ankyrin repeat domain (Chiswell et al., 2008), whereas Parvin binds to the
pseudokinase domain of ILK (Fig. 1-8) (Fukuda et al., 2009). Two Pinch isoforms (Pinch
1 and 2) and three Parvin isoforms (a, b and g) have been identified in mammals. ILK
binds all of these isoforms, forming distinct IPP complexes, each with different regulatory
capabilities vis-à-vis cell migration, cell-substrate adhesion and cytoskeleton organization
(Tu et al., 1999, 2001; Yamaji et al., 2001; Yoshimi et al., 2006; Zhang et al., 2002).
Through the IPP complex and other complexes, ILK serves as a hub for many signalling
pathways as reviewed in (Grashoff et al., 2004).
The role of ILK in F-actin dynamics, responses to integrin stimulation and directional
migration in epidermal keratinocytes is well established. In response to laminin 332, ILK
mediates localization of active Cdc42 at the leading edge of migrating cells and activation
of Rac1 during the induction of directional migration (Nakrieko et al., 2008). ILK can also
form a heterotrimeric complex containing RhoG and ELMO2 in keratinocytes. The
interaction of ILK with ELMO2 and RhoG is essential for ILK localization to lamellipodia
at the leading edge of migrating cells, and to promote Rac1 activation, necessary for the
development of front-rear cell polarity during migration (Ho et al., 2009). These
interactions are also important for growth factor-induced cell polarization. Specifically,
epidermal growth factor (EGF) receptor stimulation results in activation and localization
of RhoG to the plasma membrane. Active RhoG recruits cytoplasmic ELMO2/ILK
complexes, thus inducing Rac1 activation, lamellipodia formation, establishment of frontrear polarity and forward cell migration (Ho and Dagnino, 2012). ILK-dependent activation
of Rac1 is also required for phagocytosis in epidermal keratinocytes, and is involved in the
ability of S. aureus to invade these cells (Sayedyahossein et al., 2012, 2015). ILK also
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regulates microtubule dynamics in both undifferentiated and in differentiated keratinocytes
(Jackson et al., 2015; Wickström et al., 2010). In differentiated keratinocytes, ILK forms a
complex with ELMO2 and RhoG adjacent to the cell cortex, and this complex plays a role
in regulating microtubule stability. In the absence of ILK, microtubule catastrophe is
increased, through mechanisms that involve abnormal regulation of GSK3b, CRMP2 and
stathmin (Jackson et al., 2015).

1.6.2

Biological roles of ILK in the skin

ILK is indispensable for the development and normal function of many tissues, including
the skin (Dagnino, 2011; Widmaier et al., 2012). Inactivation of Ilk in mouse keratinocytes
results in severe defects in hair follicle formation, reduced adhesion of the epidermis to the
basement membrane, and hypopigmented skin (Lorenz et al., 2007; Nakrieko et al., 2008).
Impaired hair follicle morphogenesis is due, at least in part, to reduced keratinocyte polarity
and alterations in the mechanisms that specify hair follicle matrix keratinocytes
(Rudkouskaya et al., 2014). Although ILK-deficient epidermis stratifies, it exhibits
abnormal distribution of E-cadherin, ZO-1 and late differentiation markers, such as
involucrin (Sayedyahossein et al., 2016). As a result, the architecture and organization of
the uppermost epidermal layers is impaired, leading to reduced tight-junction formation
and a deficit in epidermal barrier function (Sayedyahossein et al., 2016). ILK is essential
for cutaneous repair following injury. Inactivation of Ilk in K15-expressing keratinocyte
stem cells in the mouse hair follicle bulge revealed that ILK is necessary for hair follicle
stem cell activation and contribution to interfollicular epidermis regeneration following
injury (Nakrieko et al., 2011). Cutaneous responses after injury also require the activation
of dermal fibroblasts and their differentiation into myofibroblasts, and inactivation of Ilk
in dermal fibroblasts impairs the ability of these cells to contribute to wound healing in
vivo and in culture (Blumbach et al., 2010; Vi et al., 2011, 2015). In dermal fibroblasts ILK
is necessary to transduce signals from extracellular matrix substrates and from TFG-b at
the wound site (Vi et al., 2011). Significantly, although the role of ILK in keratinocytes
and dermal fibroblasts has been extensively studied, whether and how ILK regulates the
melanocyte lineage remains unexplored.
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Figure 1-8. ILK connects integrins to the actin cytoskeleton.
ILK is composed of an N-terminal region with five ankyrin repeats, a pleckstrin homology
(PH)-like domain and a pseudokinase domain. In the IPP complex, ILK binds to Pinch and
Parvin, through its ankyrin repeat domain and its pseudokinase domain, respectively.
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1.7 Rationale for study
Understanding the mechanisms involved in the development and functions of melanocytic
lineage cells is a key area in biology with important ramifications for human health, as
evidenced by the plethora of human diseases associated with defects in these cells. Further,
a major shortcoming in the field has been the limited availability of appropriate animal and
cell models to study the genesis and pathophysiology of these cells. It is now clear that the
establishment of the melanocyte lineage requires extensive proliferation and migration of
embryonic melanoblasts, through interactions with their surrounding environment.
However, virtually nothing is known about how signalling through integrins and their
transducers contribute to melanoblast colonization of the skin. Similarly, in postnatal skin,
formation of dendrites in melanocytes and melanin transfer to keratinocytes requires
appropriate orchestration of complex events that involve receptor signalling, as well as
melanosome trafficking through microtubules and F-actin. Although ILK is a key regulator
of integrin-mediated adhesion and migration, and it also modulates cytoskeletal dynamics,
its role in melanocytes is currently unknown. To address this important gap in knowledge,
I developed studies to test the hypothesis that ILK is necessary for the normal
development of melanocytic lineage cells. This hypothesis was tested by fulfilling the
following aims:
1. To establish in vivo and cell-based models to study melanocytes.
2. To determine the role of ILK in melanoblast colonization of the skin.
3. To elucidate the role of ILK in melanosome trafficking and melanin transfer to
keratinocytes.
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A reporter mouse model for in vivo and in vitro molecular
studies of melanocytic lineage cells and their diseases
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2.1 Introduction
Genetic alterations that alter survival, migration, proliferation or differentiation of
embryonic neural crest cells give rise to a variety of human disorders, collectively termed
neurocristopathies. The latter include pigment, skin, thyroid and hearing disorders, as well
as craniofacial and cardiac abnormalities (Noisa and Raivio, 2014). Mutations in several
genes implicated in neural crest cell function are responsible for various human
developmental defects, such as Waardenburg syndrome, characterized by sensorineural
hearing loss and pigmentation anomalies in hair, skin and irises (Baxter et al., 2004).
Waardenburg syndrome accounts for about 3% of congenital deafness worldwide (Issa et
al., 2017). Significantly, many of the genetic mutations associated with human
neurocristopathies also occur in rodents, manifesting themselves in the form of reduced
and/or altered pigmentation phenotypes.
In mice, a subset of neural crest cells adopts a melanocytic fate around E9.5-10.5,
becoming melanoblasts, which begin to spread from areas adjacent to the neural tube and
through the developing dermis. Melanoblasts proliferate and interact with their
microenvironment to localize to specific body sites. They migrate along a dorsolateral path
towards the face, ventral abdomen and the developing limbs. In the truncal region,
melanoblasts move within the dermis, and begin to penetrate into the epidermis around
E11.5. Melanoblasts localize to the epidermis by E15.5 and, by E16.5, they also home to
developing hair follicles (Li and Machesky, 2012; Luciani et al., 2011; Mort et al., 2015).
Melanoblasts subsequently establish a melanocyte stem cell population, which can selfrenew or differentiate into melanin-producing mature melanocytes postnatally (Mort et al.,
2015).
Naturally occurring mouse coat color mutants have provided valuable information
regarding the pathways that regulate melanocytic cell specification, proliferation, survival,
migration and stem cell renewal (Baxter et al., 2004). For example, in heterozygous
Dominant Megacolon mice, white spotting is evident. This phenotype arises from a point
mutation in the Sox10 gene, which introduces a premature stop codon. Sox10 activates
Mitf transcription, functions both during melanocyte specification, and in maintaining

48

melanocyte-specific gene expression later in development (Herbarth et al., 1998; Wegner,
2005). Genetically engineered mutant mouse models that use Cre recombinase-mediated
targeting of genes in pigment-producing cells have also been generated and used to
examine the roles of many genes in melanocytic cell specification, homing, maturation and
survival. Amongst them are included transgenic lines that express Cre or Cre fused to a
modified estrogen receptor (CreERT2) under the control of the Mitf, Tyr, Dct, Tyrp1 or
MART-1 (Melan-A) promoter (Alizadeh et al., 2008; Aydin and Beermann, 2011;
Bosenberg et al., 2006; Colombo et al., 2007; Delmas et al., 2003; Guyonneau et al., 2002;
Mori et al., 2002). Some of these transgenes additionally target non-melanocytic cells;
others express Cre at low levels, whereas in tamoxifen-inducible Cre lines, targeting of
relatively small fractions of cells is often observed. For example, in Dct::Cre mice,
melanoblasts and melanocyte stem cells are targeted, as well as cells in the telencephalon
(Guyonneau et al., 2002), Tyrp1::Cre mice exhibit Cre expression in retinal pigmented
epithelium and, ectopically, in the neural retina (Mori et al., 2002), and the efficiency of
tamoxifen induction of Cre-mediated recombination can range from 12% to >80%
(Bosenberg et al., 2006). The development of mouse genetic tools and imaging approaches
that exploit the properties of fluorescent proteins specifically expressed in the melanocytic
lineage, and which allow in vivo and ex vivo studies of melanocytic cell characteristics, as
well as molecular studies of melanocytic cell behaviour, has been more limited (Colombo
et al., 2012; Li et al., 2011; Woodham et al., 2017). Moreover, the use of melanocytic cells
cultured under a variety of conditions, together with studies using melanoma tumour cells
as surrogates to model normal melanocytic cells, can yield contrasting information and
significantly complicate the elucidation of cellular and molecular processes important in
these cells. In an effort to address this void, we have bred ROSAmT/mG and Tyr::CreERT2
mice, generating animals in which melanocytic lineage cells are identified through
expression of green fluorescent protein. We have also defined the growth characteristics of
primary melanocytes isolated from mouse epidermis, and now describe the diverse
responses of these cells to various extracellular matrix substrates. Our models will facilitate
a more systematic exploration and understanding of melanocytic lineage cell biology, and
its alterations in various human pigmentation disorders and neurocristopathies.
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2.2 Materials and Methods
2.2.1

Mouse strains

All animal experiments were approved by the University of Western Ontario Animal Care
Committee (Protocol No. 2016-022), in accordance with regulations and guidelines from
the Canadian Council on Animal Care. The mice used for these studies express Cre
recombinase fused to a modified estrogen receptor under the control of the Tyr promoter
(Bosenberg et al., 2006). For in vivo lineage tracing studies, these mice were bred to
homozygosity with mice containing ROSAmT/mG Cre reporter allele background
(Muzumdar et al., 2007). The primer sequences used to genotype mouse strains were: Cre
forward: 5′-CCATCTGCCACCAGCCAG-3′, reverse: 5′-TCGCCATCTTCCAGCAGG3′ (amplicon size 281 bp); Cpxm1 forward: 5’-TCGCCATCTTCCAGCAGG-3’, Cpxm1
reverse: 5’-GATGTTGGGGCACTGCTCATTCACC-3’ (amplicon size 420 bp). To
induce Cre recombinase activation, tamoxifen (1mg/25g body weight dissolved in
ethanol:Cremophore:PBS 1:1:5 v/v) was administered intraperitoneally once to 11.5 days
post-coitus (dpc) pregnant dams (Cremophore/Kolliphor EL; C-5135 Sigma, St. Louis,
MO, USA). Midday of the day vaginal plugs appeared was considered as 0.5 dpc for timed
pregnancies. In vivo tracing studies were conducted with 3-5 embryos from at least two
litters.

2.2.2

Antibodies

The primary antibodies and their working dilutions are shown in Table 2.1
Table 2.1 List of antibodies used in Chapter 2.
Antibody
DCT
GFP
K14
Trp1

Species and Dilution
Goat 1:100
Chicken 1:1000
Rabbit 1:1000
Mouse 1:200
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Catalogue Number
10452
13970
CLPRB-155P
3312

Supplier
Santa Cruz
Abcam
Covance
Abcam

2.2.3

Primary melanocyte culture and proliferation measurements

Melanocytes from all experiments were isolated from animals not exposed to tamoxifen.
Skin was harvested from 3-day-old mice of both sexes and digested with Dispase II (5
U/ml, 4942078001, Roche, Switzerland) for 1.5 h at 37°C. The epidermis was
mechanically separated, minced and digested with a 0.025% Trypsin/ 0.01% EDTA
solution (R-001-100, Thermo Fisher, Carlsbad, CA, USA) for 10 min at 37°C, with gentle
rocking. Two volumes of trypsin neutralizer solution (R002100, Thermo Fisher, Carlsbad,
CA, USA) were added, and a cell suspension was obtained by thorough mixing. Tissue
debris and cornified envelope fragments were removed by filtration through a 100-µm pore
size nylon strainer (08-771-19, Corning, NY, USA), and the resulting cell suspension was
centrifuged (200 x g, 10 min, 22°C). Pelleted cells were suspended in MBM-4 medium
(CC-4435, Lonza, Walkersville, MD, USA) supplemented with endothelin-3 (260 ng/ml,
final, CC-4510, Lonza, Walkersville, MD, USA) and growth factors (CC-4435, Lonza,
Walkersville, MD, USA), and seeded at a density of 1 x 105 cells/cm2. The growth medium
was replaced one day after plating, and subsequently every 72 h. The cultures were
consistently maintained at 30%-90% confluence. Where indicated, cell culture surfaces
were coated with 15 µg/cm2 rat-tail Collagen Type I (354236, Corning, NY, USA), or
laminin-332 matrix obtained from 804G rat bladder squamous carcinoma cell conditioned
medium (Tripathi et al., 2008). To this end, confluent 804G cultures were rinsed with PBS,
and maintained in serum-free Eagle’s Minimum Essential Medium for 48 h. The spent
medium was filtered to remove cell debris, and used to coat culture surfaces by incubation
at 37°C for 1-2h prior to plating melanocytes. For proliferation measurements, triplicate
samples from independent cell isolates were seeded at a density of 15,000 cells/well in 24well culture dishes. Cell numbers were determined weekly from trypsinized cultures.
Unless otherwise indicated, all experiments were conducted with melanocytes passaged 23 times.

2.2.4

Immunohistochemistry and immunofluorescence microscopy

Paraffin-embedded 7-µm sections of skin harvested from E20.5 embryos were
deparaffinized and subjected to high-temperature antigen retrieval, with 10 mM sodium
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citrate (pH 6.0), followed by incubation with primary antibodies. For histological
visualization of melanin, tissue sections were treated with Fontana-Masson stain (150669,
Abcam, Cambridge, UK) and counterstained with Nuclear Fast Red, following the
manufacturer’s instructions. For indirect immunofluorescence microscopy analyses of
cultured melanocytes, cells were fixed in freshly diluted 4% paraformaldehyde (PFA), and
processed as described (Ivanova and Dagnino, 2007; Sayedyahossein et al., 2015). Alexa
Fluor®-conjugated goat anti-mouse, goat-anti chicken and goat anti-rabbit IgG were
purchased from Molecular Probes/Invitrogen (Eugene, OR, USA). Fluorescence and
phase-contrast micrographs were obtained with a Leica DMIRBE fluorescence microscope
equipped with an ORCA-ER digital camera (Hamamatsu Photonics, Hamamatsu, Japan),
using Volocity 6.1.1 software (Improvision, Coventry, UK).

2.2.5

Light and time-lapse video microscopy

Time-lapse video microscopy images were obtained with a Leica DMIRBE fluorescence
microscope equipped with an ORCA-ER digital camera (Hamamatsu Photonics,
Hamamatsu, Japan), using Volocity 6.1.1 software (Improvision, Coventry, UK). Light
microscopy images of tissue sections were obtained with a Leica DM-LRE2 microscope
equipped with a ProgRes C5 camera (Jenoptik Optical Systems, Jupiter, Florida, USA) and
ProgRes Mac CapturePro 2.7.6 imaging software.

2.2.6

Melanogenic assays

For L-DOPA reaction assays cultured melanocytes were fixed in freshly diluted 4% PFA
at 22°C for 20 min. The cells were rinsed thrice with phosphate-buffered saline (PBS), and
were then incubated with 5 mM L-Dopa diluted in PBS (pH 6.8) at 37°C for 4 h, protected
from light. After incubation, the cells were rinsed with water and mounted with Permount
(SP15-100, Fisher Scientific, ON, Canada).
For melanin quantification melanocytes (5 x 105 cells) were trypsinized from 60-mm
culture dishes. An aliquot of this cell suspension was used to determine the number of cells
present, and the remainder was centrifuged (200 x g, 10 min, 22°C). The cell pellet was
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suspended and lysed in an aqueous solution of 1 M NaOH containing 10% DMSO, which
was incubated at 80°C for 1 h with vigorous shaking. The lysates were clarified by
centrifugation (12,000 x g, 20 min, 22°C), and the melanin content in the lysate was
determined from absorbance measurements at 420 nm, interpolating the values obtained
with those from a synthetic melanin (M8631, Sigma, St. Louis, MO, USA) standard curve.
The results were normalized to cell number.

2.2.7

RNA isolation and qPCR

Total RNA was isolated using RNeasy microkits (Qiagen, Louisville, KY, USA),
following the manufacturer’s instructions. RNA quality was determined with an Agilent
2100 Bioanalyzer (Agilent, Santa Clara, CA, USA). RNA samples (200 ng) with integrity
numbers > 8.5 were subjected to reverse transcription (SuperScript II RT, Fisher Scientific,
Carlsbad, CA, USA), following the manufacturer’s protocol. Quantitative, real-time
polymerase chain reactions (qPCR) were conducted on a CFX384 Real-Time PCR system
(Bio-Rad, Hercules, CA, USA) operated by CFX Manager software (version 1.6). cDNA
samples corresponding to 20 ng of RNA were amplified using PerfeCTa qPCR SuperMix
(Quanta BioSciences, Gaithersburg, MD, USA), and using the primers in Table 2.2 below
(400 nM, final) that are written 5’ to 3’. The results were normalized to the expression of
the Rpl16 and Rps29 genes, which encode, respectively, ribosomal protein L16 and S29
(de Jonge et al., 2007). Replicate cDNA samples were amplified for 40 cycles (98°C for
10 sec, and 58°C for 30 seconds per cycle). Primer specificity and amplicon sizes were
confirmed, respectively, by analysis of melt curves conducted between 65°C and 95°C, in
0.5°C increments, and agarose gel electrophoresis. Relative mRNA levels were calculated
using the ΔΔCq method. RNA preparations obtained from three different cell isolates were
analyzed.
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Table 2.2 List of primers used for qPCR in Chapter 2.
Gene
Name
Cdkn2a

Forward
Primer
GCTGGGTGGTCTTTGTGTA

Reverse
Primer
CTGCTGGTCTCCCTACATTTC

Kit

CCTCCTGCCCTTTATCCTTTAG

GACCTCCAAACCAGCTTACTT

Mitf *

GAAAGTAGAGGGAGGAGGACTAA GCACCTGGTAGTGACTGTATTC

Trp1

GCCTTCTTTCTCCCTTCCTTAC

CTGCTGGTCTCCCTACATTTC

Sox 10

AGCCCTCAGGACCCTATTAT

GTCAGAGATGGCAGTGTAGAG

*Mitf primers allow amplification of the melanocyte-specific transcript variant 2, which
encodes MITF-M.

2.2.8

Migration assays

For single-cell motility analyses, melanocytes were seeded at 2 x 104 cells/35-mm μ-Dish
culture dish (81156; Ibidi USA, Madison WI, USA). Time-lapse video microscopy images
were obtained 24 h after plating, and cells were manually tracked using the Manual
Tracking plugin for ImageJ software (version 1.49v, Fiji, NIH). The velocity, accumulated
and euclidean distances of each cell were calculated using the Chemotaxis and Migration
Tool plugin for Image J (version 1.01, Ibidi, USA, Madison, WI, USA). At least 50
cells/condition were tracked in individual experiments. For scrape-wound assays to assess
directional migration melanocytes were seeded onto 24-well culture dishes with no
exogenous ECM, or coated laminin-332 matrix, at a density of 1 x 105 cells/ well.
Alternatively, the cells were seeded at a density of 1.5 x 105 cells/well on Collagen Type
I-coated dishes (15 µg/cm2). Twenty-four hours later, a scrape wound was created with a
sterile 200-µl pipette tip. The cell monolayer was rinsed with PBS to remove cell debris
and cultured in growth medium. Changes in gap surface area were determined from phasecontrast micrographs obtained at timed intervals following wounding, using Image J
software.
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2.2.9

Statistical analysis

Data were analyzed using one- or two-way ANOVA, as indicated in individual
experiments, with post-hoc Tukey’s correction. Significance was set at P<0.05.
Experiments with cultured melanocytes were conducted in triplicate samples, and at least
three times with independent cell isolates.

2.3 Results
2.3.1

Generation of a melanocytic lineage reporter mouse model
for cell fate mapping

Melanocytes arise from precursor melanoblasts, which begin to migrate from the mouse
neural crest at embryonic day (E) 9.5, and by E16.5 are found in both the epidermis and
the hair follicles (Luciani et al., 2011; Mort et al., 2015). We have generated a reporter
mouse model that allows tracing of melanoblasts and their progeny to better examine the
processes involved in melanoblast migration, survival and differentiation into pigmentproducing melanocytes. These animals, hereafter termed Tyr::CreERT2-mT/mG, have
been bred into a reporter ROSAmT/mG background, and express specifically in cutaneous
melanocytic cells Cre recombinase fused to a modified estrogen receptor (CreERT2) under
the control of the Tyr promoter, beginning at E10.5 (Bosenberg et al., 2006; Muzumdar et
al., 2007). Tamoxifen administration to these mice activates CreERT2 and induces
expression of a membrane-targeted form of green fluorescent protein (mGFP). Nontargeted cells constitutively express mTomato, a membrane-targeted red fluorescent
protein form. Analysis of E20.5 skins harvested from embryos exposed to tamoxifen at
E11.5 days revealed mGFP immunoreactivity detected exclusively in a subpopulation of
cells in the hair follicle (Fig. 2-1A) and in the interfollicular epidermis (data not shown).
These cells also expressed the melanocytic-specific enzyme dopachrome tautomerase
(DCT), confirming the melanocytic origin of the targeted cells (Fig. 2-1B). No detectable
recombination was observed in embryos from dams treated with vehicle only (data not
shown).
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Figure 2-1. In vivo tracing of melanocytic lineage cells.
Skin sections from E20.5 embryos with a Tyr::CreERT2-mT/mG background harvested
from a dam treated with tamoxifen at 11.5 days of gestation. Tissue sections were
processed with Fontana-Masson staining (FM) and visualized with light microscopy to
highlight melanin-producing melanocytic cells (indicated by the black arrows). Adjacent
skin sections were processed for immunofluorescence microscopy with antibodies against
the indicated proteins. DNA was visualized with Hoescht 33342. (A) Sections probed with
anti-GFP antibodies show targeted melanocytes in the hair follicle. Inset is shown at higher
magnification in the adjacent micrograph. (B) Specimens were probed with anti-GFP and
Figurelineage
1
anti-DCT antibodies to demonstrate the melanocytic
of GFP-positive cells. Bar, 25
µm.
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2.3.2

Characteristics of cultured melanocytes

The isolation of primary melanocytes and their culture to high purity is a prerequisite for
thorough cellular and molecular characterization of biological processes in melanocytic
lineage cells. We generated single-cell suspensions from newborn Tyr::CreERT2-mT/mG
mouse epidermis mainly composed of melanocytes and keratinocytes. The cells were
cultured in selective growth medium supplemented with endothelin-3 (ET-3), which we
found favoured melanocyte growth. Forty-eight hours after isolation, we observed mixed
cultures composed of 9% tyrosinase-related protein 1 (TRP1)-positive melanocytic cells,
which increased to 29% after 6 days, as the culture conditions did not allow contaminating
keratinocytes to proliferate (Fig. 2-2A). Through the combination of differential
trypsinization (Huang et al., 2013) and serial passaging, we increased the proportion of
melanocytes in the cultures to 69% and >95%, respectively, after the first and second
passages (Fig. 2-2A). The cultures maintained >95% purity from passages 2 through 6
(data not shown). The identity of melanocytic cells in these cultures was further confirmed
by their ability to oxidize L-DOPA to a dark brown pigment (Fig. 2-2A). Analysis of
melanocytic cell markers demonstrated detectable levels of Kit, Mitf-M, Sox10, Tyr and
Trp1 transcripts in these cultures as early as passage (P) 1 (Fig. 2-2B). The abundance of
these markers increased with the purity of the cultures, and was maintained for as long as
60 days, the last time analyzed corresponding to P6 cells (Fig. 2-2B).
We next determined the growth characteristics of the cultured melanocytes. We observed
that P2 and P3 cultures maintained normal proliferation as late as 28 days after plating, and
exhibited doubling times of about 10 days (Fig. 2-2C). In contrast, little if any cell growth
was observed in cultures at P4, P5 and P6 (Fig. 2-2C). Thus, under our culture conditions,
primary melanocytes remain exponentially proliferative as late as 50 days following initial
isolation. Significantly, whereas the average melanin content of P2 and P3 cultures was,
respectively 54.3 and 66.7 µg/106 cells, it increased almost 3-fold in P5 and P6 cultures,
coinciding with pronounced morphological changes characterized by reduced
nucleus:cytoplasm surface ratios and increased size, changes typical of senescent cells (Fig.
2-2D and 2-3). Mouse melanocytes escape senescence through inactivation of Cdkn2a,
which encodes the cyclin-dependent kinase inhibitor p16Ink4a. Significantly, the reduction
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in proliferative capacity and development of senescence we observed in higher passage
melanocytes was not accompanied by increases in Cdkn2a transcripts. Based on the
observed growth characteristics of these cells, all subsequent experiments were conducted
with >95% pure P2 or P3 cultures.
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Figure 2-2. Characteristics of primary mouse melanocyte cultures.
(A) Epidermal cell suspensions were cultured for the indicated number of days (D) and
passages (P). The cells were processed for immunofluorescence microscopy to detect
keratin 14 (K14) in keratinocytes and TRP1 in melanocytes (a, b, c, d), or stained with LDOPA, which is converted to a brown pigment only in melanocytes (a’, b’, c’, d’). Arrows
indicate the melanocytes in P0 cultures. Bar, 50 µm. (B) mRNA was isolated from
melanocyte cultures at the indicated passage numbers, reverse transcribed and analyzed by
qPCR to determine the relative abundance of the indicated transcripts. The results were
obtained from three technical replicates per cDNA tested, and are expressed as the mean +
SD from three independent cell isolates, relative to mRNA levels in P2 cells, which are set
to 100%, because P2 cells are the earliest passage composed of >95% melanocytes. (C)
Melanocytes at the indicated passages (P) were cultured, trypsinized and the number of
trypan blue-excluding cells was determined at the indicated intervals following seeding.
The data were obtained from duplicate samples for each of three independent cell isolates,
and are expressed as mean + SD, and * indicates P<0.05 relative to the number of cells
seeded at Day 0 (n=3, two-way ANOVA). (D) Melanin was extracted and quantified in
cultures at the indicated passages. The data are expressed as mean melanin content + SD,
and * indicates P<0.5 relative to melanin in P2 cells (n=3, one-way ANOVA).
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Figure 2-3. Senescence-associated changes in melanocyte morphology.
Supplemental Figure 1. Senescence-associated changes in melanocyte morphology.Phasecontrast micrographs of melanocytes cultures at the indicated passage numbers. Bar, 50 μm.

Phase-contrast micrographs of melanocyte cultures at the indicated passage (P) numbers.
Bar, 50 µm.
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2.3.3

Effect of extracellular matrix substrates on mouse
melanocyte dendricity

Melanocytes in situ interact with extracellular matrix (ECM) proteins in the skin basement
membrane through proteins that include integrins a3b1, a6b1 and avb1. In culture, human
primary melanocytes additionally express integrins a5b1 and avb3 (Hakkinen et al.,
2001), which allow them to interact with substrates such as fibronectin, collagen and
laminins. In embryonic and in postnatal intact epidermis, melanocytes interact with a
basement membrane mainly composed of laminin-332. On the other hand, melanocytes,
keratinocytes and fibroblasts in wounded epidermis play important roles in wound healing
and subsequent scar formation. In particular, melanocytes can mitigate keratinocytedependent contraction in co-culture models of wounds composed of fibroblasts,
keratinocytes and melanocytes in the presence of collagen I. Melanocytes may thus
contribute to reducing the formation of fibrotic scars through interactions with collagen I,
a major ECM substrate found in wounded skin (Rakar et al., 2015). In an effort to better
understand melanocyte responses to ECM substrates, we next addressed whether
melanocytes exhibit different responses when stimulated by laminin-332 or collagen I.
Because laminin-binding integrins can mediate cellular responses distinct from those
elicited by fibronectin- or collagen-binding integrins, we first compared the morphology
and ability of primary mouse melanocytes to migrate on no exogenous ECM, low or
intermediate concentrations of collagen I (5 µg/cm2 or 15 µg/cm2) or laminin-332 isolated
from 804G rat bladder epithelial cells. Cells cultured in the absence of exogenous ECM
were able to spread, frequently exhibiting polygonal morphologies with or without
formation of dendrites (Fig. 2-4A). In contrast, melanocytes seeded on collagen adopted
an elongated, and frequently bipolar, morphology (Fig. 2-4A and data not shown). The
presence of laminin-332 induced formation of extensive and frequently branched dendritic
extensions (Fig. 2-4A). Quantification of the fraction of cells that exhibited a spread,
bipolar or dendritic phenotype revealed that in the absence of exogenous matrices about
40% of cells were either spread or dendritic, in the presence of 15 µg/cm2 collagen I, about
50% of the cells were bipolar, whereas 87% of melanocytes seeded on laminin-332 were
dendritic (Fig. 2-4B). Of note, laminin-332 also increased significantly the average number
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of dendrites per cell. Specifically, only 6% and 25% of cells seeded without exogenous
ECM or on collagen, respectively, showed >3 dendrites/cell, whereas almost 45% of cells
in contact with laminin-332 formed >3 dendritic extensions (Fig. 2-4C). Thus, primary
mouse melanocytes exhibit differential responses to various ECM substrates, and their
interaction with laminin-332 appears to promote the formation of dendritic processes. The
optimal formation of dendrites is essential for normal interactions between melanocytes
and adjacent keratinocytes in the epidermis.

2.3.4

Effect of ECM substrates on melanocyte motility

In addition to regulating morphology, integrins enable melanocytes to interact with and
migrate on ECM substrates (Pinon and Wehrle-Haller, 2011). To assess the effect of
collagen and laminin on motility, we seeded melanocytes at single-cell densities and
followed their movement for 16 h using time-lapse videomicroscopy. Plots of cell
trajectories revealed substantial differences in melanocyte motility, depending on the
underlying substrate. Cells seeded in the absence of exogenous ECM or on collagen I (15
µg/cm2) displayed average speeds of 0.12 µm/min and 0.05 µm/min, respectively. The
presence of laminin-332 increased cell speed 4- to 9-fold, to 0.47 µm/min (Fig. 2-5A, 5B).
Over 75% of cells plated without exogenous ECM or on collagen I exhibited speeds lower
than 0.2 µm/min. In stark contrast, 90% of cells seeded on laminin-332 showed speeds that
exceeded 0.2 µm/min (Fig. 2-5C). In agreement with the stimulatory effects of laminin332 on melanocyte speed, we also observed an increase in mean accumulated distance
migrated during the course of this experiment to about 450 µm, compared with 48 µm for
cells plated on collagen, and 112 µm in cells plated without exogenous ECM, representing
a 5-fold increase (Fig. 2-5D). Further analysis revealed that in the presence of collagen, up
to 85% of cells did not migrate distances greater than 100 µm, whereas laminin-332
promoted migration distances greater than 200 µm in 85% of melanocytes (Fig. 5E). We
conclude that, in the concentrations used in these studies, laminin-332 promotes, whereas
collagen appears to hamper random melanocyte motility.

63

64

Figure 2-4. Laminin-332 induces dendricity in primary mouse melanocytes.
(A) Phase-contrast micrographs of melanocytes cultured 24 h in the absence of exogenous
extracellular matrix substrates (No ECM), on collagen I (Col I; 15 µg/cm2) or laminin-332
substrate (Lam 332). Bar, 64 µm. (B) The fraction of melanocytes exhibiting a “Spread”,
“Bipolar” or “Dendritic” morphology was assessed on cultures seeded without exogenous
extracellular matrix, on collagen I or on laminin-332. Each experiment was conducted in
duplicate samples, and at least 50 cells per sample were scored. The results are expressed
as the mean + SD (n=3 independent cell isolates). *P<0.05 (one-way ANOVA). Bar, 25
µm. (C) Distribution of dendrite abundance in melanocytes seeded on the indicated
substrates. Melanocytes without dendrites (herewith defined as processes > 13 µm) have
been excluded. Red lines indicate the mean number of dendrites/cell on each substrate,
irrespective of whether or not dendrites exhibited branches. Branches on dendrites were
not counted. *P<0.05 (n=150 cells from 3 independent isolates; one-way ANOVA).
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The distinct effects of collagen and laminin-332 on random melanocyte motility prompted
us to investigate their effects on directional migration, using scrape-wound assays. We
evaluated the cell-free surface area remaining at timed intervals after wounding. Within
one and three days after wounding, cells plated on laminin-332 had covered 40%, 65% and
80% of the wound area in 1, 3 and 6 days, respectively (Fig. 2-6). By comparison, those
melanocytes without exogenous ECM had covered 22%, 40% and 60% of the original
denuded area 1, 3 and 6 days after wounding (Fig. 2-6). In stark contrast, cells plated on
collagen I (15 µg/cm2) had barely covered about 35% of the cell-free area as late as 6 days
following wounding (Fig. 2-6). Together, our data show that laminin-332, but not collagen
I, induces random motility and directional migration in primary mouse melanocytes.

2.4 Discussion
Through the combined use of a transgenic mouse strain that specifically expresses Cre
recombinase in cutaneous melanocytic lineage cells (Bosenberg et al., 2006), together with
the ROSAmT/mG double fluorescent protein reporter background, we were able to efficiently
trace Cre-targeted embryonic melanocytes both in interfollicular epidermis and in the
developing hair follicles. The presence of mGFP allows the simultaneous analyses by
immunofluorescence microscopy of multiple proteins within a clearly identified targeted
melanocytic cell, an approach that has remained difficult with various other melanocytic
reporter mouse models. Following in utero induction at E11.5, the fraction of mGFPpositive cells observed in E20.5 embryos constituted about 10%-30% of DCT-positive
melanocytes, in line with the targeting efficiency reported for the original Tyr::CreERT2
transgenic mouse line (Bosenberg et al., 2006).
Melanocytes derive from multipotent neural crest cells, after they delaminate from the
dorsal neuroepithelium, and are thought to arise from two different developmental waves
(Baggiolini et al., 2015; Mort et al., 2015). The first wave of cutaneous melanocytes arises
directly from neural crest cell-derived progenitors that first migrate dorsolaterally, and then
ventrally through the dermis to finally populate the epidermis and hair follicles (Adameyko
et al., 2009). In these cells, the genes encoding tyrosinase, TYRP-1 and dopachrome
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tautomerase, three major enzymes involved in the synthesis of melanin, are expressed
shortly after E9 (Steingrimsson et al., 2004). A second subset of melanocytes arises later,
from neural crest-derived Schwann cell progenitors found along the ventral pathway
(Nitzan et al., 2013), which express MITF, TYR, and TYRP-1 later than those directly
derived from neural crest cells (Adameyko et al., 2009; Mort et al., 2015). Administration
of tamoxifen at E10-11.5 to our reporter mice allows selective labeling of the first wave of
migrating melanoblasts, excluding those generated later from Schwann cell precursors.
In culture, we have observed that 4-hydroxytamoxifen treatment results in activation of
mGFP expression in > 50% of melanocytes (data not shown), whereas no mGFP-positive
cells are observed in untreated or vehicle-treated cultures. Our model, thus, demonstrates
tight spatial and temporal regulation of genetic recombination in melanocytic cells. The
generation of pure primary melanocytes is challenging, as they constitute only 3-7% of all
epidermal cells (Hsu et al., 2005). Several reports describing a variety of growth conditions
for human and mouse melanocytes exist, including the use of phorbol ester and cholera
toxin, which yield cultures with doubling times of about 5 and 12 days, respectively
(Eisinger and Marko, 1982). Neonatal mouse melanocytes have been successfully cultured
in medium containing placental extracts (Larue et al., 1992), or in the presence of
keratinocyte feeder layers (Godwin et al., 2014). For our studies, we used melanocyte
growth medium supplemented with ET-3, which was found to improve plating efficiency
and cell growth (data not shown).
Under our culture conditions, mouse melanocytes in a C57/BL6 strain background retain
full proliferative capacity for up to 7-9 weeks following isolation, with a doubling time of
about 10 days. Although our studies did not measure the number of cell doublings that
occurred in mixed melanocyte-keratinocyte cultures prior to P2, we estimate that the
primary melanocyte cultures remain proliferative during approximately 9-10 population
doublings, at which time they senesce. In the presence of keratinocyte feeder layers,
primary mouse melanocytes reportedly exhibit doubling times of about 4-5 days, and
become senescent after 4-5 weeks in culture (Sviderskaya et al., 2002). Notably,
immortalization of mouse melanocytes through spontaneous or targeted inactivation of the
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Cdkn2a locus yields cells with doubling times as low as 2.3 days, which, however, also
display substantially reduced melanogenic capacity (Sviderskaya et al., 2002), potentially
as a result of increased genetic instability (Fung et al., 2013). Thus, our isolation and culture
conditions allow for expansion and characterization of mouse melanocytes without the
need of feeder layers and, because they retain full capacity to produce melanin, they are
ideal to investigate the consequences of targeted genetic manipulations on melanogenic
functions.
In intact epidermis, melanocyte adhesion to the basement membrane involves binding of
a6b1 integrins to laminin-332 secreted by neighbouring epidermal keratinocytes, as well
as interactions with collagen IV and collagen XVII (Hara et al., 1994; Tanimura et al.,
2011). In culture, laminin-111 and collagen IV also promote formation of dendrites in
human melanocytes, whereas fibronectin or vitronectin induce bipolar or polygonal
morphologies. We now show that mouse melanocytes exhibit substantially different
responses to laminin-332 and collagen I, developing numerous dendrites in the presence of
the former, but not the latter ECM substrate. Further, the characterization and interpretation
of primary cultured melanocyte responses on a given ECM substrate, such as laminin-332,
may also be critically dependent on the origin of the ECM tested. Further, different
maturation/processing products can induce distinct adhesive and/or migratory cellular
responses (Rousselle and Beck, 2013). Laminin-332 is synthesized by epidermal
keratinocytes and other epithelial cells as a 460-kDa precursor protein, which is secreted
into the ECM milieu and subsequently processed into smaller forms (Rousselle and Beck,
2013), and laminin-332 from rat bladder epithelial 804G cells differs from that secreted by
SCC25 squamous carcinoma cells or HaCaT immortalized human keratinocytes (Scott et
al., 1999; Zhang et al., 2013). Functionally, laminin-332 from 804G cells is vastly superior
in supporting adhesion and clonal growth of primary human melanocytes than HaCaTderived laminin-332 (Scott et al., 1999; Zhang et al., 2013). Similarly, whereas we
observed pronounced positive effects of 804G-derived laminin-332 on both random and
directional migration in our melanocyte cultures, SCC25-derived laminin-332 matrix failed
to stimulate random migration in human melanocytes (Scott et al., 1999).
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Figure 2-5. Laminin-332 promotes melanocyte motility.
(A) Spider plots for random migration tracks of melanocytes plated without exogenous
extracellular matrix (No ECM), on collagen I (Col I) or laminin-332 substrate (Lam 332),
and analyzed for 16 h. (B) The particle analysis function of Image J was used to examine
the speed of individual melanocytes on the indicated extracellular matrix substrates, with
the mean speed indicated by red lines. (C) Percentage of cells that exhibited speed values
within the indicated ranges when seeded on no exogenous matrix (black bars), on collagen
I (white bars) or on laminin-332 (gray bars). (D) The Chemotaxis and Migration Tool
plugin for Image J (Ibidi) was used to examine the accumulated distance of individual
melanocytes on the indicated extracellular matrix substrates, with the mean distance
indicated by red lines. (E) Percentage of cells that exhibited accumulated distance values
within the indicated ranges when seeded on no exogenous ECM (black bars), on collagen
I (white bars) or on laminin-332 (gray bars). The data shown in the histograms represent
the mean + SD (n=300 cells analyzed from three independent isolates, 100 cells scored per
isolate, one-way ANOVA). * P<0.05.
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Figure 2-6. Laminin-332 promotes directional melanocyte migration.
(A) Phase-contrast micrographs of melanocytes cultured in the absence of exogenous
extracellular matrix substrates (No ECM), on collagen I (Col I) or laminin-332 substrate
(Lam 332). Confluent cultures were wound-scraped, and phase-contrast images were
obtained at the indicated times following wounding. The broken lines represent the width
of the scrape-wound at time=0. Bar, 250 µm. (B) Cell-free surface areas of scrape-wounds
remaining at the indicated times post-wounding were assessed using ImageJ. The results
show the mean wound surface area values + SD (n=5 different cell isolates; two technical
replicates per cell isolate), and have been normalized to the original scrape-wound area,
which is set to 100%. The asterisks indicate P<0.05 relative to cells plated without
exogenous ECM at the corresponding time following wounding (two-way ANOVA).
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Functional differences also exist between laminin- and collagen-binding integrins (Stipp,
2010). For example, responses of epithelial cells to laminins frequently involve strong
activation of Rac1 and Cdc42, which induce formation of lamellipodia and filopodia,
respectively, as well as formation of smaller focal contacts and a dynamic actin
cytoskeleton that promotes rapid migration. In contrast, responses to collagen or
fibronectin are frequently associated with RhoA activation, formation of robust stress
fibres and focal adhesions (Stipp, 2010). Cell motility and adhesion are also influenced by
ECM substrate concentration. For example, high concentrations of fibronectin or collagen
(>30 µg/cm2) promote cell adhesion and spreading, and inhibit formation of cell
protrusions and forward movement. Conversely, intermediate concentrations (5-10
µg/cm2) provide optimal levels of cell-matrix adhesion and ability to form protrusions,
which facilitate migration (Cox et al., 2001; Gehler et al., 2017). Although melanocytes
are not epithelial in origin, we similarly observed optimal migration on laminin-332 matrix,
compared to intermediate concentrations of collagen I. However, unlike epithelial and
mesenchymal cells, primary melanocytes did not display a spread morphology when
cultured on collagen I, but rather adopted a long bipolar morphology with reduced dendrite
formation, and occupied smaller surface areas than those seeded on laminin or without
exogenous ECM. Primary melanocytes are known to shed melanosomes primarily through
dendritic extensions (Wu and Hammer, 2014), although shedding events can also be
induced from central areas in cells seeded on collagen-rich substrates (Wu et al., 2012).
Given the effects of various extracellular matrices on melanocyte morphology and
dendricity, an important area of future research will be to systematically examine the effect
of ECM substrates on the diverse pathways that modulate melanosome shedding by
melanocytes and their uptake by neighbouring epidermal keratinocytes.
In conclusion, we have developed a mouse model for in vivo tracing of melanocytic lineage
cells. We have also developed efficient isolation and culture methods to systematically
examine the characteristics of mouse primary melanocytes and their responses to various
ECM substrates. Our studies underline the importance of clearly defining culture
conditions and cell passage number during characterization of melanocyte biological
processes. The combined use of our mouse reporter model and our clearly defined and
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characterized culture systems will provide valuable tools to decipher the cellular and
molecular mechanisms that regulate melanocytic cell behaviour, and how their alterations
may contribute to neurocristopathies and pigmentation disorders.
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Chapter 3

3

Essential role for integrin-linked kinase in melanoblast
colonization of the skin
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3.1 Introduction
The neural crest is a transient structure that forms in the dorsal region of the developing
neuronal epithelium and is composed of multipotent cells. Neural crest cells undergo
epithelial-mesenchymal transition soon after their formation during neural tube closure and
begin to migrate to invade the developing embryo. These cells are essential for the
development of pigmented melanocytes, and contribute to the cardiovascular and
peripheral nervous systems (Le Douarin and Dupin, 2018). The behaviour of neural crest
cells is strongly influenced by interactions with their surrounding environment (Wang and
Astrof, 2016). Integrins containing β1 or β3 subunits are particularly important for these
interactions, modulating motility along the dorsolateral pathway and survival of neural
crest cells and their progeny (Testaz and Duband, 2001). β1 integrins are also required for
the normal establishment of the melanocyte lineage (Moore and Larue, 2004).
Melanoblasts are generated from neural crest cells that embark on two distinct migration
waves during development. The first wave involves a subset of neural crest cells that
delaminate from the neural tube at embryonic day (E) 9 in mice. Around E10.5, some
neural crest cells give rise to melanoblasts, which express Mitf, Dct, and Pmel17 (Baxter
and Pavan, 2003). Melanoblasts spread from areas adjacent to the neural tube along a
dorsolateral path towards the developing dermis. The second wave occurs around E14.5
when Schwann cell precursors, generated from neural crest cells that moved along the
ventral pathway associating with nerve endings, subsequently differentiate into
melanoblasts (Adameyko et al., 2009; Colombo et al., 2012; Mort et al., 2015). By E15.5,
all melanoblasts localize to the basal layer of the epidermis, and by E16.5 they have also
populated the developing hair follicles (Adameyko et al., 2009), later giving rise to mature
melanocytes and melanocyte stem cells.
Integrin-linked kinase (ILK) is an important cytoplasmic effector of b1 integrins and, as
such, is a key transducer of cell interactions with the surrounding environment. ILK is
necessary for cell polarization and embryo survival (Sakai et al., 2003), and its importance
for actin cytoskeletal dynamics, as well as integrin modulation of cell adhesion and
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migration has been clearly established in metazoans. For example, ILK-containing
complexes transduce signals that inhibit integrin endocytic turnover at the plasma
membrane, thus reinforcing integrin-extracellular matrix adhesion in Drosophila embryos
(Vakaloglou et al., 2016). In mouse epidermis, ILK is essential for hair follicle
morphogenesis, epidermal integrity and barrier function, as well as keratinocyte
polarization, directional migration and survival (Im and Dagnino, 2018; Nakrieko et al.,
2008; Sayedyahossein et al., 2016). Ilk inactivation in E8.5 neural crest cell subsets that
contribute to cardiac outflow tract formation results in defective focal adhesion formation
and severe cardiac defects (Dai et al., 2013). Given the importance of ILK in ectodermal
and neural crest cell-derived tissues, we have investigated its role in the establishment and
characteristics of melanocytic cells in the skin. We now demonstrate that ILK plays key
roles in first-wave embryonic melanoblast trafficking and melanocyte interactions with the
extracellular matrix, and that ILK is essential for melanocytic cell colonization of the skin.

3.2 Materials and methods
3.2.1

Mouse strains

All animal experiments were approved by the University of Western Ontario Animal Care
Committee (Protocols No. 2016-022 and 2015-021), as per regulations and guidelines from
the Canadian Council on Animal Care. Tyr::CreERT2 mice, which express Cre recombinase
fused to a modified estrogen receptor under the control of the Tyr promoter (Bosenberg et
al., 2006) were purchased from the Jackson Laboratory (B6.Cg-Tg(Tyr-cre/ERT2)13Bos/J,
Stock 02328, Bar Harbour, ME, USA). These animals were bred with mice homozygous
for the ROSAmT/mG reporter allele (Muzumdar et al., 2007) and the Ilktm1Star allele, in which
contains the Ilk gene is flanked by loxP sites (Terpstra et al., 2003), which were a generous
gift from Dr. Rashmi Kothary (Ottawa Hospital Research Institute) (Michalski et al.,
2016). The mice used in the present studies were homozygous for the Tyr::CreERT2 and
the ROSAmT/mG alleles, and either homozygous ( Tyr::CreERT2; ROSAmT/mG; Ilkf/f, hereafter
termed ILKKO) or heterozygous (hereafter termed ILK+) for the loxP-flanked Ilktm1Star
allele. Cre alleles were genotyped as described in section 2.2.1. Ilk alleles were genotyped
using two primer sets: Ilk forward: 5′-CTGTTGCAATACAAGGCTGAC-3′, and Ilk
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reverse: 5′-CTGGGAGAAGCTCTCTAAGGGG-3′ (amplicon size, 350 bp with wild type
allele, and 384 bp with loxP-containing allele). The second set of primers has been
described (Terpstra et al., 2003), and yields a 1.9-kb amplicon corresponding to the wild
type allele, a 2.1-kb amplicon corresponding to the loxP-containing allele, and a 230-bp
fragment corresponding to the Cre-excised Ilk allele. Cre-recombinase mediated gene
excision was induced as described in section 2.2.1. In vivo tracing studies were conducted
with at least 5 embryos harvested from three or more litters.

3.2.2

Antibodies
Table 3.1 Lists of antibodies used in Chapter 3.
Antibody
DCT
GFP
Ki67
Trp1
V5

3.2.3

Species and Dilution
Goat 1:100
Chicken 1:1000
Rabbit 1:200
Mouse 1:200
Mouse 1:200

Catalogue Number
10452
13970
15580
3312
R96025

Supplier
Santa Cruz
Abcam
Abcam
Abcam
Invitrogen

Isolation of cutaneous embryonic melanoblasts

Melanoblasts were isolated from skin that was harvested from E15.5 mouse embryos and
minced. Each minced skin was digested by incubation in 0.5 ml of 2.5% trypsin for 10 min
at 37°C, with gentle rocking. Two volumes of trypsin neutralizer solution were added,
followed by thorough mixing. The cell suspension generated was filtered through a 40-µm
pore size strainer (431750, Corning, NY, US) to remove tissue debris and centrifuged (140
x g, 5 min, 22°C). After removal of the supernatant, the cell pellet was suspended in PBS
containing 2% fetal bovine serum (FBS) and transferred to 5-ml glass polystyrene tubes
(352235, BD Biosciences, Franklin Lakes, NJ, USA) for subsequent flow cytometry
analysis or fluorescence activated cell sorting (FACS).

82

3.2.4

Flow cytometry analysis and fluorescence-activated cell
sorting of melanoblasts

Flow cytometry analysis was conducted on a Becton Dickinson FACSCanto Flow
Cytometer (BD Biosciences, Mississauga, ON, Canada) with FACSDiVa software (v
8.0.1). The blue laser trigon was configured to detect GFP from detector B (530/30
bandpass and 502 long pass filter). The yellow-green laser octagon was configured to
detect mTomato from detector C (610/20 band pass and 600 long pass filter), and 7-AAD
from detector B (670/30 bandpass and 655 long pass filter). The following gating strategy
was used to analyze viable GFP- and/or mTomato-positive cells: Viable cells were first
selected based on exclusion of 7-AAD. Cell doublets were excluded based on consecutive
gates on forward scatter (FSC)-Height vs. FSC-Width, and side scatter (SSC)-Height vs.
SSC-Width plots. GFP-positive cells were selected by comparison with GFP-negative
control samples, which were composed of cells isolated from three different populations
of melanoblasts: Cells isolated from Tyr::CreERT2; ROSAmT/mG; Ilkf/f and from ROSAm/TmG;
Ilkf/f embryos not exposed to tamoxifen, as well as cells isolated from C57BL/6J embryos.
The number of targeted GFP-expressing melanoblasts from each embryo was normalized
to the total number of viable skin cells obtained (averaging approximately 5x105
cells/embryo).
For purification of targeted melanoblasts, embryonic skin cell suspensions were sorted
using a Becton Dickinson FACSAria III cell sorter (BD Biosciences, Mississauga, ON,
Canada) with FACSDiVa software (v 8.0.1). To obtain >99% pure populations of viable
targeted GFP-expressing melanoblasts, the blue laser trigon was configured to detect GFP
from detector B (530/30 bandpass and 502 long pass filter). The yellow-green laser octagon
was configured to detect mTomato from detector C (610/20 band pass and 600 long pass
filter), and 7-AAD was detected from detector B (670/14 bandpass and 630 long pass
filter). Embryonic skin cell suspensions were sorted at 4°C, using a 100 m nozzle at low
pressure (20 psi) and at a maximum event rate of 2000 events/s. Flow cytometry and FACS
experiments were conducted at the London Regional Flow Cytometry Facility of the
Robarts Research Institute.
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3.2.5

Analysis of melanoblast proliferation and apoptosis

The fraction of apoptotic cells in embryonic melanoblast isolates was analyzed by flow
cytometry, with eBioscience Annexin V Apoptosis Detection Kit eFluor 450 (88-8006,
Thermo Fisher, Carlsbad, CA, US). Single-cell suspensions prepared from embryonic skin
isolates were suspended in 1X Binding Buffer at a density of 1-3 x105 cells/100 µl, mixed
with 10 µl of fluorochrome-conjugated Annexin V, and incubated for 15 min at 22°C in
the dark. Cells were centrifuged and re-suspended in 300 µl 1X Binding Buffer. To stain
non-viable cells, 5 µl of 7-AAD (50 µg/ml dissolved in PBS) were added to each sample.
Targeted, GFP-positive melanoblasts were immediately analyzed on a Becton Dickinson
FACSCanto Flow Cytometer FACSCanto as described above. In addition, the violet/red
laser octagon was configured to detect Annexin V eFluor450 from detector D (450/50
bandpass). The proportion of targeted early apoptotic (GFP+, Annexin V+, 7-AAD-), late
apoptotic (GFP+, Annexin V+, 7-AAD+) and necrotic cells (GFP+, Annexin V-, 7-AAD+)
was determined. Samples consisting of cultured primary epidermal keratinocytes exposed
to 100 J/m2 UVB light 24 h prior to Annexin V processing were used as positive controls
for apoptosis (Singh and Dagnino, 2016).

3.2.6

Melanoblast culture and motility measurements

ST2 cells were plated into the wells of 4-well culture inserts included with 35-mm µ-Dishes
(80466, Ibidi, Madison, WI, USA), at a density of 7, 000 cells/ 0.03 cm2 well, and cultured
in ST2 growth medium for 24 h. Pooled GFP-expressing melanoblasts from genotypematched embryos were FACS-sorted and seeded onto the confluent ST2 monolayers in
which the culture medium had been replaced with a mixture of 50 µl RPMI medium
supplemented with 10% FBS and 50 µl of melanocyte growth medium just prior to addition
of embryonic melanoblasts. Sixteen hours later, the motility of GFP-positive cells was
recorded during 3-hr periods by time-lapse videomicroscopy with a Leica DMIRBE
fluorescence microscope equipped with an ORCA-ER digital camera (Hamamatsu
Photonics), using Volocity 6.1.1 software (Improvision). The cells were manually tracked
using the Manual Tracking Version-1 plugin for ImageJ software version 1.50i (Fiji, NIH).
The speed, accumulated distance and directionality of each cell were calculated using
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MTrackJ and the ImageJ Chemotaxis & Migration Tool (version 1.48, Ibidi USA, Madison
WI, USA). Ten to twenty cells were tracked in each individual experiment.

3.2.7

Melanocyte isolation, culture and transfection

Mouse epidermal melanocytes were isolated from 3-day-old mice and cultured and as
described in section 2.2.3. For transfections, melanocytes were incubated for 48 hours at
37°C with 1.5 µg of DNA mixed with 4.5 µl of Lipofectamine 3000 and 3 µl of P3000
reagent (L3000-001, Thermo Fisher Carlsbad, CA, US). Where indicated, melanocytes
were plated on laminin-332 matrix isolated from 804G rat bladder squamous carcinoma
cell conditioned medium (Tripathi et al., 2008) or cultured for 24 h in CnT-PR-MD
medium (“MD medium”) purchased from CellNTec (Stauffacherstrasse, Bern,
Switzerland). To induce Cre-mediated recombination, melanocytes were cultured in
medium containing 1 µM 4OHT or ethanol, as control vehicle, for 48 h. After a PBS rinse,
the cells were cultured in melanocyte growth medium for an additional 72-h period, unless
otherwise indicated. ILK-deficient melanocytes were identified through GFP
epifluorescence. For adenoviral transduction, cells were cultured in the presence of Ad-Cre
viruses diluted in melanocyte growth medium at a multiplicity of infection (MOI) of 120.
Four hours later, the medium was removed, melanocytes were rinsed once with PBS and
cultured in melanocyte growth medium for 5 days. Under these conditions, transduction
efficiency was ³95%, with no significant loss of cell viability.

3.2.8

Immunohistochemistry, immunofluorescence and time-lapse
videomicroscopy

For immunohistochemistry and immunofluorescence details see section 2.2.4. For details
on single-cell motility assays see section 2.2.8. For experiments with Rac1-encoding
plasmids, melanocytes were seeded in 24-well µ-dishes (82046, Ibidi, USA, Madison WI,
USA) that had been coated with Collagen Type I (15 µg/cm2). To measure cell circularity,
the area and perimeter of each cell imaged were determined from cell outlines generated
using the free hand tool of ImageJ software version 1.50i (Fiji, NIH). Circularity values for
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individual cells were calculated with the equation 4pA/P2, where A=cell area and P=cell
perimeter (Robinson et al., 2019).

3.2.9

Immunoblot analysis

Cell lysates were prepared in a modified RIPA buffer (50 mM Tris-HCl pH 7.4, 150 mM
NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% sodium dodecylsulphate), 1 mM
Na3VO4, 5 mM NaF, 1 mM phenylmethylsulfonyl fluoride, 10 mg/ml each aprotinin,
leupeptin and pepstatin). Proteins in lysates were resolved by denaturing polyacrylamide
gel electrophoresis and transferred to polyvinylidene fluoride membranes, which were
probed with antibodies against proteins indicated in individual experiments.

3.2.10

Caspase-3/7 activity measurements

Melanocytes were seeded in 96-well plates at a density of 15x103 melanocytes/well and
cultured for 24 h. Caspase-3/7 activity was measured using Caspase-Glo Assay kits,
according to the manufacturer’s instructions. The Caspase-Glo Reagent was prepared by
thoroughly mixing the reaction buffer and the substrate supplied in the kit, pre-warmed to
22°C. The Reagent was added to the cells (100 µ/well), followed by incubation at 22°C
for 2 h. Caspase-3/7 activity-associated luminescence was then measured in triplicate
samples, using a Wallac Victor3 V plate reader (Perkin Elmer, Waltham, MA, US).

3.2.11

Analysis of cell spreading and dendrite outgrowth following
integrin activation

Following treatment with ethanol or 4OHT, melanocytes were trypsinized and resuspended
in MBM-4 Basal medium without endothelin-3 or growth supplements, but containing 0.1
mM MnCl2. The cells were seeded onto 4-well culture dishes (uncoated, coated with
laminin 332 matrix or with 15 µg/cm2 collagen I), at a density of 12, 500 cells/cm2 well.
Cell morphology was analyzed from mTomato or mGFP fluorescence micrographs, using
ImageJ software version 1.50i (Fiji, NIH). Changes in melanocyte circularity, used as a
measure of dendrite outgrowth, were assessed 30- and 60-min following plating on
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uncoated or laminin 332-coated surfaces. For melanocytes seeded on collagen I, cell
surface area was measured 2 h after plating, by manually rendering the cell contour in the
mTomato or mGFP fluorescence micrographs. Sixty cells per treatment were scored from
three independent cell isolates.

3.2.12

Quantification of active Rac1 levels

Rac1-GTP abundance was measured using a luminescence-based G-LISA Rac1 activation
kit (BK126; Cytoskeleton, Denver, CO, USA), according to the manufacturer’s
instructions. For these experiments, melanocytes were cultured in growth medium
containing 1 µM 4OHT or ethanol for 48 h to induce Cre-mediated Ilk excision. The cells
were then trypsinized, seeded onto 60-mm uncoated culture dishes (300,000 cells/dish),
and cultured in normal melanocyte growth medium for an additional 48-h period.
Following removal of the growth medium and two PBS rinses, melanocytes were cultured
for 16 h in MBM-4 Basal medium without endothelin-3 or growth supplements. To activate
Rac1, the MBM-4 Basal medium was replaced with pre-warmed complete growth medium,
containing endothelin-3 and growth supplements. The cells were incubated at 37°C, and
lysates were prepared at timed intervals thereafter, using the lysis buffer supplied with the
G-LISA Rac1 activation kit. Rac1-GTP-associated luminescence was measured at 440 nm
in a Wallac Victor3 plate reader (Perkin Elmer, Waltham, MA, USA), using duplicate
lysate samples containing 1 µg protein each. In each experiment, background luminescence
was measured in protein-free lysis buffer, and was subtracted from values obtained with
cell lysates.

3.2.13

Statistical analyses

Data were analyzed, as appropriate, using Student’s t-test, and one- or two-way ANOVA
with post-hoc Tukey’s correction, using Prism 6, version 6.0c software. Significance was
set at p<0.05. Experiments with cultured melanocytes were conducted in duplicate or
triplicate samples at least three times, and using independent cell isolates.
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3.3 Results
3.3.1

Defects in melanoblast ability to populate the skin in the
absence of ILK

To investigate the role of ILK in the first wave of melanogenesis, we developed a reporter
mouse model in which Cre-mediated coordinate inactivation of loxP-flanked Ilk alleles and
expression of membrane-targeted green fluorescent protein (GFP) are induced specifically
in melanocytic lineage cells upon administration of tamoxifen at E11.5. In these animals,
non-targeted cells express a membrane-bound form of Tomato fluorescent protein
(mTomato). Analysis of skin sections generated from E20.5 embryos that were
heterozygous (Tyr::CreERT2;ROSAmT/mG;Ilkf/+, hereafter termed ILK+) for the loxP-flanked
Ilk allele, and which were exposed to tamoxifen at E11.5 revealed subsets of cells that
expressed GFP in some hair follicles as well as in the interfollicular epidermis. These GFP+
cells also expressed the melanocyte-specific enzyme marker dopachrome tautomerase
(DCT), confirming their melanocytic identity (Fig. 3-1 and data not shown). Similarly,
GFP+

cells

were

detected

in

hair

follicles

from

Ilkf/f

homozygous

Tyr::CreERT2;ROSAmT/mG;Ilkf/f (hereafter termed ILKKO) mice (Fig. 3-1).
We next analyzed the consequences of Ilk gene inactivation on cutaneous embryonic
melanocytic cell abundance. Truncal melanoblasts are scarce, and about 18,000 cells have
been estimated to exist in each E15.5 embryo, mainly localized to the epidermis and the
developing hair follicle (Delmas et al., 2007). Given that our tamoxifen treatments were
designed to target only the first wave of melanoblasts, and given the potential intrinsic
efficiency limitations of tamoxifen-inducible Cre recombination in vivo, we generated
single-cell suspensions from the skin of E15.5 ILK+ and ILKKO embryos that had been
treated with tamoxifen at E11.5. We subsequently analyzed the proportion of GFP+
melanoblasts in these isolates by flow cytometry. The number of GFP-positive ILK+
melanoblasts per embryo ranged from 50 to 1,400, averaging ~470 (n=14 embryos), and
constituting ~0.1% of the entire skin cell population isolated, and ~3% of the estimated
total number of melanoblasts in E15.5 skin (Delmas et al., 2007). Inactivation of Ilk
resulted in a ~60% reduction in the number of cutaneous trunk ILKKO melanoblasts, which
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averaged ~200 cells/embryo (Fig. 3-2A). There was negligible non-induced Cre activity,
with only 0.002% of GFP+ cells (~10 cells/embryo) detected in isolates from embryos that
had not received tamoxifen (Fig. 3-2A). Analysis of tissue sections from E17.5 embryos
also revealed a deficit of ILKKO melanocytic cells. Specifically, we detected a ~50%
reduction in GFP+ ILKKO cells located in the interfollicular epidermis, relative to ILK+
cells. Similar proportions of developing hair follicles exhibiting GFP+ melanoblasts were
observed in ILK+ and ILKKO animals (Fig. 3-2B). Notably, in E20.5 embryos, the mean
number of GFP-positive ILK+ and ILKKO melanoblasts per 6 mm of interfollicular
epidermis was, respectively, 18 and 1, indicating a ~96% reduction in the abundance of
ILK-deficient melanoblasts, relative to ILK-expressing cells (Fig. 3-2C). At this time, there
was also a ~4-fold decrease in the proportion of hair follicles with detectable GFP+
melanocytic cells in ILKKO tissues, relative to those expressing ILK (Fig. 3-2C). Together,
these observations indicate that ILK is essential for the normal establishment of cutaneous
melanoblast populations in vivo. To determine if these alterations caused postnatal
pigmentation defects, E20.5 embryos were delivered by cesarean section, because the
tamoxifen treatment interfered with parturition. The coat colour patterns in ILKKO mice
were indistinguishable from those of ILK+ animals as late as 3 weeks of age (data not
shown), likely due to the presence of a significant fraction of untargeted melanocytes in
the hair follicles.
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Figure 3-1. Tamoxifen-mediated Cre targeting of 1st-wave melanocytic lineage cells
in vivo.
Skin sections showing hair follicles from E20.5 ILK+ or ILKKO littermate embryos isolated
from a dam treated with tamoxifen at 11.5 days of gestation were processed for
immunofluorescence microscopy. (A, C) Sections were immunostained using antibodies
against GFP or dopachrome-tautomerase (DCT). (B, D) Sections were immunostained
using antibodies against GFP or keratin 14 (K14). DNA was visualized with Hoescht
33342. Insets in panels A and C are shown at higher magnification in the accompanying
micrographs directly underneath. Arrows indicate the position of representative GFPexpressing DCT-positive cells. Bars, 25 µm.

91

1600

ILK+

ILKKO

-103 0 103

104

105

GFP

G

O

Tamoxifen

57

105

C

104

GFP

m

-103 0 103

0

T/

-103

KK

-103

200

m

0

KO

0

400

IL

10

103

IL
K

104

E15.5
600

K+

mTomato

104
3

GFP
0.04%

105

IL

GFP
0.1%

105

*

1400

GFP+ cells

A

Vehicle

GFP

K14

GFP K14

GFP

ILKKO

GFP+ HF (%)

ILK+

K14

GFP+ IFE Cells

B
15

*

10
5
0
50
40
30
20
0
ILK+ ILKKO

E17.5

GFP
GFP

K14

GFP K14

GFP

ILKKO

GFP+ HF (%)

ILK+

K14

GFP+ IFE Cells

C

E20.5

92

15
10

*

6
4
2
0
80

*

60
40
20
0

ILK+ ILKKO

Figure 3-2. Defects in ILK-deficient embryonic melanoblast populating of the skin.
(A) FACS dot plots of dissociated skin cells from ILK+ and ILKKO E15.5 littermate
embryos analyzed according to mTomato and GFP fluorescence intensities. The associated
graph shows the number of viable (i.e. 7-AAD-negative) GFP-positive cells in individual
embryos obtained from 4-5 independent litters of tamoxifen-treated ILK+ and ILKKO mice,
or 1 litter for embryos treated with vehicle. Red lines represent the mean number of GFPpositive cells in each group. mTmG and C57 indicate, respectively, Ilkf/f;mT/mG and
C57BL/6J mice, and * indicates P<0.05 (Student’s t-test). (B, C) Skin sections from
embryos of the indicated gestational ages were processed for immunofluorescence
microscopy with antibodies against keratin 14 (K14) or GFP. Insets are shown at higher
magnification in the adjacent micrographs. Bar, 25 µm. The graphs represent the mean
number ± SEM of GFP-positive melanocytic cells per 2 mm of interfollicular epidermis
(IFE), or the mean percentage ± SEM of hair follicles (HF) containing GFP-positive
melanocytes. Plots show results from 5 different embryos of each genotype (3 independent
litters). * indicates P<0.05 (Student’s t-test).
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3.3.2

Abnormal motility and proliferation of embryonic ILKKO
melanoblasts

Complex interactions between embryonic melanoblasts and their surrounding environment
determine their ability to migrate through various tissues, home to the skin, and eventually
distribute throughout the epidermis and the hair follicles (Petit and Larue, 2016). Given the
decreased abundance of ILKKO melanoblasts as early as E15.5, we next determined if these
cells exhibit defective motility. To this end, we first developed a system that supports
culture of embryonic melanoblasts for subsequent analyses. We isolated single-cell
suspensions of cutaneous cells from ILK+ and ILKKO E15.5 embryos that had been exposed
to tamoxifen at E11.5. GFP+ melanoblasts were isolated and purified by fluorescence
activated cell sorting (FACS). In these isolates, we first evaluated the proportion of GFP+
viable cells, defined as the population that was negative for both 7-AAD- and Annexin Vassociated fluorescence. We found that in each isolate, ≥85% of cells were viable (Fig. 33A). These FACS-purified cells were then seeded on ST2 bone marrow-derived
mesenchymal stem cell-like feeder layers. Under these conditions, melanoblasts remained
viable for at least a week, the longest interval after isolation we tested. Further, all GFP+
melanoblasts were able to transition into TRP1-expressing, melanin-producing cells by day
7 after isolation, and no longer exhibited detectable mTomato-associated fluorescence,
irrespective of whether or not they expressed ILK (Fig. 3-3B), although the abundance of
ILKKO melanoblasts was lower than that of ILK+ cells by this time (data not shown).
Melanoblast migration through embryonic tissues is modulated through attractive and
repulsive interactions with the extracellular matrix and with adjacent cells. In particular,
extracellular matrix proteins, such as laminins and collagen, provide adhesive substrates
that melanoblasts can use for integrin-mediated attachment and directional movement
(Laurent-Gengoux et al., 2018; Petit and Larue, 2016). Thus, we first investigated if ILK
is necessary for proper melanoblast adhesion. Although both ILK-expressing and ILKdeficient melanoblasts had attached to the ST2 feeder layers 16 h after FACS purification
and plating, there were clear morphological differences between the two melanoblast types.
Specifically, whereas ~70% of ILK+ melanoblasts displayed a well-spread morphology and
exhibited multiple protrusions, ~77% of ILKKO cells failed to spread, as evidenced by their
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spherical morphology (Fig. 3-4A). Time-lapse videomicroscopy analysis of well-spread
melanoblasts of both genotypes revealed highly dynamic extension and retraction of
pseudopods. The formation of long pseudopods is a requirement for optimal migration and
homing of embryonic melanoblasts. Hence, we assessed the ability of these cells to
generate long protrusions ³ 20 µm in length during a 3-h recording period. Whereas 55%
of ILK+ cells generated at least one long protrusion, only 16% of spread ILKKO
melanoblasts did (Fig. 3-4B). Random motility of well-spread ILK+ and ILKKO cells 1-3
days after initial seeding recorded over 3-h intervals was similar, with ~60% of these cells
migrating ≤ 50 µm (Fig. 3-4C). In contrast, ~50% of non-spread ILKKO melanoblasts
exhibited total migration distances >100 µm, with proportionally higher velocities (Fig. 34C, D). Significantly, the mean directional persistence of cell movement (“Directionality”,
calculated as Euclidean/Total distance migrated) was significantly greater in ILK+ cells
(0.46) than in either spread or non-spread ILKKO cells (0.32 and 0.17, respectively, Fig. 34E). Thus, ILK is essential for normal spreading, pseudopod formation and persistence of
directional motility in embryonic melanoblasts.
We also determined if Ilk inactivation alters melanoblast proliferation or apoptosis, which
might contribute to the reduced abundance of cutaneous E15.5 ILKKO melanoblasts.
Pregnant dams treated with tamoxifen at 11.5 days of gestation were subsequently
administered EdU 3 h prior to embryo harvesting; melanoblasts were FACS-purified,
plated on ST2 feeder layers, allowed to attach and processed for microscopy 16 h later.
This approach was necessary to simultaneously detect GFP immunoreactivity and EdU in
this cell population. We found that ~35% and ~19%, respectively, of ILK+ and ILKKO
melanoblasts were EdU-positive, indicating an almost 2-fold reduction in the proportion of
proliferative melanoblasts in the absence of ILK (Fig. 3-5A). In addition, only ~4% of ILK+
melanoblasts were Annexin V-positive at isolation, a fraction that was indistinguishable
from that observed in ILKKO cells (Fig. 3-5B). Collectively, these observations are
consistent with the notion that deficits in embryonic ILKKO melanoblast ability to populate
the skin are likely due, at least in part, to impaired proliferation, motility and ability to
interact with the extracellular milieu.
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Figure 3-3. Differentiation of melanoblasts into melanin-producing cells in culture.
(A) Single-cell suspensions were obtained from the skin of E15.5 ILK+ and ILKKO embryos
exposed to tamoxifen at E11.5. The cells were analyzed by flow cytometry to determine
the fraction of GFP-positive non-viable melanoblasts that exhibited 7-AAD and/or
Annexin V fluorescence. The data are plotted as the percentage of non-viable GFPexpressing cells in individual tamoxifen-treated embryos obtained from 4-5 independent
litters of ILK+ and ILKKO mice. The lines in the graph represent the mean and SD of GFPpositive non-viable cells for each genotype. (B) FACS-purified GFP-positive melanoblasts
isolated from E15.5 tamoxifen-treated embryos were cultured on ST2 feeder layers for 7
days and processed for immunofluorescence microscopy using antibodies against GFP or
TRP1. The specimens were also examined for mTomato direct fluorescence. Bright-field
images with pigment-containing cells are shown on the left. Bar, 25 µm.
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Figure 3-4. Impaired spreading and motility in ILKKO melanoblasts.
GFP-expressing melanoblasts from E15.5 tamoxifen-treated mouse embryos of the
indicated genotype were isolated by FACS and seeded on ST2 cell feeder layers. (A) GFP
immunofluorescence and GFP/phase-contrast overlay micrographs of melanoblasts 1 day
after seeding. Bar, 25 µm. (B) The mean percentage of cells (+ SD) that exhibited spread
morphology after 1 day in culture and those cells that generated at least one pseudopodium
> 20 µm in length during a 3-h time lapse videorecording period during the first 3 days of
culture are indicated in the histograms. For each genotype, > 60 melanoblasts isolated from
four different litters were scored. * indicates P < 0.05 (Student’s t-test). (C-E) Spread (S)
or round (R) melanoblasts were recorded by time-lapse videomicroscopy in 3-h intervals,
over 3 days of culture. Single-cell plots for random migration tracks were obtained (Panel
C), from which accumulated distance, speed, Euclidean distance and directionality were
calculated, and are presented as the mean + SD (Panels D, E). In the histograms of panels
D and E, the data for spread ILK+ (black bars), spread ILKKO (white bars) and round ILKKO
cells (gray bars) are shown.

* indicates P < 0.05, ANOVA (40 cells scored from 4

independent isolates).
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Figure 3-5. Impaired proliferative capacity in ILKKO melanoblasts.
(A) Representative micrographs of GFP-expressing melanoblasts isolated from embryos
of the indicated genotype treated with tamoxifen and EdU, and seeded onto ST2 feeder
layers. The cells were processed for fluorescence microscopy 16 h post-seeding to detect
EdU, and also using anti-GFP antibodies. DNA was visualized with Hoechst 33342. The
histogram represents the mean percentage + SD of EdU+ melanoblasts (360 cells from 3
independent isolates obtained from 14 ILK+ embryos; 70 cells from 3 independent isolates
obtained from 24 ILKKO embryos). Scale bar, 25 µm. * indicates P<0.05 (Student’s t test).
(B) Representative flow cytometry plots of melanoblast cell suspensions incubated with 7AAD and Annexin V (AnnV). The graph represents the percentage of Annexin V- and
GFP-positive melanoblasts in each of 12-15 embryos from 3 independent litters. Bars
indicate mean + SD.
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3.3.3

Abnormal proliferation and motility in postnatal ILK-deficient
melanocytes

To better understand how Ilk inactivation affects postnatal melanocytic cell functions, we
characterized primary melanocytes isolated from 3-day-old mice and cultured to ³ 95%
purity. Cre-mediated excision of the loxP-containing Ilk alleles was exclusively observed
in cultures treated with 4-hydroxytamoxifen (4-OHT), although only ~50% of the cells
appeared to be targeted, as indicated by the fraction of GFP-expressing cells in the cultures
(Fig. 3-6A,B). ILK protein levels in FACS-purified GFP+ melanocytes 5 days after
treatment with 4-OHT were barely detectable and were similar to those in lysates prepared
from cells that had been incubated with a Cre-encoding adenovirus with > 90%
transduction efficiency (Fig. 3-6C). mTomato fluorescence was detectable in all
melanocytes as late as 5 days following the initial 4OHT treatment. We also measured the
proliferation and apoptosis status in the cultures, and found Ki67 immunoreactivity in
~40% of ILK-expressing and ~18% of ILK-deficient melanocytes (Fig. 3-7A). Negligible
fractions of melanocytes showed either fragmented nuclear DNA or caspase 3/7 activity,
irrespective of the presence or absence of ILK (Fig. 3-7B,C). Thus, the proliferative defects
observed in ILKKO melanoblasts were maintained in ILK-deficient postnatal melanocytes.
In vivo and in culture, melanocytes interact with laminin 332 through various integrins,
including a3b1and a6b1 (Hara et al., 1994; Tanimura et al., 2011), and ILK is a key
mediator of cellular responses to laminin 332 in epithelial tissues (Jackson et al., 2015).
Because laminin 332 promotes motility in primary cultured melanocytes (Crawford et al.,
2017), we next examined the role of ILK in these responses, recording single melanocytes
for 16 h using time-lapse videomicroscopy (Fig. 3-8A). Cell trajectory plot analyses
revealed that 43% of ILK-expressing and only 2% of GFP+ ILK-deficient melanocytes
migrated distances >300 µm (Fig. 3-8B). During this time interval, ILK-expressing and
ILK-deficient cells moved on average ~307 µm and ~87 µm, respectively, which was
reflected in a ~3.5-fold difference in speed (Fig. 3-8B,C). Thus, ILK is required to maintain
normal postnatal melanocyte proliferation and for random migration on laminin-332
substrates.
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Figure 3-6. Inactivation of Ilk in cultured post-natal melanocytes.
Epidermal melanocytes were isolated from 3-day-old TyrCreERT2;mT/mG;Ilkf/f mice and
cultured to passage 2-3. (A) Cells were treated with 1 µM 4-hydroxytamoxifen (4OHT) or
control vehicle (0.25% ethanol, EtOH) for 48 h. Genomic DNA was isolated at the
indicated times following the initial addition of 4OHT or EtOH, and analyzed by PCR.
Amplicons corresponding to the Cre-excised Ilk (230 bp) or the Cre allele (280 bp) are
shown. (B) Melanocytes were treated with EtOH or 4OHT as in panel (A) and processed
for microscopy 120 h later. Phase-contrast, mTomato direct fluorescence or GFP
immunofluorescence are shown. DNA was visualized with Hoechst 33342. Bar, 64 µm.
(C) Melanocytes were treated with EtOH or 4OHT as in panel (A), or transduced for 4 h
with a Cre-encoding adenovirus at a MOI of 120. Following 5 days in culture, GFP+ cells
in 4OHT-treated samples were FACS-purified, and cell lysates from each treatment group
were prepared and analyzed by immunoblot with antibodies against ILK or GAPDH (used
as loading control).
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Figure 3-7. Proliferation defects in ILK-deficient melanocytes.
Epidermal melanocytes were isolated from 3-day-old TyrCreERT2;mT/mG;Ilkf/f mice and
cultured to passage 2-3. Cells were treated with 1 µM 4-hydroxytamoxifen (4OHT) or
control vehicle (0.25% ethanol, EtOH) for 48 h, and cultured for an additional 72-h
interval. (A) Cells were processed for immunofluorescence microscopy using anti-GFP
and anti-Ki67 antibodies. DNA was visualized with Hoechst 33342. The corresponding
phase-contrast micrographs are also shown. The arrows indicate examples of GFP- and
Ki67-positive cells. (B) Melanocyte nuclei were scored for the presence of
condensed/fragmented DNA following staining with Hoechst 33342, indicated by arrows.
Bar, 50 µm. (C) Melanocyte lysates were prepared 120 h following treatment with EtOH
or 4OHT. Relative caspase 3/7 activities were determined using a proluciferin caspase
substrate in the presence of luciferase, as described in Materials and Methods, and
measuring luminescence in relative light units (RLU). The histograms indicate the mean +
SEM, with only GFP-positive cells scored in the 4OHT group in panels A and B. *
represents P<0.05 (n=3, Student’s t test)
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Figure 3-8. Motility defects in ILK-deficient melanocytes.
Epidermal melanocytes were isolated from 3-day-old TyrCreERT2;mT/mG;Ilkf/f mice and
cultured to passage 2-3. Cells were treated with 1 µM 4-hydroxytamoxifen (4OHT) or
control vehicle (0.25% ethanol, EtOH) for 48 h, and cultured for an additional 72-h
interval. (A) Representative phase-contrast and GFP-fluorescence micrographs of cells that
were recorded by time-lapse videomicroscopy for 16 h. The adjacent diagrams show cell
trajectory plots. (B, C) The percentage of ILK-expressing melanocytes (black bars) and
ILK-deficient/GFP-positive cells (gray bars) that travelled the accumulated distance (panel
B) and speed (panel C) ranges shown were calculated. The histograms show the mean +
SD. Numbers in brackets indicate the average distance or speed, and * represents P<0.05
(70-95 cells scored from 4 independent isolates, Student’s t test). Bar, 70 µm.
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3.3.4

ILK modulates melanocyte dendricity in response to integrin
activation

Laminin 332 and collagen stimulate integrins to promote dendrite formation in
melanocytes (Hara et al., 1994). Dendritic extensions are essential for melanocyte
interactions with the epidermal basement membrane and with neighbouring keratinocytes.
We found that ~80% of ILK-expressing melanocytes seeded on laminin 332 matrix
generated on average 3-4 dendrites/cell, with at least one dendrite measuring ≥ 14 µm in
length (Fig. 3-9). Inactivation of Ilk resulted in a 25% reduction in the fraction of dendritic
melanocytes, which generated on average only ~2 dendrites/cell (Fig. 3-9).
To confirm that ILK functions downstream from activated integrins during dendrite
development, we analyzed morphological changes in response to integrin activation by
divalent cations (Hara et al., 1994). To this end, cells were suspended in growth medium
supplemented with 0.1 mM Mn2+ and seeded onto a laminin 332 matrix. We then assessed
time-dependent decreases in circularity (a ratio of cell surface-area to perimeter), as a
measure indicative of melanocyte spreading and dendricity (Robinson et al., 2019).
Integrin activation by Mn2+ significantly accelerated the formation of cell extensions within
the first 30 min after seeding in ILK-expressing melanocytes, as evidenced by a decrease
in mean circularity values from 0.71 to 0.62 in the absence and presence of this ion,
respectively (Fig. 3-10A). Circularity values in these cells further decreased after 60 min,
but were no longer affected by the presence of Mn2+. In stark contrast, circularity values in
ILK-deficient cells were not altered by Mn2+, and were significantly higher than those in
normal melanocytes at all times analyzed (Fig. 3-10A). Significantly, both ILK-expressing
and ILK-deficient cells seeded in the absence of exogenous extracellular matrix substrates
exhibited circularity values in the 0.80 range, irrespective of whether or not Mn2+ was
present (Fig. 3-10B). Similar experiments were conducted with cells suspended in medium
with or without Mn2+, but plated on collagen I. Because the development of pseudopodial
extensions in melanocytes seeded on collagen required longer intervals and was less
pronounced than in cells plated on laminin 332 matrix, we measured cell surface area,
rather than circularity, 2 h after seeding. The presence of Mn2+ increased surface area in
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both types of melanocytes. However, the loss of ILK was associated with attenuated
responses to collagen, as evidenced by the ~40% lesser mean surface area values measured
in ILK-deficient cells (Fig. 3-10C). Together, our results are consistent with the notion that
the effects observed in cells seeded on laminin 332 matrix or collagen I are associated with
integrin activation, and that ILK is necessary to transduce those signals, ultimately
promoting spreading and formation of cell extensions.

3.3.5

Role of ILK in Rac1 activation

In melanocytes, paracrine bFGF and other growth factors promote dendricity, through
mechanisms that involve activation of Rac1 (Scott and Leopardi, 2003; Shi et al., 2016).
To investigate the role of ILK in this process, we cultured melanocytes without exogenous
extracellular matrix substrates, but with growth medium supplemented with soluble factors
that promote melanin synthesis and dendrite formation (“MD medium”). Under these
conditions, the fraction of ILK-expressing cells that exhibited branched dendrites increased
~30-fold relative to the normal (“basal”) culture medium (from ~2% to ~60%; Fig. 3-11).
In contrast, only a partial response was observed in GFP+ ILK-deficient melanocytes, in
which ~18% of cells showed branched dendrites, whereas >50% of these cells remained
non-dendritic (Fig. 3-11).
ILK contributes to Rac1 activation in response to growth factors and extracellular matrix
substrates in various cell types (Ho and Dagnino, 2012; Lorenz et al., 2007;
Sayedyahossein et al., 2012). Similarly, treatment of melanocytes with basic fibroblast
growth factor (bFGF) induces Rac1 activation and motility (Shi et al., 2016). Hence, we
next investigated if ILK is involved in Rac1 activation in melanocytes. Analysis of FACSpurified GFP+, ILK-deficient cells generated by 4OHT treatment revealed no significant
decreases in Rac1 protein levels, relative to ILK-expressing melanocytes (Fig. 3-12A).
Because Rac1 activity assays were not possible using FACS-purified GFP+ ILK-deficient
melanocytes, we measured changes in active Rac1-GTP levels in cultures pre-treated with
4OHT and subsequently incubated for 16 h in the absence of growth supplements, followed
by stimulation with culture medium containing bFGF. In these cultures, we estimated that
Ilk gene inactivation occurred in ~40% of the melanocytes, based on the observed decrease
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in ILK abundance, without any significant changes in total Rac1 protein levels (Fig. 312B). Active Rac1-GTP levels increased ~2.5-fold five min following growth factor
addition in control ILK-expressing cultures, and returned to pre-stimulation levels by 10
min (Fig. 3-12C). In contrast, Rac1-GTP levels did not significantly change in response to
bFGF in 4OHT-treated cultures, suggesting that at least some pathways involved in Rac1
activation are impaired in the absence of ILK.
In response to collagen I, melanocytes form cell protrusions in a Rac1-dependent manner
(Crawford et al., 2017; Li et al., 2011). Thus, we next determined the relationship between
ILK and Rac1-associated morphological responses to this ECM substrate. To this end, we
compared the ability of exogenously expressed Rac1 proteins to modulate melanocyte
circularity, as a measure indicative of dendricity (Robinson et al., 2019). Fifty-six percent
of ILK-expressing melanocytes exhibited circularity values ≤ 0.13 sixteen hours after being
seeded on collagen I (Fig. 3-13). This fraction was not significantly altered by exogenous
expression of wild type or constitutively active G12V Rac1 (Fig. 3-13B, C). However,
expression of dominant-negative T17N Rac1 decreased this proportion to ~25% (Fig. 313D). In analogous experiments, we observed that only 29% of ILK-deficient cells
exhibited circularity values ≤ 0.13, and this fraction was not altered by expression of either
wild type or T17N Rac1. In contrast, expression of G12V Rac1 increased the proportion
of ILK-deficient cells with circularity values ≤ 0.13 to 60%, which were indistinguishable
from those in ILK-expressing cells (Fig. 3-13C). Collectively, our findings suggest that
ILK is necessary for transduction of signals from integrins and/or growth factors that result
in Rac1 activation and dendrite formation.

3.4 Discussion
In the present study we report two major findings. First, we have established ILK as a
previously unrecognized key contributor to processes that drive embryonic melanoblasts
to populate the skin. Second, we demonstrate that melanocytes require activation of ILKdependent pathways for normal interactions with the extracellular matrix, which, in turn,
modulate motility and dendricity.
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Figure 3-9. Impaired dendrite formation in ILK-deficient melanocytes in response
to laminin-332.
Epidermal melanocytes were isolated from 3-day-old TyrCreERT2;mT/mG;Ilkf/f mice and
cultured to passage 2-3. Cells were seeded on plates coated with laminin-332 substrate, and
treated one day later with 1 µM 4-hydroxytamoxifen (4OHT) or control vehicle (0.25%
ethanol, EtOH) for 48 h. Five days after initial addition of 4OHT, the cells were processed
for microscopy. (A) Phase-contrast and fluorescence micrographs of melanocyte cultures.
mTomato and GFP were visualized, respectively, by direct fluorescence or by
immunofluorescence using anti-GFP antibodies. Bar, 50 µm. (B) The percentage of cells
with at least one dendrite >14 µm in length, and the number of dendrites/cell exclusively
in dendrite-positive cells were determined, and are presented as the mean + SEM. Only
GFP-expressing cells were scored in the 4OHT-treated cultures. * represents P<0.05 (300
cells scored from 3 independent isolates, Student’s t test).
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Figure 3-10. Impaired responses to integrin activation in ILK-deficient melanocytes.
Epidermal melanocytes were treated with 1 µM 4-hydroxytamoxifen (4OHT) or control
vehicle (0.25% ethanol, EtOH) for 48 h, and cultured for an additional 72-h interval. The
cells were trypsinized and resuspended in MBM-4 Basal medium without growth
supplements, in the presence or absence of 0.1 mM MnCl2. The cells were seeded on
culture dishes coated with (A) laminin 332 matrix, (B) no exogenous matrix, or (C) 15
µg/cm2 collagen I. At the indicated times after plating, circularity or surface area values
were determined. The red lines in the dot plots represent the mean values for each treatment
group. Only GFP+ cells were scored in the 4OHT-treated population. * indicates P<0.05
(ANOVA, 60 cells/group from 3 independent isolates were scored).
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Figure 3-11. Impaired dendrite formation in ILK-deficient melanocytes in response
to soluble dendrite-inducing factors.
Epidermal melanocytes were isolated from 3-day-old TyrCreERT2;mT/mG;Ilkf/f mice and
cultured to passage 2-3. Cells were incubated with 1 µM 4-hydroxytamoxifen (4OHT) or
control vehicle (0.25% ethanol, EtOH) for 48 h. Four days after the initial addition of
4OHT, the cells were cultured in normal growth medium (“Basal medium”), or medium
supplemented with dendrite-inducing soluble factors (“MD medium”) for 24 h. The cells
were then processed for microscopy. (A) Phase-contrast and fluorescence micrographs of
melanocyte cultures in which mTomato and GFP were visualized, respectively, by direct
fluorescence or by immunofluorescence using anti-GFP antibodies. Bar, 80 µm. (B) The
percentage of cells with at least one dendrite >14 µm in length (“Dendrites”, black bars),
with branched dendrites (gray bars), or without visible dendrites (“No dendrites”, white
bars) are shown as the mean + SEM. Only GFP-expressing cells were scored in the 4OHTtreated cultures. * represents P<0.05 (300 cells scored from 3 independent isolates,
Student’s t test).
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Figure 3-12. Abnormal Rac1 activation in ILK-deficient melanocytes.
(A) The immunoblots generated with lysates prepared from FACS-purified GFP+ cells in
4OHT-treated samples shown in Fig. 3-6 were analyzed with anti-Rac1 antibodies. Rac1
intensity signals normalized to GAPDH are shown in the accompanying histogram, and
are expressed relative to values in lysates from untreated cells. (B) Melanocytes were
treated with EtOH or 1 µM 4-hydroxytamoxifen (4OHT) for 48 h, trypsinized and cultured
on uncoated dishes for 48h in normal growth medium. After incubation for 16 h in growth
supplement-free basal medium, the cells were stimulated with medium containing growth
supplements, and lysed at the indicated times thereafter. A representative immunoblot
probed with antibodies against ILK, Rac1 or GAPDH (used as a loading control) is shown.
The histograms represent ILK or Rac1 abundance normalized to GAPDH, and are
expressed as the mean +SD relative to lysates from EtOH-treated melanocytes at t=0
(which are set to 100%). # indicates P<0.05 (ANOVA, n=3). (C) Rac1-GTP levels in the
melanocyte lysates described in (B) were measured as detailed in Supplemental Materials
and Methods, and are expressed as the mean +SD, relative to the maximum Rac1-GTP
levels measured, which are set to 100%. * indicates P<0.005; n.s., not significant
(ANOVA, n=3).
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Figure 3-13. Expression of constitutively active Rac1 restores dendricity in ILKdeficient melanocytes.
(A)

Epidermal

melanocytes

(passage

2-3)

were

isolated

from

3-day-old

TyrCreERT2;mT/mG;Ilkf/f mice, and cultured for 48 h with control vehicle (0.25% ethanol,
EtOH) or with 1 µM 4-hydroxytamoxifen (4OHT) to induce Ilk gene inactivation. Twentyfour hours after initial addition of 4OHT, the cells were transfected with vectors encoding
mCardinal (“Vector”), or mCardinal- and V5-tagged wild type (WT), constitutively active
G12V or dominant negative T17N Rac1. Cells were cultured for an additional 48-h period,
and were processed for immunofluorescence microscopy. (A) Dot plots showing
circularity values of individual ILK-expressing (EtOH) and ILK-deficient (4OHT)
melanocytes expressing the indicated Rac1 proteins. Horizontal bars show the mean values.
(B-D) The percentage of EtOH- or 4OHT-treated melanocytes transfected with empty
vector (black bars) or the indicated Rac1 proteins (white bars), and with circularity values
in the indicated ranges are expressed as the mean + SEM. Only GFP+ cells were scored in
the 4OHT treatment group. * indicates P<0.05 (ANOVA, 50-110 cells scored per group in
3 separate experiments using independent isolates).
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The reporter mouse model we generated allowed us to trace melanoblasts derived from
neural crest cells during the first wave of dorsolaterally migrating melanocytic cells. In this
model, tamoxifen-induced Ilk gene inactivation occurred at E11.5, corresponding to a stage
of active melanoblast proliferation and migration through the embryo (Luciani et al., 2011;
Woodham et al., 2017). Although ILK-deficient melanoblasts were present in the E15.5
skin, their numbers were substantially reduced, likely due to abnormal proliferation and
motility, rather than decreased viability at this stage. However, by E20.5, they were
virtually undetectable in the interfollicular epidermis. In mice, melanocytic cells are
present in the interfollicular epidermis as late as the perinatal period, and are subsequently
found only in hair follicles. Given the defects in motility we observed in E15.5
melanoblasts and early postnatal melanocytes, it appears unlikely that the loss of
interfollicular epidermal melanocytic cells we observed at E20.5 is due to migration out of
this compartment. Whether this loss is associated with reduced viability remains an
important area for future research. Our mouse model clearly established the importance of
ILK in melanoblast colonization of the skin. However, our model did not allow us to
determine the importance of ILK to overall hair pigmentation. Multiple factors likely
contributed to the lack of obvious alterations in coat colour. First, based on our analysis of
ILK- and GFP-expressing embryonic melanoblasts, we estimate that only ~3% of all
melanoblasts present at E15.5 are targeted in our mice, partly because tamoxifen did not
likely target all first-wave melanoblasts. Further, as many as 65% of melanocytes in
postnatal hair follicles have been estimated to arise from Schwann precursors that give rise
to the second wave of melanogenesis (Adameyko et al., 2009). In our model, melanocytic
cells formed from Schwann cell precursors are not likely targeted, because these cells are
only born several days after tamoxifen administration. Indeed, in every hair follicle that
contained GFP+, ILK-deficient melanoblasts, we also observed a substantial presence of
non-targeted melanocytes, which conceivably contribute to hair pigmentation.
Pigmentation defects reported in genetically modified mouse models have been associated
with as much as ~85% melanocyte depletion (Tokuo et al., 2018), well above the fraction
of targeted melanocytes in our model.
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The ST2-feeder-layer culture system we developed supported E15.5 skin melanoblast
viability and differentiation into TRP1-expressing, melanin-producing cells after 7 days in
culture. This differs from the reported behaviour of cKit-positive/CD45-negative putative
melanoblasts isolated from E12.5 or E14.5 mouse skin, which generated multiple lineages
when cultured on ST2 feeder layers, with only a minor proportion of melanin-producing
cells (Watanabe et al., 2016). Whether our GFP+ melanoblasts constitute a lineagerestricted fraction of the cKit-positive/CD45-negative population, or whether the culture
conditions we used mimic embryonic skin environmental signals that instruct melanoblasts
to evolve into melanin-producing cells is an important topic for future study.
Melanoblast expansion and homing to the skin during development are influenced by the
surrounding environment and the genetic context. Our studies indicate impaired ability of
ILKKO melanoblasts to interact with their environment, as evidenced by deficits in
adhesion/spreading, formation of long pseudopods, directional persistence of movement
and proliferative capacity. The observed requirement for ILK in responses to integrin
activation in melanocytes suggests that ILK also may coordinate melanoblast interactions
with their surrounding environment through collagen and laminin receptors. ILK is a
central component of various signalling modules that contribute to cell migration,
including integrins, Rac1, and both the microtubule and F-actin networks (Jackson et al.,
2015; Li et al., 2011; Nakrieko et al., 2008; Sayedyahossein et al., 2012). Both ILK and
Rac1 modulate the frequency of formation of long pseudopodia in melanoblasts, which in
turn contributes to their ability to move among adjacent cells in the developing embryo (Li
et al., 2011). ILK may thus be an upstream modulator of Rac1 activation in embryonic
melanoblasts.
Dendrites are morphological hallmarks of melanocytic lineage cells, and fulfill important
functions as conduits for melanosome transfer to neighbouring keratinocytes. Dendrite
formation is a complex process, triggered by activation of multiple signalling pathways in
response to distinct agents, including peptide hormones, growth factors and extracellular
matrix proteins, (Scott, 2002). We found that ILKKO melanocytes have deficits in dendrite
formation, and that bypassing Rac1 activation steps through exogenous expression of
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constitutively active Rac1 restored the ability of ILKKO melanocytes to develop cell
extensions in the presence of collagen. This is consistent with the notion that collagen
interactions with a2b1 integrins likely trigger signalling pathways transmitted through
ILK, which culminate in activation of Rac1 and induction of morphological changes
characterized by dendrite outgrowth.
In humans, benign nevus melanocytes can migrate from the skin to lymph nodes (Leblebici
et al., 2016). Further, the highly metastatic behaviour of melanomas has been ascribed to
expression in these cells of genes that participate in neural crest and melanoblast migration
during embryonic development (Gupta et al., 2005; Lindsay et al., 2011). Similar to their
embryonic precursors, interactions of melanoma cells with their surrounding environment
lead to activation of pronounced motile and invasive behaviour. ILK expression is
significantly increased in melanomas, relative to nevus melanocytes. ILK has also been
implicated in mediating integrin b1-driven melanoma invasion and metastasis (El Kharbili
et al., 2017). Thus, the identification of ILK as a key regulator of melanoblast motility may
have potential important implications as a therapeutic target in human pathologies
associated with melanocytic cell movements.
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Chapter 4

4

Integrin-linked kinase regulation of melanosome
trafficking and melanin transfer to epidermal
keratinocytes

4.1 Introduction
Melanocytes are specialized cells found in the various tissues, including the skin, inner ear
and heart. Their main function is to produce melanin, a protective pigment with antioxidant
and free radical-scavenging properties (Brenner and Hearing, 2008). In the skin,
melanocytes are found in the basal layer of the epidermis and in hair follicles. Melanocytes
constitute about 10% of the epidermal cell population, with the remaining proportion
consisting mainly of keratinocytes (Cichorek et al., 2013). Melanocytes transfer melanin
to neighbouring keratinocytes to provide pigment to hair and skin, as well as for
photoprotection (Cichorek et al., 2013).
Within melanocytes, melanosomes are specialized organelles where melanin synthesis
occurs. Melanosomes undergo a defined biogenesis pathway through distinct stages of
maturation. Stage I immature melanosomes do not contain melanin and are identified by
the presence of unorganized fibrous structures, which become organized into parallel
striations in stage II melanosomes. Melanin synthesis begins in stage III melanosomes and
by stage IV, melanosomes contain maximum amounts of melanin (Marks and Seabra,
2001). Melanosomes of different stages can be identified morphologically, or by their
differential association with Rab GTPases. Stage I and II melanosomes are associated with
Rab7, whereas stage III and IV melanosomes are mainly associated with Rab27a (Jordens
et al., 2006).
Immature melanosomes are anchored in the perinuclear region of melanocytes, where they
receive the enzymes necessary for melanin synthesis (Watabe et al., 2008). These enzymes,
such as tyrosinase and tyrosinase-related protein I, are delivered to stage II melanosomes.
Once melanin production begins, mature melanosomes undergo microtubule- and actin-
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dependent transport towards the cell periphery and, in particular, towards cell extensions,
termed dendrites. The specific motors that drive melanosome transport are the microtubuleassociated motors Kinesin and Dynein, as well as the actin motor protein MyosinVa.
Mature melanosomes in the cell periphery become associated with Rab27a, which recruits
the adaptor protein melanophilin. The latter subsequently recruits MyosinVa. Together,
this tripartite complex tethers melanosomes to the F-actin fibres adjacent to the plasma
membrane. Melanin is then transferred to neighbouring keratinocytes, which likely
involves the exocytosis of melanin from melanocytes and subsequent phagocytosis by
keratinocytes (Ando et al., 2012; Tarafder et al., 2014). Within keratinocytes, melanin
granules form a perinuclear cap, protecting DNA from UV radiation-induced damage.
Integrin-liked kinase (ILK) is a ubiquitous scaffold protein, and a key cytoplasmic effector
of b1-integrins. In various cell types, the importance of ILK in regulating actin and
microtubule cytoskeletal dynamics has been clearly demonstrated. For example, ILKdeficient keratinocytes exhibit severe defects in the actin cytoskeleton organization at the
leading edge, leading to impaired directional cell migration (Nakrieko et al., 2008). In
oligodendrocytes, loss of ILK results in morphological defects characterized by
abnormalities in the actin cytoskeleton (O’Meara et al., 2013). ILK also regulates
microtubule dynamics during caveolar trafficking to the cell membrane, by recruiting the
F-actin binding protein IQGAP1 and promoting microtubule stabilization in
undifferentiated keratinocytes (Wickström et al., 2010). In differentiated keratinocytes,
ILK, together with ELMO2 and RhoG, regulates microtubule dynamic stability (Jackson
et al., 2015). In melanocytes, we have shown previously that ILK is required for dendrite
formation in response to both extracellular matrix substrates and soluble factors (Crawford
et al., 2019). Significantly, formation of dendrites is necessary for melanosome transport
and efficient melanin transfer to keratinocytes (Wu and Hammer, 2014). Given the
importance of ILK in regulating cytoskeletal dynamics and dendrite formation, we have
investigated its role in melanosome trafficking. We now demonstrate that ILK is essential
for melanosome trafficking, and for normal transfer of melanin to epidermal keratinocytes.
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4.2 Materials and methods
4.2.1

Mouse strains

For details on the mouse strains used see sections 2.2.1 and 3.2.1.

4.2.2

Antibodies

The primary antibodies and their working dilutions are shown in Table 4.1.
Table 4.1 List of antibodies used in Chapter 4.
Antibody
GFP
Rab7

Species and Dilution
Chicken 1:1000
Mouse 1:50

Catalogue Number
13970
376362

Supplier
Abcam
Santa Cruz

E7 hybridoma that produces anti–β-tubulin, developed by M. Klymkowsky, was obtained
from the Developmental Studies Hybridoma Bank, created by the National Institute of
Child Health and Human Development of the National Institutes of Health, and maintained
at the University of Iowa, Department of Biology (Iowa City, IA)

4.2.3

Adenoviral and plasmid vectors

The recombinant adenovirus encoding GFP together with Cre recombinase (“Ad-CreGFP”, catalog No. 1700) was obtained from Vector Biolabs (Philadelphia, PA, US). The
plasmid encoding Dsred-tagged melanophillin (pDsred monomer C1–MLPH) was a gift
from William Gahl (Addgene plasmid # 89236; (Fukuda and Itoh, 2004; Hume et al.,
2006); RRID:Addgene 89236), and was verified by dideoxy sequencing.

4.2.4

Cell isolation, culture and drug treatments

Mouse epidermal melanocytes were isolated and cultured as described in section 2.2.3.
Cre-mediated recombination was conducted as described in section 3.2.7. Where indicated,
melanocytes were incubated at 37°C with 10 µM paclitaxel (33069-62-4, Millipore Sigma,
Burlington, Massachusetts, US) for 1 h, or with 10 µM Ciliobrevin D (250401, Millipore
Sigma, Burlington, Massachusetts, US) for 30 min prior to time-lapse live cell imaging.
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For experiments using GSK3 inhibitors, melanocytes were cultured in medium with growth
supplements, and incubated in the presence or absence of 5 µM SB216763 (1616, Tocris
Biosciences, Bristol, United Kingdom) for 16 h. The cells were then processed for
microscopy analysis, or trypsinized and used in melanocyte/keratinocyte co-culture
experiments.
Primary epidermal keratinocytes were isolated from 4-days-old mice, and cultured in “Low
Ca2+ medium” composed of Ca2+-free Eagle's minimum essential medium (06-174G,
Lonza, Rockland, ME) supplemented with 8% fetal bovine serum (FBS) pre-treated with
Chelex-100 ion-exchange resin (1422832, Bio-Rad Laboratories, Mississauga, Canada),
antibiotics (100 unites/ml penicillin, 0.5 mg/ml streptomycin), murine epidermal growth
factor (5 ng/ml), hydrocortisone (74 ng/ml), cholera toxin (10-10 M), insulin (5 µg/ml) and
triiodothyronine (6.7 ng/ml). Culture medium was replaced every 2 days.

4.2.5

Transfection and viral transduction of melanocytes

For adenoviral transduction, cells were cultured for 4 h in the presence of Ad-Cre-GFP
virus diluted in melanocyte growth medium, at a multiplicity of infection (MOI) of 120.
Following a PBS rinse, the cells were cultured in normal growth medium for 5 days. Under
these conditions, transduction efficiency was ³95%, with no significant cytotoxicity. For
sequential transduction and transfection, melanocytes were seeded in 24-well culture
dishes at a density of 25,000 cells/cm2, and transduced with Ad-Cre-GFP as above, but 72
h after transduction, the cells in each well were transfected with 1.5 µg plasmid DNA and
4.5 µl Lipofectamine 3000. Melanocytes were processed for microscopy 48 h after the
initial addition of plasmid DNA.

4.2.6

Fluorescence microscopy and image analysis

For immunofluorescence microscopy analyses details see section 2.2.4. For circularity
analysis details see section 3.2.8.
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To analyze clustering and distribution of Rab7-positive vesicles, which mainly represent
stage I-II melanosomes (Jordens et al., 2006), we first examined images of Rab7
immunoreactivity in a random population of normal melanocytes, which showed
predominantly perinuclear Rab7-positive melanosome clusters, and visualized nuclear
DNA with Hoechst 33342 staining. To maximize the resolution, Rab7 images were
obtained using a Plan-Apochromat 63x/1.32 Oil PH3 objective (506082, Leica). We
determined that a majority of Rab7-positive melanosomes were distributed around the
nucleus within an elliptical area hereafter termed the “perinuclear belt”, defined by a minor
and a major radius equal to 2r (where r represents the minor radius of the nucleus) and 2R
(where R represents the major radius of the nucleus), respectively. For each melanocyte
imaged, pixels corresponding to Rab7-associated immunoreactivity found within and
outside the perinuclear belt were quantified using ImageJ.

4.2.7

Analysis of melanosome movements

Cells seeded on laminin 332 coated 35-mm µ-Dishes (81156, Ibidi, Madison WI, USA) at
a density of 30, 000 cells/dish were cultured for 24 h, and treated with 4OHT as described
above. For live-cell imaging, melanocytes on a heated/CO2 perfused microscope stage were
maintained at 37°C in a humidified 5%-CO2 atmosphere. Bright-field and fluorescence
time-lapse videomicroscopy images were obtained during 5- or 10-min intervals at a rate
of 6 frames/min, with a Nikon Eclipse Ti inverted microscope and a Plan-Apochromat VC
100 ×/1.4 Oil DIC N2 objective (at the Functional Proteomics Facility, Department of
Biochemistry, University of Western Ontario). Video images were acquired with NICElements Imaging Software version 4.20 (Nikon Instruments Inc., Melville, NY). The
resulting videos were exported as tagged image file formatted image stacks. Melanosomes
were manually tracked using the Manual Tracking plugin for ImageJ software, version
1.50i (Fiji, NIH). The speed, accumulated and Euclidian distance for each melanosome
were calculated using the ImageJ Chemotaxis & Migration Tool (version 1.48, Ibidi USA,
Madison WI, USA).
Single-particle melanosome trajectories were quantified using mean-squared displacement
(MSD) and processivity analysis, implemented using our previously published algorithms
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in a custom-written Matlab script (Goiko et al., 2016, 2018). Briefly, the movements of
individual melanosomes were manually tracked with the Manual Tracking plugin for
ImageJ software, as described above, and the resulting files imported into Matlab.
Directionality of melanosome movement was quantified by three different measures. First,
the MSD for individual melanosomes was calculated for lag-times (τ) of <time of 1 video
frame> to two-thirds the total length of the melanosome track (typically XX to yy min),
defined as:
#
#
&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&
&&&&&&&
〈𝑟 # 𝜏〉 = 〈(𝑥(𝑡 , + 𝜏) − 𝑥(𝑡′)1 + (𝑦(𝑡 , + 𝜏) − 𝑦(𝑡′)1 〉

Melanosome movement was then classified based on the fitting of MSD and τ to a singlepower model, with powers <1 indicating random motion, and powers >1 indicating linear
motion (Goiko et al., 2016). Processivity was calculated by scoring the average number of
frames where the melanosome moved in the same direction ± 45°. Finally, the migration
index was calculated as the ratio between the displacement of the melanosome over the
duration of the track and the total distance moved by the melanosome over the duration
of the track, using the following equation:
((𝑥= − 𝑥> )# + (𝑦= − 𝑦> )# )?/#
𝑀𝑖𝑔𝑟𝑎𝑡𝑖𝑜𝑛 𝐼𝑛𝑑𝑒𝑥 = C
∑?D=DC((𝑥= − 𝑥=B? )# + (𝑦= − 𝑦=B? )# )?/#
For each experiment, > 30 melanosomes from > 3 cells were tracked.

4.2.8

Melanin quantification

For details on melanin quantification see section 2.2.6.

4.2.9

Analysis of melanosome transfer to keratinocytes

Primary epidermal keratinocytes were seeded in 24-well µ-plates (82046, Ibidi, USA,
Madison WI, USA) at a density of 100,000 cells/cm2 and cultured for 3-4 days. After
removal of the culture medium, keratinocytes were rinsed with PBS. Trypsinized
melanocytes suspended in melanocyte medium containing growth supplements (10,00020,000 cells) were seeded onto the keratinocyte monolayers. Under these conditions,
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melanocyte:keratinocyte ratios were typically 1:6. After 8 h of co-culture at 37°C, the cells
were fixed and processed for microscopy. To evaluate melanosome uptake, the surface area
occupied by melanin granules in keratinocytes was determined from bright-field images
and expressed in pixels/cell, using the Analyze Particle function of ImageJ.

4.2.10

Statistical analyses

Data were analyzed using Student’s t-test, one- or two-way analysis of variance (ANOVA)
with post-hoc Tukey correction, as appropriate, using Graphpad Prism version 6.0c
software. Significance was set at P<0.05. All experiments were conducted in duplicate or
triplicate samples with at least three biological replicates, using independent cell isolates.
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4.3 Results
4.3.1

Defects in microtubule organization in the absence of ILK

To examine the role of ILK in microtubule organization, we isolated primary melanocytes
from 3-day-old Tyr::CreERT2;ROSAmT/mG;Ilkf/f mice. After obtaining melanocyte cultures
of ³ 95% purity, we generated ILK-expressing (ILK+) and ILK-deficient (ILKKO)
melanocytes by treatment with EtOH or 4-hydroxytamoxifen (4-OHT), respectively (Fig.
4-1). Analysis of b-tubulin immunoreactivity revealed that in ILK+ cells, microtubules
formed a dense network surrounding the perinuclear region, which was often absent or
disorganized in ILKKO cells (Fig. 4-2A). In addition, linear tracks extending from the
perinuclear region towards the cell periphery that were at least 2 nuclear diameters in length
were present in ~40% of ILK+ cells, whereas this pattern was observed in only ~10% of
ILKKO cells (Fig. 4-2B). This data indicate that ILK is necessary for normal microtubule
organization in melanocytes.

4.3.2

Abnormal distribution of Stage I-II melanosomes in ILKKO
cells

Given the defects in microtubule organization in the absence of ILK, we next analyzed the
distribution of immature melanosomes, which are identified by their association with Rab7
(Jordens et al., 2006). In ILK+ cells, Rab7 immunoreactivity was mainly localized around
the nucleus, whereas in ILKKO cells it was dispersed throughout the entire cell (Fig. 4-3A).
Analysis of three-dimensional surface plots representing the Rab7 signal throughout the
cell revealed that in ILK+ cells, Rab7 was concentrated around the nucleus, with very little
fluorescence at the cell periphery. In contrast, Rab7-associated pixels were distributed
throughout the cell in ILKKO cells (Fig. 4-3B). To quantify our observations, we determined
the fraction of Rab7 immunoreactivity outside a perinuclear belt zone, which we defined
as the area surrounding the nucleus that was within one nuclear diameter in each the X and
Y axes (Nabavi et al., 2008)(Fig. 4-3C). We found a 1.6-fold increase in the proportion of
Rab7 signal outside of the perinuclear belt in ILKKO cells compared to ILK+ (Fig. 4-3C).
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ILK+

ILKKO

mTomato

GFP

Figure 4-1. Inactivation of Ilk in cultured postnatal melanocytes.
Epidermal melanocytes were isolated from 3-day-old TyrCreERT2;mT/mG;Ilkf/f mice and
cultured to passage 2-3. Cells were treated with 1 µM 4-hydroxytamoxifen (4OHT) or
control vehicle (0.25% ethanol, EtOH) for 48 h, and cultured for an additional 72-h interval
to generate ILKKO and ILK+ melanocytes, respectively. Micrographs show mTomato direct
fluorescence or GFP immunofluorescence. Bar, 10 µm.
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Figure 4-2. Microtubule defects in ILKKO melanocytes.
Epidermal melanocytes were isolated from 3-day-old TyrCreERT2;mT/mG;Ilkf/f mice and
cultured to passage 2-3. Cells were seeded on plates coated with laminin-332 substrate, and
treated one day later with 1 µM 4-hydroxytamoxifen (4OHT) or control vehicle (0.25%
ethanol, EtOH) for 48 h to generate ILK-deficient (ILKKO) and ILK-expressing (ILK+)
melanocytes, respectively. (A) Five days after initial addition of 4OHT, the cells were
processed for immunofluorescence microscopy using antibodies against b-tubulin and
GFP. Bar, 10 µm. (B) The percentage of cells with linear microtubules extending at least
2 nuclear diameters. Results are shown as the mean + SEM, with only GFP-positive cells
scored in the 4OHT group in panel A (shown in inset). * represents P<0.05 (n=3, Student’s
t test)
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Figure 4-3. Irregular distribution of immature melanosomes in the absence of ILK.
Epidermal melanocytes were isolated from 3-day-old TyrCreERT2;mT/mG;Ilkf/f mice and
cultured to passage 2-3. Cells were seeded on plates coated with laminin-332 substrate and
treated one day later with 1 µM 4-hydroxytamoxifen (4OHT) or control vehicle (0.25%
ethanol, EtOH) for 48 h to generate ILK-deficient (ILKKO) and ILK-expressing (ILK+)
melanocytes, respectively. Five days after initial addition of 4OHT, the cells were
processed for microscopy. (A) Fluorescence micrographs of ILK+ and ILKKO melanocytes.
mTomato was visualized by direct fluorescence and GFP was visualized by
immunofluorescence using an anti-GFP antibody. Immature melanosomes were identified
using an antibody against Rab7. Bar, 10 µm. (B) 3D surface plots representing the intensity
of Rab7 signal throughout the cell outlined in panel A. Nuclei are indicated by blue circle.
(C) Left: An illustration representing the region defined as the perinuclear belt where d =
diameter of nucleus. Right: The fraction of Rab7 signal outside of the perinuclear belt.
Results are shown as the mean + SD, with only GFP-positive cells scored in the 4OHT
group in panel A. * represents P<0.05 (n=3, Student’s t test).

139

We next analyzed the distribution of early melanosomes relative to mature melanosomes.
Both Stage I and II and melanin-containing Stage III-IV melanosomes were detected in the
perinuclear region in both melanocyte types. However, cell extensions of ILK+ cells
contained almost exclusively mature melanosomes, whereas in ILKKO cells both Rab7positive and melanin-containing mature melanosomes were found at the cell periphery
(Fig. 4-4A). The mature melanosomes at the cell periphery in ILK+ cells appeared to be
associated with microtubule tracks. In contrast, microtubules did not fully extend to cell
protrusions in ILKKO cells (Fig. 4-4B). Thus, loss of ILK results in abnormal distribution
of melanosomes.

4.3.3

Defects in melanosome trafficking in the absence of ILK

Because microtubule tracks are essential for trafficking of melanosomes, we next analyzed
the consequences of Ilk gene inactivation on melanosome movements, using time-lapse
videomicroscopy. Analysis of melanosome trajectory plots revealed substantial differences
in melanosome movements in each cell type (Fig. 4-5A). Melanosomes in ILK+ cells and
ILKKO cells displayed average speeds of 0.02 µm/s and 0.05 µm/s, respectively (Fig.4-5B).
Similarly, we observed a significant difference in the accumulated distance, which
averaged about 17 µm in ILK+ cells and 28 µm in ILKKO cells, during a 10-min imaging
interval (Fig. 4-5B).
Melanosomes are highly dynamic, traveling throughout the cell at various speeds. Some
melanosomes have speeds less than 0.01 µm/s, a slow movement that has been interpreted
to signify that melanosomes are docked to the cytoskeleton. Other melanosomes exhibit
linear bi-directional movements with speeds ³ 0.01 µm/s, indicative of active transport
along microtubules (Bruder et al., 2012). To further characterize melanosomes in ILK+ and
ILKKO cells, we determined the proportion of melanosomes that exhibited each type of
movement, based on their speed and direction (Fig. 4-5C). The proportion of melanosomes
presumably docked to the cytoskeleton, and with speeds £ 0.01 µm/s was similar in both
melanocyte types. About 52% of melanosomes in ILK+ cells traveled in a linear direction,
whereas only 27% of melanosomes in ILKKO cells exhibited this type of movement (Fig.
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4-5D). Significantly, 24% of melanosomes in ILKKO cells showed random movements
traveling at speeds greater than 0.05 µm/s, a type of movement that was not detected in
ILK+ cells (Fig. 4-5D). Melanosomes in ILKKO cells were also defective in their ability to
sustain forward movement (“Processivity”) (Fig. 4-5E, F).
Kinesin and Dynein are the main microtubule motors that transport melanosomes towards
the cell periphery or the perinuclear area, respectively. Given the abnormal melanosome
movement and dispersion of immature melanosomes to the cell periphery in the absence
of ILK, we first investigated if these defects might be associated with Dynein, and
measured melanosome movements in cells treated with the dynein inhibitor Ciliobrevin D.
In cells treated with DMSO (vehicle), there was a 3-fold greater distance traveled and speed
of melanosomes in ILKKO cells compared to melanosomes in ILK+ cells. Treatment with
Ciliobrevin D reduced the accumulated distance and speed of melanosomes in both ILK+
and ILKKO cells to similar levels (Fig. 4-5G). These data suggest that by inhibiting Dynein
activity, melanosome movement is also reduced, regardless of whether ILK is present or
absent. Thus, Dynein appears to contribute to melanosome movements in both ILK+ and
ILKKO cells.

4.3.4

Effects of paclitaxel on melanosome trafficking

Loss of ILK increases dynamic microtubule instability (Jackson et al., 2015; Wickström et
al., 2010). Thus, we next determined the effect of stabilizing microtubules with paclitaxel.
Microtubule tracks extending from the nucleus to the cell periphery could be visualized in
both ILK+ and ILKKO cells treated with this drug (Fig. 4-6A). These microtubules reached
cell extensions and appeared to be in close proximity with mature melanosomes (Fig. 46B). Paclitaxel did not significantly alter melanosome movement in ILK+ cells (Fig. 4-6C).
In ILKKO cells, paclitaxel significantly increased the proportion of melanosomes that
exhibited speeds > 0.01 µm/s and traveled in a linear direction, from 17% to 36%.
Additionally, the percentage of melanosomes moving randomly and at > 0.01 µm/s
significantly decreased from 48% to 17% in these cells (Fig. 4-6C). The fraction of
melanosomes in ILKKO cells that exhibited linear movements after paclitaxel treatment,
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was indistinguishable from that in ILK+, suggesting that microtubule stabilization can
restore melanosome movements in the absence of ILK, at least under the conditions of
these experiments.

4.3.5

Altered melanophilin distribution in ILKKO cells

After travelling along microtubules melanosomes become bound to actin filaments at the
plasma membrane. Essential for this capture is a tripartite complex composed of Rab27a,
melanophilin and Myosin-Va. The adaptor protein melanophilin localizes to various
cellular structures, including the + ends of microtubules, the mature melanosomes in the
cell periphery, and cortical F-actin. Melanophilin contains sequences that are sensitive to
degradation by cytosolic proteases, and when overexpressed, it can disrupt melanosome
transport, suggesting that its levels are highly regulated within melanocytes (Fukuda and
Itoh, 2004; Hume et al., 2006). As a result, lower levels of overexpressed protein are often
difficult to detect (Fukuda and Itoh, 2004; Hume et al., 2006). To facilitate detection and
analysis of the distribution of melanophilin in ILK+ and ILKKO cells, we exogenously
expressed DsRed-tagged melanophilin in melanocytes isolated from mice with lox-Pflanked Ilk alleles (hereafter termed Ilkf/f), and transduced them with an adenovirus that
encodes a Cre-GFP fusion protein (AdCreGFP) to generate ILKKO cells with ~90%
efficiency. In non-transduced ILK+ cells, melanophilin was detected throughout the
cytoplasm and at the cell membrane in a punctate pattern (Fig. 4-7A). Similar results were
observed in control melanocytes isolated from mice heterozygous for the floxed Ilk allele
and transduced with AdCreGFP (Fig. 4-7A). In ~97% of ILK+ cells, the mean surface area
of melanophilin puncta at the periphery was £ 2.5 µm2 (Fig. 4-7B). In contrast,
melanophilin aggregates with a mean surface area > 2.5 µm2 were found in ~37% of ILKKO
cells, representing a > 10-fold increase, and suggesting that, in the absence of ILK, the
distribution of melanophilin is abnormal (Fig. 4-7B). Of note, overexpression of
melanophilin resulted in perinuclear clustering of melanosomes as previously reported
(Fukuda and Itoh, 2004), irrespective of whether ILK was present or absent (Fig. 4-7C).
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Figure 4-4. Melanosome defects in the absence of ILK.
Epidermal melanocytes were isolated from 3-day-old TyrCreERT2;mT/mG;Ilkf/f mice and
cultured to passage 2-3. Cells were seeded on plates coated with laminin-332 substrate, and
treated one day later with 1 µM 4-hydroxytamoxifen (4OHT) or control vehicle (0.25%
ethanol, EtOH) for 48 h to generate ILK-deficient (ILKKO) and ILK-expressing (ILK+)
melanocytes, respectively. Five days after initial addition of 4OHT, the cells were
processed for immunofluorescence microscopy using antibodies against GFP and (A) Rab7
to identify early melanosomes or (B) b-tubulin to visualize microtubule tracks. The white
dashed line indicates the cell periphery. Mature melanosomes are pseudocolored red (Mel).
Arrows point to regions that are shown at high magnification in the micrographs directly
below. Inset shows GFP-positive cells in 4OHT-treated samples. Bar, 10 µm
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Figure 4-5. Abnormal melanosome trafficking in ILKKO melanocytes.
Epidermal melanocytes were isolated from 3-day-old TyrCreERT2;mT/mG;Ilkf/f mice and
cultured to passage 2-3. Cells were treated with 1 µM 4-hydroxytamoxifen (4OHT) or
control vehicle (0.25% ethanol, EtOH) for 48 h to generate ILK-deficient (ILKKO) and
ILK-expressing (ILK+) melanocytes, respectively. Cells were then cultured for an
additional 72 h interval. (A) Representative phase-contrast and GFP-fluorescence
micrographs of cells that were recorded by time-lapse videomicroscopy for 10 minutes at
100 x magnification. Bar, 20 µm. The adjacent diagrams show cell trajectory plots of
melanosomes in ILK+ and ILKKO cells from which (B) the accumulated distance and speed
ranges were examined using the Chemotaxis and Migration Tool plugin for Image J (Ibidi).
Results are expressed at the mean + SD. (C) Categories representing the types of
melanosome movement based on speed (µm/s) and direction traveled. (D) The percentage
of melanosomes exhibiting each type of movement based on their speed and direction
traveled. Results are expressed as the mean + SEM (E) Processivity of melanosomes.
Results are expressed as the line at median. Only melanosomes in GFP-positive cells
scored in the 4OHT-treated cells shown in panel A. * represents P<0.05 (150 melanosomes
from 4 independent isolates were tracked, Student’s t test). (F) Migration index of
melanosomes. Result are expressed as the mean + SD. (G) Accumulated distance and speed
values after treatment with 10 µM Ciliobrevin D or control vehicle (0.1% DMSO) for 30
min at 37°C. Results are expressed as the mean + SD indicated by the red line. * represents
P<0.05 (50 melanosomes from 3 independent isolates were tracked, One-way ANOVA).
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Figure 4-6. Effects of paclitaxel on microtubules and melanosome movement.
Epidermal melanocytes were isolated from 3-day-old TyrCreERT2;mT/mG;Ilkf/f mice and
cultured to passage 2-3. Cells were seeded on plates coated with laminin-332 substrate,
treated one day later with 1 µM 4-hydroxytamoxifen (4OHT) or control vehicle (0.25%
ethanol, EtOH) for 48 h to generate ILK-deficient (ILKKO) and ILK-expressing (ILK+)
melanocytes, respectively. Five days after the initial addition of 4OHT, cells were treated
with 10 µM paclitaxel or control vehicle (0.1% DMSO) for 1 h at 37°C, and then
melanosomes were recorded using time-lapse videomicroscopy for 5 min or processes for
immunofluorescence microscopy. (A) microtubules were visualized with an antibody
against b-tubulin. Adjacent plots show representative melanosome tracks. (B) Overlay of
microtubules with mature melanosomes (Mel). Arrows point to regions shown at higher
magnification in the micrographs directly below in which arrowheads point to mature
melanosomes that appear to be associated with microtubule tracks. Bar, 10 µm. (C) The
fraction of melanosomes exhibiting each category of movement based on their speed and
direction traveled. Only melanosomes in GFP-positive cells scored in the 4OHT-treated
cells (shown in inset). Results are expressed as the mean + SEM (100 melanosomes from
4 independent isolates were tracked, Student’s t-test, * P<0.05).
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Figure 4-7. Effects of Ilk deficiency on melanophilin distribution.
Epidermal melanocytes were isolated from 3-day-old Ilkf/f and Ilkf/+ mice and cultured to
passage 2-3. Cells were seeded on plates coated with laminin-332 substrate and transduced
one day later with a CreGFP-encoding adenovirus (AdCreGFP) for 4 h. Three days later
melanocytes were transfected with a vector encoding melanophilin and cultured for an
additional 48-h interval. Melanophilin was visualized by direct fluorescence. (A) Cells
were processed for immunofluorescence microscopy with an antibody against GFP. Bar,
10 µm. (B) The percentage of cells with melanophilin aggregates with a mean surface area
> 2.5 µm2. Results are expressed as the mean + SD (60 cells scored from 3 independent
cell isolations, Student’s t-test, * P < 0.05). (C) Melanosomes (Mel) pseudocolored green
with adjacent corresponding bright-field images. Red dotted line indicates the cell
periphery.
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4.3.6

Effect of Ilk deficiency on melanin transfer from melanocytes
to keratinocytes

We next investigated the ability of melanocytes to transfer melanin to keratinocytes in coculture (Fig. 4-8A). Quantification of total melanin contents in ILK+ or ILKKO
monocultures revealed no significant differences (Fig. 4-8B). We co-cultured ILK+ or
ILKKO melanocytes with primary keratinocytes at a ratio of 1:6 for 8 h. To measure melanin
transfer, we determined the area within keratinocytes that was occupied by melanin
granules in pixels/cell, using bright-field microscopy as previously reported (Tarafder et
al., 2014). Given that the primary epidermal keratinocytes used were isolated from mice
with a C57BL/6 background, we determined a baseline of melanin within keratinocytes
that would have presumably been transferred from melanocytes in vivo. The area occupied
by melanin in keratinocyte monocultures was on average 220 pixels/cell (Fig. 4-8C).
Following 8 h of co-culture with ILK+ cells, the amount of melanin increased 3-fold to 786
pixels/cell, indicating efficient melanin transfer. In stark contrast, keratinocytes co-cultured
with ILKKO cells contained similar amounts of melanin compared to keratinocyte
monocultures, indicating very poor transfer of melanin in the absence of ILK (Fig. 4-8C).
Together our data suggest that ILK is not essential for melanin synthesis, but is necessary
for melanin transfer to keratinocytes.

4.3.7

Effects of GSK-3 inhibition on melanocyte responses

GSK-3 phosphorylates CRMP2, reducing its ability to interact with tubulin dimers and
promote microtubule polymerization (Kim et al., 2011). Reciprocally, inhibition of GSK3 is associated with microtubule formation and stabilization (Jackson et al., 2015; Kim et
al., 2011). To investigate the role of GSK-3 in melanocytes, we treated ILK+ or ILKKO
melanocytes with DMSO (vehicle) or with the GSK-3 inhibitor SB216763 (5 µM) for 24
h. Given that microtubules are an essential component of dendrites (Delandre et al., 2016),
we determined the effects of GSK-3 inhibition on dendricity of ILK+ or ILKKO melanocytes
(Fig. 4-9A). In the absence of exogenous ECM substrates or in the presence of laminin
332, ILKKO melanocytes had significantly higher circularity values compared to ILK+ cells,
indicating reduced formation of dendrites (Fig. 4-9B) (Robinson et al., 2019).
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Significantly, GSK-3 inhibition partially restored the ability of melanocytes to form
dendrites in the absence of ILK (Fig. 4-9B).
We next investigated the effects of GSK-3 inhibition on dendricity and melanin transfer in
the melanocyte-keratinocyte co-culture system. We first conducted a pilot study to
determine the effects of pre-treating melanocytes with the inhibitor for 24 h followed by 8
h of co-culture in the absence of the inhibitor, compared to a 24 h pre-treatment followed
by 8 h of co-culture in the presence of the inhibitor (total = 32 h). We observed that the
maximum effect of GSK-3 inhibition occurred following the 24 h pre-treatment, with
minimal additional effect when the inhibitor was added during co-culturing (Appendix 1).
From these observations, we conducted melanin transfer experiments by pre-treating
melanocytes with the inhibitor for 24 h, washing the melanocytes, and completing the coculture period in the absence of the inhibitor, avoiding potential drug effects on the
keratinocytes.
When cultured with keratinocytes, we observed that ILK+ melanocytes responded by
forming multiple dendrites. In contrast, ILKKO melanocytes were less dendritic, indicating
an impaired ability to respond to keratinocyte-derived factors (Fig. 4-10A). ILK+ and
ILKKO melanocytes treated with DMSO exhibited average circularity values of 0.17 and
0.31, respectively. (Fig. 4-10B). Following GSK-3 inhibition, there was no significant
change in the circularity of ILK+ melanocytes. However, the circularity of ILKKO
melanocytes treated with the drug significantly decreased to 0.16 (Fig. 4-10B). Thus, in
the absence of ILK, melanocytes are defective in their ability to form dendrites in response
to keratinocyte-secreted factors. Further, inhibition of GSK-3 in ILK-deficient cells
partially restored dendricity, suggesting that ILK is required to modulate GSK-3 activity
and promote dendrite growth.
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Figure 4-8. Defects in melanin transfer in the absence of ILK.
Epidermal melanocytes were isolated from 3-day-old TyrCreERT2;mT/mG;Ilkf/f mice and
cultured to passage 2-3. Cells were treated with 1 µM 4-hydroxytamoxifen (4OHT) or
control vehicle (0.25% ethanol, EtOH) for 48 h to generate ILK-deficient (ILKKO) and
ILK-expressing (ILK+) melanocytes, respectively. Cells were then cultured for an
additional 72 h interval. Epidermal keratinocytes (KT) were isolated from 3-day-old
TyrCreERT2;mT/mG;Ilkf/f mice and cultured for 3-4 days. ILK+ and ILKKO melanocytes
were added to keratinocytes at a ratio of 1:6 and following 8 h of co-culture, cells were
processed for microscopy. (A) mTomato and GFP were visualized by direct fluorescence,
and immunofluorescence using an anti-GFP antibody, respectively. Mature ILK+
melanocytes are pseudocolored white (Mel). Corresponding bright-field images are shown
below, with keratinocytes outlined by a black dashed line. Bottom panels represent high
magnification images of keratinocytes. Bar, 10 µm. (B) Melanin was extracted and
quantified in melanocyte monocultures. Results expressed as the mean + SD. (C) The area
occupied by melanin in pixels per cell was determined using the Particle Analysis function
of Image J (NIH). The baseline of melanin transfer, indicated by the red line, was
determined from keratinocyte monocultures. In co-cultures with keratinocytes and ILKKO
melanocytes, only keratinocytes next to GFP-positive melanocytes were scored. Results
are expressed as the mean + SEM (100 keratinocytes scored from 4 independent
experiments, One-Way ANOVA, * represents P<0.05).
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We also determined the effect of GSK-3 inhibition on melanin transfer. Following 8 h of
co-culture the area occupied by melanin within keratinocytes co-cultured with ILK+ and
ILKKO cells treated with DMSO was 718 pixels/cell and 260 pixels/cell, respectively (Fig.
4-10C). Inhibition of GSK-3 in ILK+ melanocytes resulted in a 40 % reduction in the area
occupied by melanin within keratinocytes, suggesting that at least some of the mechanisms
involved in melanin transfer are dependent on active GSK-3. In ILKKO cells, inhibition of
GSK-3 had no significant effect on the ability of ILK-deficient melanocytes to transfer
melanin (Fig. 4-10C). Thus, our data suggest that active GSK-3 is required for optimal
melanin transfer.

4.4

Discussion

This study reveals important and novel insights into how ILK regulates melanosome
trafficking and melanin transfer to epidermal keratinocytes. Our data also suggest that ILK
functions upstream from GSK-3 to promote dendrite formation.
In the absence of ILK, microtubules are disorganized. Specifically, there is a loss of a
defined perinuclear microtubule network, as well as a substantial decrease in linear
microtubules extending to the cell periphery. As a result, immature Rab7-associated
melanosomes that are normally maintained in the perinuclear region, are dispersed
throughout the cell. Immature melanosomes are anchored to microtubules in the central
area of the cell surrounding the nucleus, through interactions with Rab7, Dynein and
Spectrin (Watabe et al., 2008). Inhibition of Dynein causes dispersion of immature
melanosomes to the cell periphery in primary human melanocytes (Jordens et al., 2006).
Given that we observed a similar distribution of immature melanosomes in ILKKO cells,
and that the movement of mature melanosomes was abnormal, we investigated if these
defects might be associated with Dynein. However, following treatment with the Dynein
inhibitor Ciliobrevin D, melanosome movement was reduced irrespective of whether ILK
was present or absent, demonstrating that Dynein is associated with the movement of
melanosomes in both cell types. Stabilization of microtubules with paclitaxel restored, to
some degree, the presence of a dense microtubule network in the perinuclear region in

155

ILKKO cells. Therefore, it is possible that the irregular distribution of immature
melanosomes is due, at least in part, to microtubule destabilization in the absence of ILK.
In the absence of ILK, mature melanosomes are defective in their ability to sustain forward
movement. Stabilization of microtubules with paclitaxel also increased the presence of
linear microtubules and partially restored normal melanosome movements. Given that
melanosomes in ILKKO cells treated with paclitaxel exhibit similar speed and directionality
to melanosomes in ILK+ cells treated with DMSO, microtubule destabilization may be a
major factor contributing to the abnormal movement of melanosomes in the absence of
ILK. These results are consistent with the role of ILK in stabilization of microtubules in
keratinocytes (Jackson et al., 2015; Wickström et al., 2010) and other cell types (Akhtar
and Streuli, 2013).
Melanophilin localizes to microtubules and mature melanosomes throughout the cell, as
well as F-actin at the plasma membrane (Robinson et al., 2019). In the absence of ILK, we
observed large aggregates of melanophilin at the cell membrane. The distribution of
melanophilin can be affected by certain factors, such as PKA-dependent phosphorylation,
which causes melanophilin to preferentially bind actin and suppresses its affinity towards
microtubules (Oberhofer et al., 2017). Thus, our data may suggest that since microtubules
are unorganized in the absence of ILK there is a shift from melanophilin associating with
both microtubules and actin, to it mainly localizing to F-actin. Whether the altered
distribution affects the ability of melanophilin to interact normally with Rab27a or MyosinVa remains to be investigated. Our observations that exogenous expression of wild-type
melanophilin causes perinuclear clustering of melanosomes, are consistent with previous
findings (Fukuda and Itoh, 2004). The proposed mechanism by which overexpressed
melanophilin results in perinuclear clustering of melanosomes is poorly understood, but
may involve inhibition of melanosome transfer from microtubules to actin filaments at the
plasma membrane (Fukuda and Itoh, 2004). As a result, melanosomes cluster in the
perinuclear region via retrograde transport. We observed perinuclear clustering in both
ILK-expressing and -deficient cells, which suggest that retrograde transport mechanisms
are functional in both cell types. This confirms our previous data showing disruptions in
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melanosome movements in ILK-expressing and -deficient cells following inhibition of
Dynein by Ciliobrevin D.
Melanocytes respond to growth factors secreted by keratinocytes by forming dendrites and
transferring melanin (Scott, 2002). Loss of ILK resulted in an impaired ability of
melanocytes to form dendrites and transfer melanin in response to keratinocytes. Following
inhibition of GSK-3, the ability of ILK-deficient melanocytes to form dendrites was
partially restored. Thus, ILK may be necessary to promote inhibition of GSK-3 during
dendrite formation. Our results are consistent with previous studies, that demonstrated
inhibition of GSK3b is essential for dendritic growth in neurons, which share a common
embryonic origin with melanocytes (Rui et al., 2013). In epidermal keratinocytes, ILK is
required for Rac1 activation. Active Rac1 phosphorylates and inactivates GSK-3,
promoting microtubule stability (Jackson et al., 2015). We have previously shown that ILK
functions upstream from Rac1 activation in melanocytes (Crawford et al., 2019, In Press).
Therefore, it is possible that the mechanism by which ILK promotes inactivation of GSK3 is through Rac1 activation. Given that dendrites are the primary site for melanin transfer,
we investigated if inhibition of GSK-3 would restore melanin transfer. Melanin transfer
from ILK-expressing cells in the presence of the inhibitor was significantly reduced,
suggesting that the transfer of melanin occurs through both active GSK-3-independent and
dependent mechanisms. Therefore, our data uncovers a previously unknown role for active
GSK-3 in melanin transfer. GSK-3 phosphorylates and activates MITF, which enhances
the binding of MITF to its target sequences (Khaled et al., 2002). MITF regulates the
expression of genes that encode for proteins involved melanosome transport, such as
Rab27a (Chiaverini et al., 2008). Therefore, in addition to promoting microtubule
stabilization, it is possible that inhibition of GSK-3 disrupted other cellular processes, such
as MITF activation, that are required for optimal melanin transfer. Following inhibition of
GSK-3 the ability of ILKKO cells to transfer melanin was comparable to that of ILK+ cells.
This suggests that during at least some of the processes involved in melanin transfer, ILK
may be required for inactivation of GSK-3.
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Figure 4-9. GSK-3 inhibition restores melanocyte dendricity.
Epidermal melanocytes were isolated from 3-day-old TyrCreERT2;mT/mG;Ilkf/f mice and
cultured to passage 2-3. Cells seeded in the absence of exogenous ECM (no ECM), or in
the presence of laminin 332 (Lam 332) were treated with 1 µM 4-hydroxytamoxifen
(4OHT) or control vehicle (0.25% ethanol, EtOH) for 48 h. On day 4, melanocytes were
treated with DMSO (V) or 5 µM of SB216763 (SB) for 24 h. (A) mTomato and GFP were
visualized by direct fluorescence and immunofluorescence using an antibody against GFP,
respectively. Bar, 50 µm. (B) The circularity of melanocytes was determined using the
equation 4pA/P2 where A = cell area and P = cell perimeter. Results are expressed as the
mean (red line) + SD (90 melanocytes scored from 3 independent experiments, with only
GFP-expressing cells scored in 4OHT treated samples).
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Figure 4-10. Effect of GSK-3 inhibition on melanocyte responses to keratinocytes.
Epidermal melanocytes were isolated from 3-day-old TyrCreERT2;mT/mG;Ilkf/f mice and
cultured to passage 2-3. Epidermal keratinocytes (KT) were isolated from 3-day-old
TyrCreERT2;mT/mG;Ilkf/f mice and cultured for 3-4 days. Melanocytes were treated with
1 µM 4-hydroxytamoxifen (4OHT) or control vehicle (0.25% ethanol, EtOH) for 48 h.
Melanocytes were pretreated with SB216763 for 24 h prior to their addition to
keratinocytes. (A) Bright-field images of melanocyte-keratinocyte co-cultures. Directly
below are the corresponding micrographs where mTomato was visualized by direct
fluorescence, GFP was visualized by immunofluorescence microscopy with an antibody
against GFP, ILK+ cells are shown by images with mature melanosomes pseudocolored
white (Mel). Bar, 50 µm. (B) The circularity of melanocytes was determined using the
equation 4pA/P2 where A = cell area and P = cell perimeter. Results are expressed as the
mean (red line) + SD (90 melanocytes scored from 3 independent experiments). (C) The
area occupied by melanin in pixels/cell was determined. The results are expressed as the
mean + SEM (75 keratinocytes scored from 3 independent experiments). The red line
indicates the baseline of melanin transfer in keratinocyte monocultures. * indicates P <
0.05 (One-way ANOVA).
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In conclusion, our studies demonstrate that ILK is a key component of the mechanisms that
regulate microtubule stability and melanosome trafficking in melanocytes. In addition, ILK
is essential for melanin transfer to epidermal keratinocytes, a biological function necessary
for both skin pigmentation and photoprotection. Whether keratinocytes co-cultured with
ILKKO melanocytes are more susceptible to damage by UV radiation remains an important
area for future research.

161

4.5 References
Akhtar, N., and Streuli, C.H. (2013). An integrin-ILK-microtubule network orients cell
polarity and lumen formation in glandular epithelium. Nat. Cell Biol. 15, 17–27.
Ando, H., Niki, Y., Ito, M., Akiyama, K., Matsui, M.S., Yarosh, D.B., and Ichihashi, M.
(2012). Melanosomes Are transferred from melanocytes to keratinocytes through the
processes of packaging, release, uptake, and dispersion. J. Invest. Dermatol. 132, 1222–
1229.
Brenner, M., and Hearing, V.J. (2008). The protective role of melanin against UV damage
in human skin. Photochem. Photobiol. 84, 539–549.
Chiaverini, C., Beuret, L., Flori, E., Busca, R., Abbe, P., Bille, K., Bahadoran, P., Ortonne,
J.-P., Bertolotto, C., and Ballotti, R. (2008). Microphthalmia-associated transcription factor
regulates RAB27A gene expression and controls melanosome transport. J. Biol. Chem.
283, 12635–12642.
Cichorek, M., Wachulska, M., Stasiewicz, A., and Tymińska, A. (2013). Skin melanocytes:
biology and development. Adv. Dermatol. Allergol. Dermatol. Alergol. 30, 30–41.
Delandre, C., Amikura, R., and Moore, A.W. (2016). Microtubule nucleation and
organization in dendrites. Cell Cycle 15, 1685–1692.
Fukuda, M., and Itoh, T. (2004). Slac2-a/melanophilin contains multiple PEST-like
sequences that are highly sensitive to proteolysis. J. Biol. Chem. 279, 22314–22321.
Goiko, M., de Bruyn, J.R., and Heit, B. (2016). Short-Lived cages restrict protein diffusion
in the plasma membrane. Sci. Rep. 6, 34987.
Goiko, M., de Bruyn, J.R., and Heit, B. (2018). Membrane diffusion occurs by Continuoustime random walk sustained by vesicular trafficking. Biophys. J. 114, 2887–2899.
Hume, A.N., Tarafder, A.K., Ramalho, J.S., Sviderskaya, E.V., and Seabra, M.C. (2006).
A coiled-coil domain of melanophilin is essential for Myosin Va recruitment and
melanosome transport in melanocytes. Mol. Biol. Cell 17, 4720–4735.
Jackson, B.C., Ivanova, I.A., and Dagnino, L. (2015). An ELMO2-RhoG-ILK network
modulates microtubule dynamics. Mol. Biol. Cell 26, 2712–2725.
Jordens, I., Westbroek, W., Marsman, M., Rocha, N., Mommaas, M., Huizing, M.,
Lambert, J., Naeyaert, J.M., and Neefjes, J. (2006). Rab7 and Rab27a control two motor
protein activities involved in melanosomal transport. Pigment Cell Res. 19, 412–423.
Khaled, M., Larribere, L., Bille, K., Aberdam, E., Ortonne, J.-P., Ballotti, R., and
Bertolotto, C. (2002). Glycogen synthase kinase 3beta is activated by cAMP and plays an
active role in the regulation of melanogenesis. J. Biol. Chem. 277, 33690–33697.

162

Kim, Y.T., Hur, E.-M., Snider, W.D., and Zhou, F.-Q. (2011). Role of GSK3 Signaling in
Neuronal Morphogenesis. Front. Mol. Neurosci. 4.
Marks, M.S., and Seabra, M.C. (2001). The melanosome: membrane dynamics in black
and white. Nat. Rev. Mol. Cell Biol. 2, 738–748.
Nabavi, N., Urukova, Y., Cardelli, M., Aubin, J.E., and Harrison, R.E. (2008). Lysosome
dispersion in osteoblasts accommodates enhanced collagen production during
differentiation. J. Biol. Chem. 283, 19678–19690.
Nakrieko, K.-A., Welch, I., Dupuis, H., Bryce, D., Pajak, A., St. Arnaud, R., Dedhar, S.,
D’Souza, S.J.A., and Dagnino, L. (2008). Impaired hair follicle morphogenesis and
polarized keratinocyte movement upon conditional inactivation of integrin-linked kinase
in the epidermis. Mol. Biol. Cell 19, 1462–1473.
Oberhofer, A., Spieler, P., Rosenfeld, Y., Stepp, W.L., Cleetus, A., Hume, A.N., MuellerPlanitz, F., and Ökten, Z. (2017). Myosin Va’s adaptor protein melanophilin enforces track
selection on the microtubule and actin networks in vitro. Proc. Natl. Acad. Sci. U. S. A.
114, E4714–E4723.
O’Meara, R.W., Michalski, J.-P., Anderson, C., Bhanot, K., Rippstein, P., and Kothary, R.
(2013). Integrin-linked kinase regulates process extension in oligodendrocytes via control
of actin cytoskeletal dynamics. J. Neurosci. 33, 9781–9793.
Robinson, C.L., Evans, R.D., Sivarasa, K., Ramalho, J.S., Briggs, D.A., and Hume, A.N.
(2019). The adaptor protein melanophilin regulates dynamic myosin-Va:cargo interaction
and dendrite development in melanocytes. Mol. Biol. Cell 30, 742–752.
Rui, Y., Myers, K.R., Yu, K., Wise, A., De Blas, A.L., Hartzell, H.C., and Zheng, J.Q.
(2013). Activity-dependent regulation of dendritic growth and maintenance by glycogen
synthase kinase 3β. Nat. Commun. 4, 2628.
Scott, G. (2002). Rac and rho: the story behind melanocyte dendrite formation. Pigment
Cell Res. 15, 322–330.
Tarafder, A.K., Bolasco, G., Correia, M.S., Pereira, F.J.C., Iannone, L., Hume, A.N.,
Kirkpatrick, N., Picardo, M., Torrisi, M.R., Rodrigues, I.P., et al. (2014). Rab11b mediates
melanin transfer between donor melanocytes and acceptor keratinocytes via coupled
exo/endocytosis. J. Invest. Dermatol. 134, 1056–1066.
Watabe, H., Valencia, J.C., Le Pape, E., Yamaguchi, Y., Nakamura, M., Rouzaud, F.,
Hoashi, T., Kawa, Y., Mizoguchi, M., and Hearing, V.J. (2008). Involvement of Dynein
and Spectrin with early melanosome transport and melanosomal protein trafficking. J.
Invest. Dermatol. 128, 162–174.
Wickström, S.A., Lange, A., Hess, M.W., Polleux, J., Spatz, J.P., Krüger, M., Pfaller, K.,
Lambacher, A., Bloch, W., Mann, M., et al. (2010). Integrin-linked kinase controls

163

microtubule dynamics required for plasma membrane targeting of caveolae. Dev. Cell 19,
574–588.
Wu, X., and Hammer, J.A. (2014). Melanosome transfer: it is best to give and receive.
Curr. Opin. Cell Biol. 29, 1–7.

164

Chapter 5

5

Discussion

5.1 Summary
ILK is a scaffold protein that interacts with b1 and b3 integrins, as well as many other
proteins (Widmaier et al., 2012). The importance of ILK in other cell types is well
established, however the role of ILK in melanocytic cells had not been investigated prior
to this work. The goal of my research was to understand how ILK regulates melanocyte
development and cell behavior. To this end, I first established in vivo and cell-based
models to study melanocytes. With these experimental systems in place, I was able to
determine the role of ILK in melanoblast colonization of the skin, and to elucidate the role
of ILK in melanosome trafficking and melanin transfer to keratinocytes.

5.2 Melanocyte models
In chapter 2, I describe the development of a reporter mouse model in which melanocytic
lineage cells are identified through expression of GFP. Tamoxifen administration to these
mice enabled me to 1) target the first wave of migrating melanoblasts, and 2) inactivate the
Ilk gene specifically in melanocytic cells. Genetically engineered mouse models that use
Cre recombinase-mediated targeting of genes in melanocytic cells have been used to study
melanocyte development (Alizadeh et al., 2008; Delmas et al., 2003). To study
melanoblasts in vivo, those mice have been bred with transgenic mice carrying the reporter
gene, lacZ, under the control of the Dct promoter (Li et al., 2011; Lindsay et al., 2011; Ma
et al., 2013; Woodham et al., 2017). In those reporter mice, Cre is constitutively expressed,
and both first- and second-wave melanoblasts are lacZ-positive. Therefore, these models
do not allow for the investigation of first-wave or second-wave melanoblasts,
independently. To the best of my knowledge, the reporter mouse model I have developed
is the only one that selectively labels the first wave of migrating melanoblasts and excludes
melanoblasts formed from Schwann cell precursors. Additionally, my model enables the
inactivation of a target gene that is flanked by loxP sites, specifically in melanocytic cells.
Therefore, it can be used to examine the processes involved in first-wave melanoblast
migration, proliferation and differentiation into pigment-producing melanocytes.
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In Tyr::CreERT2 mice, the mutated estrogen receptor is activated by synthetic tamoxifen
and not endogenous estrogen (Feil et al., 1997). Some studies have reported additional side
effects of tamoxifen, such as acting as a partial agonist for estrogen receptors. However,
estrogen receptors have not been detected in primary melanocytes by either qRT-PCR,
RNA sequencing, or western blot (Natale et al., 2016). Furthermore, for my in vivo
experiments, tamoxifen was administered to both ILK+ and ILKKO embryos, therefore any
potential side effects would be present in mice of both genotypes. To investigate if there
are side effects of tamoxifen in culture, analysis of ILK-expressing cultured melanocytes
treated with 4OHT should be conducted.
In chapter 2, I have also defined conditions to isolate primary melanocytes, and culture
them to ³ 95% purity without the use of feeder layers. Many studies have used melanoma
cells as a model for primary melanocytes. This is likely because of the small contribution
of melanocytes to epidermal cells, and their slow growth, which both contribute to the
difficulty in generating pure melanocyte cultures. However, this approach has important
limitations due to the inherent differences between normal primary melanocytes and
transformed melanoma cells. The culture conditions I defined involve the use of
endothelin-3, which was previously shown to support neural crest cell proliferation and
differentiation (Lahav et al., 1996, 1998). The addition of endothein-3 to the culture
medium provides a novel and simple mechanism to enhance primary melanocyte growth.
Under these conditions, melanocytes grow significantly faster, which greatly improves the
efficiency of purifying melanocyte cultures. By developing effective and reproducible
methods to culture primary melanocytes, scientists have useful tools to help better
understand the processes important in these cells.
Furthermore, I have shown that primary mouse melanocytes exposed to laminin 332 are
highly dendritic, and exhibit an increased migratory capacity compared to cells seeded on
collagen I or without exogenous ECM. This is important because it demonstrates that
melanocytes exhibit differential responses to various ECM substrates. Thus, the specific
type of ECM must be taken into consideration when designing experiments. When studying
the mechanisms that regulate dendrite formation, culture of melanocytes in the presence of
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laminin 332 should be considered. My data provide useful information on morphology and
migration of melanocytes on various ECM substrates, which could be followed with studies
to address the effects of laminin and collagen on gene expression, growth and/or
differentiation.

5.3 ILK and melanoblast colonization of the skin
In chapter 3, I describe the role of ILK in melanoblast colonization of the skin. To this end,
I compared the abundance of ILK+ and ILKKO melanoblasts isolated from littermate
embryos, that were either heterozygous or homozygous for the loxP-flanked Ilk allele,
respectively. Although a lack of gene dosage effects has been observed both in vivo and in
culture in epidermal keratinocytes, this remains to be confirmed in melanocytic cells
(Nakrieko et al., 2008; Sayedyahossein et al., 2016). Using these mice, I demonstrated that
in the absence of ILK, the ability of first-wave melanoblasts to populate the skin is severely
reduced. These defects are likely due to abnormal proliferation, motility and ability of
melanoblasts to interact with their surrounding environment.
My research is the first to demonstrate the importance of ILK in melanocyte development.
Observations in cultured melanocytes, together with the similarities between ILK- and
Rac1-null melanoblasts, suggest that ILK likely modulates melanoblast homing to the skin
through mechanisms that include activation of Rac1. In the absence of either Rac1 or ILK,
melanoblasts do not form long pseudopods normally and exhibit defects in motility (Li et
al., 2011). Loss of ILK and reduced formation of long pseudopods could potentially be due
to defects in Rac1 signalling via Scar/WAVE and Arp2/3 complexes (Li et al., 2011). The
mechanism by which ILK regulates Rac1 activation in melanocytic cells remains
unexplored, although it is possible that ILK forms a complex with ELMO2 and RhoG,
leading to Rac1 activation as shown in epidermal keratinocytes (Jackson et al., 2015).
My work developing a novel method to culture embryonic melanoblasts should provide a
framework to conduct future studies aimed at gaining a deeper understanding of
melanocyte biology. The use of cultured embryonic skin to visualize live melanoblasts has
greatly advanced our understanding of melanoblast behavior, however it requires
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specialized equipment not widely available (Mort et al., 2010, 2014). Furthermore, that
technique allows for imaging of melanoblasts for no longer than 48 hours, and therefore
does not permit the analysis of melanoblast differentiation into melanocytes. For my
studies, I cultured embryonic melanoblasts on ST2 feeder layers, which supported
melanoblast viability for up to 7 days, and allowed their differentiation into pigmentproducing cells. ST2 express collagens and fibroblast growth factors, which likely
contributed to their ability to support melanoblasts in culture (Abdallah et al., 2019). To
the best of my knowledge, my studies are the first to demonstrate the successful culturing
of embryonic melanoblasts, and their transition into melanin-producing cells. Although the
latter cells generated dendrites, produced melanin, and expressed the mature melanocyte
marker Trp1, the extent to which these melanin-producing cells recapitulate mature
melanocytes remains to be addressed. This system now opens exciting doors for scientists
to conduct experiments that were not previously possible, such as single-cell analysis and
whole genome screens of melanoblasts.
It is well known that when melanocytes transform into melanoma cells, they re-activate
molecular pathways that contribute to melanoblast proliferation and melanocyte
development. For example, Kit is essential for melanoblast proliferation and migration,
and activating Kit mutations are found in human melanomas (Slipicevic and Herlyn, 2015).
Therefore, by understanding the pathways that regulate melanocyte development, we can
potentially better understand the transformation of melanocytes into melanoma cells.
Melanoma invasion and progression are linked to increased levels of ILK (Dai et al., 2003).
In addition, overexpression of ILK is inversely correlated to 5-year survival in individuals
with melanoma (Dai et al., 2003). Knockdown of ILK in metastatic melanoma cells results
in reduced cell migration, which is associated with defects in stress fiber formation, cell
spreading and cell adhesion (Wong et al., 2007). However, the functional role of ILK in
melanoma progression and invasion is not fully understood (Lu et al., 2013; Wong et al.,
2007). The ability to culture embryonic melanoblasts could provide useful models to begin
to determine how normal biological processes are hijacked by melanoma cells during
oncogenesis.
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5.4 ILK and melanosome trafficking
In chapter 4, I focused on the role of ILK in melanosome trafficking and transfer of melanin
to epidermal keratinocytes. My results demonstrate that the microtubules in ILK-deficient
melanocytes are altered. As a result, immature melanosomes are dispersed throughout the
cell, and the trafficking of mature melanosomes is abnormal. Further, in the absence of
ILK, melanocytes are defective in their ability to form dendrites, and melanin transfer to
keratinocytes is very inefficient. From the studies presented in chapter 4, I concluded that
ILK is essential to generate normal microtubule networks and for melanosome trafficking
in melanocytes.
Skin pigmentation is an important phenotypic trait for many species, and is critical for
photoprotection (Videira et al., 2013). Prior studies from our laboratory suggest that ILK
is important for skin pigmentation. For example, mice with a keratinocyte-restricted
inactivation of the Ilk gene exhibit hypopigmentation (Judah et al., 2012; Nakrieko et al.,
2008). In ILK-deficient epidermis, there is an increase in the abundance of mRNAs
encoding SOX10, MITF, TYR and TRP1, suggesting that loss of ILK from keratinocytes
does not reduce the ability of normal melanoblasts to colonize the skin (Judah et al., 2012).
However, it remains to be addressed whether the hypopigmented skin is due to defects in
melanin uptake by keratinocytes, given that ILK-deficient keratinocytes exhibit defects in
phagocytosis (Judah et al., 2012; Sayedyahossein et al., 2012). Findings from my research
now suggest a novel function of ILK in normal melanosome trafficking, and transfer of
melanin to epidermal keratinocytes. My studies did not address additional mechanisms
potentially involved in altered melanin exocytosis consequent to loss of ILK. The actin
cytoskeleton plays essential roles in melanin transfer from melanocytes to keratinocytes
(Wäster et al., 2016). Given the established role of ILK in actin cytoskeletal organization
(Nakrieko et al., 2008), it is possible that the observed reduction in melanin transfer is also
due, at least in part, to actin abnormalities in the absence of ILK.
Melanin synthesis is a complex process, and when disturbed can cause hyper- or
hypopigmentation (Fistarol and Itin, 2010). Many pigmentation disorders have an
enormous negative impact on the quality of life of affected individuals, and treatments are
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often unsatisfactory (Videira et al., 2013). As a result, the pharmaceutical and cosmetic
industries have aimed at developing more effective therapies. Treatments that inhibit
melanin transfer have emerged as a potential alternative to current depigmentation
therapies and skin lightening agents (Ebanks et al., 2009). To transfer melanin efficiently,
melanocytes must form dendrites and extend them towards neighboring keratinocytes. The
small GTPases Rac and Rho are important regulators of dendrites, by regulating their
extension and retraction, respectively (Scott, 2002). Treatment of melanocyte-keratinocyte
co-cultures with methylophiopogonanone B (MOPB), a Rho activator, causes dendrite
retraction and inhibits melanin transfer (Ito et al., 2006). Therefore, MOPB can potentially
be used to treat hyperpigmented skin. Similar to Rac and Rho, my research has now
identified ILK as a key regulator of dendrite formation and melanin transfer. Thus, ILK
could also potentially be used as a therapeutic target for pigmentation disorders. For
example, topical applications of a formulation consisting of ILK modulators may be used
to alter dendricity and melanin transfer. Given the accessibility of the skin, delivery of a
variety of small and larger molecules into the epidermis is attainable (Zaid Alkilani et al.,
2015).
Exposure to UV-radiation has important health implications as almost everyone is exposed
to it on a daily basis (de Jager et al., 2017). When reactive oxidant species (ROS) generated
by UV-radiation exceeds the body’s defense mechanisms, oxidative stress can lead to tissue
damage and cell death (de Jager et al., 2017). An important function of melanin is to
scavenge ROS (Tada et al., 2010). As demonstrated in chapter 4, keratinocytes co-cultured
with ILK-deficient melanocytes take up significantly less melanin. Whether these
keratinocytes are more susceptible to UVB-induced damage or to oxidative stress remains
an important topic for future research.
Collectively, my data provide two key overall contributions to the melanocyte biology
field. The first is the development of both in vivo and cell-based models to study embryonic
melanoblasts and postnatal melanocytes. The reporter mouse model I developed can be
used for lineage tracing experiments to better examine melanoblast behavior during
development. The method I established for culturing embryonic melanoblasts can allow
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for investigation of the cellular and molecular mechanisms that regulate melanoblast
migration, proliferation and survival. In addition, the primary melanocyte culture system I
characterized can be used for in vitro gene expression studies and biological assays. The
second overall contribution I have made to the field is the identification of ILK as a key
regulator of melanoblasts during development and of postnatal melanocyte behavior.

5.5 Future directions
The data presented demonstrate the importance of ILK in first-wave melanoblast
colonization of the skin. However, because tamoxifen administration in our model did not
label melanocytes that arise from Schwann cell precursors, it did not allow us to investigate
if ILK is necessary for overall hair pigmentation. Tamoxifen administration to our mice at
E15.5, just after the second wave of melanoblast formation, might allow us to address this
question. Alternatively, the use of a transgenic line that expresses Cre under the control of
the Tyr promoter (Tyr-Cre;Ilkf/f mice), in which deletion of the Ilk gene would occur in
both first- and second-wave melanoblasts could help address the overall role of ILK in all
cutaneous melanocytic cell types.
As mentioned in section 3.3.1, between E17.5 and E20.5 there is a substantial reduction in
the number of targeted melanoblasts in the interfollicular epidermis. It is possible that the
observed loss of melanoblasts between E17.5 and E20.5 may be due to apoptosis, which
would suggest ILK is important for the maintenance of melanoblast populations in vivo.
Analysis of melanoblasts isolated from E17.5 and E20.5 skin by Annexin-V would address
this question.
A key next step for future study would include examining the role of ILK in melanocyte
stem cells. Melanocyte stem cell biology is a newly developing field that remains poorly
understood (Lang et al., 2013; Li, 2014). Understanding the molecular mechanisms that
regulate melanocyte stem cells can greatly impact regenerative medicine, as well as cancer
and anti-aging therapies (Li, 2014). Melanocyte stem cells in the lower permanent portion
of mouse hair follicles can be isolated by FACS based on low levels of Kit and low side
scatter profiles (Lin and Chuong, 2011). Isolation of melanocyte stem cells from my
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reporter mouse model could provide valuable information of the role of ILK in
proliferation, migration and differentiation of melanocyte stems cells.
There is currently no information on the role of ILK in cell-cell adhesion between
melanocytes and keratinocytes. E-cadherin mediates adhesion of normal melanocytes to
keratinocytes (Tang et al., 1994). Conversely, during melanoma metastasis transformed
melanocytes displayed reduced levels of E-cadherin and exhibit a decreased affinity for
keratinocytes (Tang et al., 1994). Given that ILK regulates the delivery of E-cadherin from
recycling endosomes to the plasma membrane, and formation of adherens junctions in
keratinocytes (Ho et al., 2016), an important area of future research will be to understand
the role of ILK in melanocyte-keratinocyte cell-cell adhesion. Analysis of E-cadherin
distribution in co-cultures of keratinocytes with ILK-expressing and -deficient
melanocytes would be a first step to address this aspect.
The capacity of melanocytes to transfer melanin to keratinocytes is greatly reduced in the
absence of ILK, likely through mechanisms that involve abnormalities in microtubule
dynamics, melanosome movement, and melanophilin distribution contribute to these
deficits. An additional possible mechanism may involve the actin cytoskeleton. Labeling
of F-actin with phalloidin in ILK-deficient and -expressing melanocytes, and visualization
of the actin cytoskeleton by fluorescence microscopy could help to address this. Exploring
the role of ILK in organization of the actin cytoskeleton in melanocytes will potentially
allow deeper understanding of processes involved in tethering of melanosomes to actin
filaments and melanin exocytosis.
Finally, to complement my co-culture studies, melanin transfer from ILK-deficient
melanocytes to keratinocytes could also be analyzed in vivo. Analysis of skin sections from
Tyr-Cre;Ilkf/f mice, in which deletion of the Ilk gene would occur in all melanoblasts, and
the quantification of melanin within keratinocytes by transmission electron microscopy,
may provide useful information on this topic.
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In conclusion, the data presented in my thesis have shed light on several important
regulatory functions of ILK in melanocytic lineage cells. In addition, I have contributed to
the skin biology field by developing elegant and efficient new tools to investigate the
mechanisms that regulate melanocytic cell behaviour, and to decipher how alterations in
these cells may contribute to neurocristopathies and pigmentation disorders.
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Appendix 1

Area occupied by
melanin in pixels/cell
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Effect of GSK-3 inhibition on melanin transfer to keratinocytes.
Epidermal melanocytes were isolated from 3-day-old TyrCreERT2;mT/mG;Ilkf/f mice and
cultured to passage 2-3. Epidermal keratinocytes (KT) were isolated from 3-day-old
TyrCreERT2;mT/mG;Ilkf/f mice and cultured for 3-4 days. Melanocytes were treated with
1 µM 4-hydroxytamoxifen (4OHT) or control vehicle (0.25% ethanol, EtOH) for 48 h. (A)
On day 4, melanocytes were treated with 0.1% DMSO (V) or 5 µM of SB216763 (SB) for
24 h followed by co-culture in melanocyte medium, or the inhibitor was also added for the
duration of the co-culture experiment (total 32 h). ILK+ and ILKKO melanocytes were
added to keratinocytes at a ratio of 1:6 and the area occupied by melanin in pixels/cell was
determined. The results are expressed as the mean (30 keratinocytes scored).
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